id	sid	tid	token	lemma	pos
hls-11323	1	1	hrev_master	hrev_master	NOUN
hls-11323	1	2	healthcare	healthcare	NOUN
hls-11323	1	3	in	in	ADP
hls-11323	1	4	low	low	ADJ
hls-11323	1	5	-	-	PUNCT
hls-11323	1	6	resource	resource	NOUN
hls-11323	1	7	settings	setting	NOUN
hls-11323	1	8	2023	2023	NUM
hls-11323	1	9	;	;	PUNCT
hls-11323	1	10	volume	volume	NOUN
hls-11323	1	11	11(s2):11323	11(s2):11323	NUM
hls-11323	1	12	value	value	NOUN
hls-11323	1	13	of	of	ADP
hls-11323	1	14	biochemical	biochemical	ADJ
hls-11323	1	15	markers	marker	NOUN
hls-11323	1	16	in	in	ADP
hls-11323	1	17	predicting	predict	VERB
hls-11323	1	18	outcome	outcome	NOUN
hls-11323	1	19	of	of	ADP
hls-11323	1	20	covid-19	covid-19	PROPN
hls-11323	1	21	infection	infection	NOUN
hls-11323	1	22	in	in	ADP
hls-11323	1	23	university	university	NOUN
hls-11323	1	24	hospital	hospital	NOUN
hls-11323	1	25	,	,	PUNCT
hls-11323	1	26	alexandria	alexandria	PROPN
hls-11323	1	27	,	,	PUNCT
hls-11323	1	28	egypt	egypt	PROPN
hls-11323	1	29	neveen	neveen	PROPN
hls-11323	1	30	rashad	rashad	VERB
hls-11323	1	31	mostafa,1	mostafa,1	NOUN
hls-11323	1	32	abeer	abeer	PROPN
hls-11323	1	33	ahmed	ahmed	PROPN
hls-11323	1	34	mohamed	mohamed	PROPN
hls-11323	1	35	ali,2	ali,2	PROPN
hls-11323	1	36	rehab	rehab	PROPN
hls-11323	1	37	moustafa	moustafa	PROPN
hls-11323	1	38	ezzat,3	ezzat,3	PROPN
hls-11323	1	39	mostafa	mostafa	PROPN
hls-11323	1	40	kamel	kamel	PROPN
hls-11323	1	41	bakry,4	bakry,4	PROPN
hls-11323	1	42	roy	roy	PROPN
hls-11323	1	43	rillera	rillera	PROPN
hls-11323	1	44	marzo5,6	marzo5,6	PROPN
hls-11323	1	45	1department	1department	NUM
hls-11323	1	46	of	of	ADP
hls-11323	1	47	internal	internal	ADJ
hls-11323	1	48	medicine	medicine	NOUN
hls-11323	1	49	;	;	PUNCT
hls-11323	1	50	2department	2department	NUM
hls-11323	1	51	of	of	ADP
hls-11323	1	52	chemical	chemical	ADJ
hls-11323	1	53	pathology	pathology	PROPN
hls-11323	1	54	,	,	PUNCT
hls-11323	1	55	medical	medical	PROPN
hls-11323	1	56	research	research	PROPN
hls-11323	1	57	institute	institute	PROPN
hls-11323	1	58	,	,	PUNCT
hls-11323	1	59	alexandria	alexandria	PROPN
hls-11323	1	60	university	university	PROPN
hls-11323	1	61	;	;	PUNCT
hls-11323	1	62	3department	3department	NUM
hls-11323	1	63	of	of	ADP
hls-11323	1	64	pulmonology	pulmonology	NOUN
hls-11323	1	65	,	,	PUNCT
hls-11323	1	66	alexandria	alexandria	PROPN
hls-11323	1	67	student	student	PROPN
hls-11323	1	68	university	university	PROPN
hls-11323	1	69	hospital	hospital	NOUN
hls-11323	1	70	,	,	PUNCT
hls-11323	1	71	alexandria	alexandria	PROPN
hls-11323	1	72	university	university	PROPN
hls-11323	1	73	;	;	PUNCT
hls-11323	1	74	4department	4department	NUM
hls-11323	1	75	of	of	ADP
hls-11323	1	76	ent	ent	PROPN
hls-11323	1	77	,	,	PUNCT
hls-11323	1	78	alexandria	alexandria	PROPN
hls-11323	1	79	student	student	PROPN
hls-11323	1	80	university	university	PROPN
hls-11323	1	81	hospital	hospital	NOUN
hls-11323	1	82	,	,	PUNCT
hls-11323	1	83	alexandria	alexandria	PROPN
hls-11323	1	84	university	university	PROPN
hls-11323	1	85	,	,	PUNCT
hls-11323	1	86	egypt	egypt	PROPN
hls-11323	1	87	;	;	PUNCT
hls-11323	2	1	5department	5department	NUM
hls-11323	2	2	of	of	ADP
hls-11323	2	3	community	community	NOUN
hls-11323	2	4	medicine	medicine	NOUN
hls-11323	2	5	,	,	PUNCT
hls-11323	2	6	international	international	ADJ
hls-11323	2	7	medical	medical	ADJ
hls-11323	2	8	school	school	NOUN
hls-11323	2	9	,	,	PUNCT
hls-11323	2	10	management	management	NOUN
hls-11323	2	11	and	and	CCONJ
hls-11323	2	12	science	science	NOUN
hls-11323	2	13	university	university	PROPN
hls-11323	2	14	,	,	PUNCT
hls-11323	2	15	shah	shah	PROPN
hls-11323	2	16	alam	alam	PROPN
hls-11323	2	17	;	;	PUNCT
hls-11323	2	18	6global	6global	NUM
hls-11323	2	19	public	public	ADJ
hls-11323	2	20	health	health	NOUN
hls-11323	2	21	,	,	PUNCT
hls-11323	2	22	jeffrey	jeffrey	PROPN
hls-11323	2	23	cheah	cheah	PROPN
hls-11323	2	24	school	school	PROPN
hls-11323	2	25	of	of	ADP
hls-11323	2	26	medicine	medicine	NOUN
hls-11323	2	27	and	and	CCONJ
hls-11323	2	28	health	health	NOUN
hls-11323	2	29	sciences	sciences	PROPN
hls-11323	2	30	,	,	PUNCT
hls-11323	2	31	monash	monash	PROPN
hls-11323	2	32	university	university	PROPN
hls-11323	2	33	malaysia	malaysia	PROPN
hls-11323	2	34	,	,	PUNCT
hls-11323	2	35	kuala	kuala	PROPN
hls-11323	2	36	lumpur	lumpur	PROPN
hls-11323	2	37	,	,	PUNCT
hls-11323	2	38	malaysia	malaysia	PROPN
hls-11323	2	39	abstract	abstract	NOUN
hls-11323	2	40	this	this	DET
hls-11323	2	41	paper	paper	NOUN
hls-11323	2	42	aims	aim	VERB
hls-11323	2	43	to	to	PART
hls-11323	2	44	examine	examine	VERB
hls-11323	2	45	the	the	DET
hls-11323	2	46	value	value	NOUN
hls-11323	2	47	of	of	ADP
hls-11323	2	48	different	different	ADJ
hls-11323	2	49	biochemical	biochemical	ADJ
hls-11323	2	50	markers	marker	NOUN
hls-11323	2	51	in	in	ADP
hls-11323	2	52	predicting	predict	VERB
hls-11323	2	53	the	the	DET
hls-11323	2	54	outcome	outcome	NOUN
hls-11323	2	55	of	of	ADP
hls-11323	2	56	covid-19	covid-19	PROPN
hls-11323	2	57	infection	infection	NOUN
hls-11323	2	58	.	.	PUNCT
hls-11323	3	1	a	a	DET
hls-11323	3	2	total	total	NOUN
hls-11323	3	3	of	of	ADP
hls-11323	3	4	140	140	NUM
hls-11323	3	5	patients	patient	NOUN
hls-11323	3	6	with	with	ADP
hls-11323	3	7	confirmed	confirm	VERB
hls-11323	3	8	covid-19	covid-19	PROPN
hls-11323	3	9	infection	infection	NOUN
hls-11323	3	10	by	by	ADP
hls-11323	3	11	polymerase	polymerase	NOUN
hls-11323	3	12	chain	chain	NOUN
hls-11323	3	13	reaction	reaction	NOUN
hls-11323	3	14	(	(	PUNCT
hls-11323	3	15	pcr	pcr	PROPN
hls-11323	3	16	)	)	PUNCT
hls-11323	3	17	,	,	PUNCT
hls-11323	3	18	different	different	ADJ
hls-11323	3	19	biochemical	biochemical	ADJ
hls-11323	3	20	markers	marker	NOUN
hls-11323	3	21	were	be	AUX
hls-11323	3	22	tested	test	VERB
hls-11323	3	23	,	,	PUNCT
hls-11323	3	24	their	their	PRON
hls-11323	3	25	relation	relation	NOUN
hls-11323	3	26	to	to	ADP
hls-11323	3	27	the	the	DET
hls-11323	3	28	outcome	outcome	NOUN
hls-11323	3	29	of	of	ADP
hls-11323	3	30	the	the	DET
hls-11323	3	31	disease	disease	NOUN
hls-11323	3	32	was	be	AUX
hls-11323	3	33	monitored	monitor	VERB
hls-11323	3	34	,	,	PUNCT
hls-11323	3	35	and	and	CCONJ
hls-11323	3	36	the	the	DET
hls-11323	3	37	most	most	ADV
hls-11323	3	38	reliable	reliable	ADJ
hls-11323	3	39	tests	test	NOUN
hls-11323	3	40	were	be	AUX
hls-11323	3	41	determined	determine	VERB
hls-11323	3	42	.	.	PUNCT
hls-11323	4	1	the	the	DET
hls-11323	4	2	study	study	NOUN
hls-11323	4	3	found	find	VERB
hls-11323	4	4	a	a	DET
hls-11323	4	5	significant	significant	ADJ
hls-11323	4	6	correlation	correlation	NOUN
hls-11323	4	7	between	between	ADP
hls-11323	4	8	all	all	DET
hls-11323	4	9	evaluated	evaluate	VERB
hls-11323	4	10	biochemical	biochemical	ADJ
hls-11323	4	11	markers	marker	NOUN
hls-11323	4	12	and	and	CCONJ
hls-11323	4	13	severity	severity	NOUN
hls-11323	4	14	of	of	ADP
hls-11323	4	15	the	the	DET
hls-11323	4	16	disease	disease	NOUN
hls-11323	4	17	,	,	PUNCT
hls-11323	4	18	including	include	VERB
hls-11323	4	19	c	c	NOUN
hls-11323	4	20	-	-	PUNCT
hls-11323	4	21	reactive	reactive	ADJ
hls-11323	4	22	protein	protein	NOUN
hls-11323	4	23	(	(	PUNCT
hls-11323	4	24	crp	crp	PROPN
hls-11323	4	25	)	)	PUNCT
hls-11323	4	26	,	,	PUNCT
hls-11323	4	27	d	d	X
hls-11323	4	28	-	-	PUNCT
hls-11323	4	29	dimer	dimer	ADJ
hls-11323	4	30	,	,	PUNCT
hls-11323	4	31	alanine	alanine	NOUN
hls-11323	4	32	aminotransferase	aminotransferase	NOUN
hls-11323	4	33	(	(	PUNCT
hls-11323	4	34	alt	alt	PROPN
hls-11323	4	35	)	)	PUNCT
hls-11323	4	36	,	,	PUNCT
hls-11323	4	37	aspartate	aspartate	NOUN
hls-11323	4	38	aminotransferase	aminotransferase	NOUN
hls-11323	4	39	(	(	PUNCT
hls-11323	4	40	ast	ast	PROPN
hls-11323	4	41	)	)	PUNCT
hls-11323	4	42	,	,	PUNCT
hls-11323	4	43	prothrombin	prothrombin	NOUN
hls-11323	4	44	time	time	NOUN
hls-11323	4	45	(	(	PUNCT
hls-11323	4	46	pt	pt	NOUN
hls-11323	4	47	)	)	PUNCT
hls-11323	4	48	,	,	PUNCT
hls-11323	4	49	activated	activate	VERB
hls-11323	4	50	partial	partial	ADJ
hls-11323	4	51	thromboplastin	thromboplastin	NOUN
hls-11323	4	52	time	time	NOUN
hls-11323	4	53	(	(	PUNCT
hls-11323	4	54	aptt	aptt	ADJ
hls-11323	4	55	)	)	PUNCT
hls-11323	4	56	.	.	PUNCT
hls-11323	5	1	in	in	ADP
hls-11323	5	2	addition	addition	NOUN
hls-11323	5	3	,	,	PUNCT
hls-11323	5	4	ferritin	ferritin	ADJ
hls-11323	5	5	,	,	PUNCT
hls-11323	5	6	lactate	lactate	NOUN
hls-11323	5	7	dehydrogenase	dehydrogenase	NOUN
hls-11323	5	8	(	(	PUNCT
hls-11323	5	9	ldh	ldh	PROPN
hls-11323	5	10	)	)	PUNCT
hls-11323	5	11	,	,	PUNCT
hls-11323	5	12	procalcitonin	procalcitonin	ADJ
hls-11323	5	13	(	(	PUNCT
hls-11323	5	14	pct	pct	NOUN
hls-11323	5	15	)	)	PUNCT
hls-11323	5	16	and	and	CCONJ
hls-11323	5	17	probrain	probrain	VERB
hls-11323	5	18	natriuretic	natriuretic	ADJ
hls-11323	5	19	peptide	peptide	NOUN
hls-11323	5	20	(	(	PUNCT
hls-11323	5	21	probnp	probnp	NOUN
hls-11323	5	22	)	)	PUNCT
hls-11323	5	23	demonstrated	demonstrate	VERB
hls-11323	5	24	highly	highly	ADV
hls-11323	5	25	sensitivity	sensitivity	NOUN
hls-11323	5	26	and	and	CCONJ
hls-11323	5	27	specificity	specificity	NOUN
hls-11323	5	28	as	as	ADV
hls-11323	5	29	well	well	ADV
hls-11323	5	30	as	as	ADP
hls-11323	5	31	significant	significant	ADJ
hls-11323	5	32	prognostic	prognostic	ADJ
hls-11323	5	33	performance	performance	NOUN
hls-11323	5	34	.	.	PUNCT
hls-11323	6	1	these	these	DET
hls-11323	6	2	markers	marker	NOUN
hls-11323	6	3	were	be	AUX
hls-11323	6	4	also	also	ADV
hls-11323	6	5	independently	independently	ADV
hls-11323	6	6	significant	significant	ADJ
hls-11323	6	7	in	in	ADP
hls-11323	6	8	predicting	predict	VERB
hls-11323	6	9	mortality	mortality	NOUN
hls-11323	6	10	.	.	PUNCT
hls-11323	7	1	early	early	ADJ
hls-11323	7	2	assessment	assessment	NOUN
hls-11323	7	3	of	of	ADP
hls-11323	7	4	biochemical	biochemical	ADJ
hls-11323	7	5	markers	marker	NOUN
hls-11323	7	6	in	in	ADP
hls-11323	7	7	patients	patient	NOUN
hls-11323	7	8	with	with	ADP
hls-11323	7	9	covid-19	covid-19	PROPN
hls-11323	7	10	can	can	AUX
hls-11323	7	11	help	help	VERB
hls-11323	7	12	clinicians	clinician	NOUN
hls-11323	7	13	in	in	ADP
hls-11323	7	14	tailoring	tailor	VERB
hls-11323	7	15	treatment	treatment	NOUN
hls-11323	7	16	and	and	CCONJ
hls-11323	7	17	providing	provide	VERB
hls-11323	7	18	more	more	ADV
hls-11323	7	19	intensive	intensive	ADJ
hls-11323	7	20	care	care	NOUN
hls-11323	7	21	to	to	ADP
hls-11323	7	22	those	those	PRON
hls-11323	7	23	with	with	ADP
hls-11323	7	24	greater	great	ADJ
hls-11323	7	25	mortality	mortality	NOUN
hls-11323	7	26	risk	risk	NOUN
hls-11323	7	27	.	.	PUNCT
hls-11323	8	1	in	in	ADP
hls-11323	8	2	particular	particular	ADJ
hls-11323	8	3	,	,	PUNCT
hls-11323	8	4	the	the	DET
hls-11323	8	5	assessment	assessment	NOUN
hls-11323	8	6	of	of	ADP
hls-11323	8	7	ferritin	ferritin	PROPN
hls-11323	8	8	,	,	PUNCT
hls-11323	8	9	ldh	ldh	PROPN
hls-11323	8	10	,	,	PUNCT
hls-11323	8	11	procalcitonin	procalcitonin	ADJ
hls-11323	8	12	and	and	CCONJ
hls-11323	8	13	probnp	probnp	NOUN
hls-11323	8	14	can	can	AUX
hls-11323	8	15	independently	independently	ADV
hls-11323	8	16	predict	predict	VERB
hls-11323	8	17	mortality	mortality	NOUN
hls-11323	8	18	.	.	PUNCT
hls-11323	9	1	introduction	introduction	NOUN
hls-11323	9	2	in	in	ADP
hls-11323	9	3	late	late	ADJ
hls-11323	9	4	2019	2019	NUM
hls-11323	9	5	,	,	PUNCT
hls-11323	9	6	an	an	DET
hls-11323	9	7	outbreak	outbreak	NOUN
hls-11323	9	8	of	of	ADP
hls-11323	9	9	atypical	atypical	ADJ
hls-11323	9	10	pneumonia	pneumonia	NOUN
hls-11323	9	11	cases	case	NOUN
hls-11323	9	12	emerged	emerge	VERB
hls-11323	9	13	in	in	ADP
hls-11323	9	14	wuhan	wuhan	PROPN
hls-11323	9	15	,	,	PUNCT
hls-11323	9	16	hubei	hubei	PROPN
hls-11323	9	17	province	province	PROPN
hls-11323	9	18	,	,	PUNCT
hls-11323	9	19	china	china	PROPN
hls-11323	9	20	,	,	PUNCT
hls-11323	9	21	and	and	CCONJ
hls-11323	9	22	sars	sars	PROPN
hls-11323	9	23	-	-	PUNCT
hls-11323	9	24	cov2	cov2	PROPN
hls-11323	9	25	was	be	AUX
hls-11323	9	26	identified	identify	VERB
hls-11323	9	27	as	as	ADP
hls-11323	9	28	the	the	DET
hls-11323	9	29	causative	causative	ADJ
hls-11323	9	30	organism	organism	NOUN
hls-11323	9	31	.	.	PUNCT
hls-11323	10	1	this	this	DET
hls-11323	10	2	atypical	atypical	ADJ
hls-11323	10	3	pneumonia	pneumonia	NOUN
hls-11323	10	4	was	be	AUX
hls-11323	10	5	called	call	VERB
hls-11323	10	6	corona	corona	PROPN
hls-11323	10	7	virus	virus	NOUN
hls-11323	10	8	disease	disease	NOUN
hls-11323	10	9	2019	2019	NUM
hls-11323	10	10	(	(	PUNCT
hls-11323	10	11	covid-19	covid-19	PROPN
hls-11323	10	12	)	)	PUNCT
hls-11323	10	13	,	,	PUNCT
hls-11323	10	14	with	with	ADP
hls-11323	10	15	the	the	DET
hls-11323	10	16	primary	primary	ADJ
hls-11323	10	17	target	target	NOUN
hls-11323	10	18	of	of	ADP
hls-11323	10	19	the	the	DET
hls-11323	10	20	virus	virus	NOUN
hls-11323	10	21	being	be	AUX
hls-11323	10	22	the	the	DET
hls-11323	10	23	lung	lung	NOUN
hls-11323	10	24	,	,	PUNCT
hls-11323	10	25	although	although	SCONJ
hls-11323	10	26	it	it	PRON
hls-11323	10	27	can	can	AUX
hls-11323	10	28	infect	infect	VERB
hls-11323	10	29	other	other	ADJ
hls-11323	10	30	organs	organ	NOUN
hls-11323	10	31	that	that	PRON
hls-11323	10	32	express	express	VERB
hls-11323	10	33	angiotensin	angiotensin	NOUN
hls-11323	10	34	converting	convert	VERB
hls-11323	10	35	enzyme	enzyme	NOUN
hls-11323	10	36	2	2	NUM
hls-11323	10	37	receptors	receptor	NOUN
hls-11323	10	38	(	(	PUNCT
hls-11323	10	39	ace2).1	ace2).1	PROPN
hls-11323	10	40	sars	sar	NOUN
hls-11323	10	41	-	-	PUNCT
hls-11323	10	42	cov-2	cov-2	PART
hls-11323	10	43	is	be	AUX
hls-11323	10	44	a	a	DET
hls-11323	10	45	single	single	ADJ
hls-11323	10	46	stranded	strand	VERB
hls-11323	10	47	rna	rna	NOUN
hls-11323	10	48	virus	virus	NOUN
hls-11323	10	49	,	,	PUNCT
hls-11323	10	50	belonging	belong	VERB
hls-11323	10	51	to	to	ADP
hls-11323	10	52	coronaviridae	coronaviridae	NOUN
hls-11323	10	53	family	family	NOUN
hls-11323	10	54	,	,	PUNCT
hls-11323	10	55	and	and	CCONJ
hls-11323	10	56	has	have	VERB
hls-11323	10	57	a	a	DET
hls-11323	10	58	characteristic	characteristic	ADJ
hls-11323	10	59	corona	corona	NOUN
hls-11323	10	60	when	when	SCONJ
hls-11323	10	61	viewed	view	VERB
hls-11323	10	62	under	under	ADP
hls-11323	10	63	and	and	CCONJ
hls-11323	10	64	electron	electron	NOUN
hls-11323	10	65	microscope	microscope	NOUN
hls-11323	10	66	due	due	ADP
hls-11323	10	67	to	to	ADP
hls-11323	10	68	its	its	PRON
hls-11323	10	69	spike	spike	NOUN
hls-11323	10	70	like	like	ADP
hls-11323	10	71	surface	surface	NOUN
hls-11323	10	72	glycoproteins	glycoprotein	NOUN
hls-11323	10	73	,	,	PUNCT
hls-11323	10	74	which	which	PRON
hls-11323	10	75	attach	attach	VERB
hls-11323	10	76	to	to	PART
hls-11323	10	77	target	target	VERB
hls-11323	10	78	cell	cell	NOUN
hls-11323	10	79	receptors	receptor	NOUN
hls-11323	10	80	in	in	ADP
hls-11323	10	81	the	the	DET
hls-11323	10	82	host.1	host.1	PROPN
hls-11323	10	83	the	the	DET
hls-11323	10	84	world	world	PROPN
hls-11323	10	85	health	health	NOUN
hls-11323	10	86	organization	organization	NOUN
hls-11323	10	87	(	(	PUNCT
hls-11323	10	88	who	who	PRON
hls-11323	10	89	)	)	PUNCT
hls-11323	10	90	has	have	AUX
hls-11323	10	91	classified	classify	VERB
hls-11323	10	92	covid-19	covid-19	PROPN
hls-11323	10	93	patients	patient	NOUN
hls-11323	10	94	into	into	ADP
hls-11323	10	95	four	four	NUM
hls-11323	10	96	categories	category	NOUN
hls-11323	10	97	:	:	PUNCT
hls-11323	10	98	ordinary	ordinary	ADJ
hls-11323	10	99	,	,	PUNCT
hls-11323	10	100	mild	mild	ADJ
hls-11323	10	101	,	,	PUNCT
hls-11323	10	102	severe	severe	ADJ
hls-11323	10	103	and	and	CCONJ
hls-11323	10	104	critically	critically	ADV
hls-11323	10	105	ill	ill	ADJ
hls-11323	10	106	types	type	NOUN
hls-11323	10	107	.	.	PUNCT
hls-11323	11	1	patient	patient	NOUN
hls-11323	11	2	may	may	AUX
hls-11323	11	3	progress	progress	VERB
hls-11323	11	4	from	from	ADP
hls-11323	11	5	one	one	NUM
hls-11323	11	6	category	category	NOUN
hls-11323	11	7	to	to	ADP
hls-11323	11	8	another	another	PRON
hls-11323	11	9	within	within	ADP
hls-11323	11	10	7	7	NUM
hls-11323	11	11	-	-	SYM
hls-11323	11	12	10	10	NUM
hls-11323	11	13	days	day	NOUN
hls-11323	11	14	,	,	PUNCT
hls-11323	11	15	particularly	particularly	ADV
hls-11323	11	16	if	if	SCONJ
hls-11323	11	17	the	the	DET
hls-11323	11	18	virus	virus	NOUN
hls-11323	11	19	replicates	replicate	VERB
hls-11323	11	20	rapidly	rapidly	ADV
hls-11323	11	21	and	and	CCONJ
hls-11323	11	22	causes	cause	VERB
hls-11323	11	23	a	a	DET
hls-11323	11	24	cytokine	cytokine	NOUN
hls-11323	11	25	storm.2	storm.2	VERB
hls-11323	11	26	clinical	clinical	ADJ
hls-11323	11	27	presentation	presentation	NOUN
hls-11323	11	28	of	of	ADP
hls-11323	11	29	covid-19	covid-19	PROPN
hls-11323	11	30	includes	include	VERB
hls-11323	11	31	fever	fever	NOUN
hls-11323	11	32	,	,	PUNCT
hls-11323	11	33	cough	cough	NOUN
hls-11323	11	34	,	,	PUNCT
hls-11323	11	35	muscle	muscle	NOUN
hls-11323	11	36	pain	pain	NOUN
hls-11323	11	37	and	and	CCONJ
hls-11323	11	38	fatigue	fatigue	NOUN
hls-11323	11	39	,	,	PUNCT
hls-11323	11	40	with	with	SCONJ
hls-11323	11	41	the	the	DET
hls-11323	11	42	patient	patient	NOUN
hls-11323	11	43	may	may	AUX
hls-11323	11	44	also	also	ADV
hls-11323	11	45	show	show	VERB
hls-11323	11	46	additional	additional	ADJ
hls-11323	11	47	symptoms	symptom	NOUN
hls-11323	11	48	such	such	ADJ
hls-11323	11	49	as	as	ADP
hls-11323	11	50	olfactory	olfactory	NOUN
hls-11323	11	51	and	and	CCONJ
hls-11323	11	52	gustatory	gustatory	ADJ
hls-11323	11	53	dysfunction	dysfunction	NOUN
hls-11323	11	54	.	.	PUNCT
hls-11323	12	1	progression	progression	NOUN
hls-11323	12	2	to	to	ADP
hls-11323	12	3	severe	severe	ADJ
hls-11323	12	4	disease	disease	NOUN
hls-11323	12	5	may	may	AUX
hls-11323	12	6	be	be	AUX
hls-11323	12	7	affected	affect	VERB
hls-11323	12	8	by	by	ADP
hls-11323	12	9	comorbidities	comorbiditie	NOUN
hls-11323	12	10	of	of	ADP
hls-11323	12	11	the	the	DET
hls-11323	12	12	patient	patient	NOUN
hls-11323	12	13	such	such	ADJ
hls-11323	12	14	as	as	ADP
hls-11323	12	15	diabetes	diabetes	NOUN
hls-11323	12	16	mellitus	mellitus	NOUN
hls-11323	12	17	,	,	PUNCT
hls-11323	12	18	dyslipidemia	dyslipidemia	NOUN
hls-11323	12	19	,	,	PUNCT
hls-11323	12	20	pulmonary	pulmonary	ADJ
hls-11323	12	21	disease	disease	NOUN
hls-11323	12	22	,	,	PUNCT
hls-11323	12	23	and	and	CCONJ
hls-11323	12	24	cardiovascular	cardiovascular	ADJ
hls-11323	12	25	disorders	disorder	NOUN
hls-11323	12	26	;	;	PUNCT
hls-11323	12	27	therefore	therefore	ADV
hls-11323	12	28	,	,	PUNCT
hls-11323	12	29	good	good	ADJ
hls-11323	12	30	history	history	NOUN
hls-11323	12	31	taking	take	VERB
hls-11323	12	32	correspondence	correspondence	NOUN
hls-11323	12	33	:	:	PUNCT
hls-11323	12	34	neveen	neveen	PROPN
hls-11323	12	35	rashad	rashad	PROPN
hls-11323	12	36	mostafa	mostafa	PROPN
hls-11323	12	37	,	,	PUNCT
hls-11323	12	38	associate	associate	ADJ
hls-11323	12	39	professodepartment	professodepartment	NOUN
hls-11323	12	40	of	of	ADP
hls-11323	12	41	internal	internal	ADJ
hls-11323	12	42	medicine	medicine	NOUN
hls-11323	12	43	,	,	PUNCT
hls-11323	12	44	medical	medical	ADJ
hls-11323	12	45	research	research	PROPN
hls-11323	12	46	institute	institute	PROPN
hls-11323	12	47	,	,	PUNCT
hls-11323	12	48	alexandria	alexandria	PROPN
hls-11323	12	49	university	university	PROPN
hls-11323	12	50	,	,	PUNCT
hls-11323	12	51	egypt	egypt	PROPN
hls-11323	12	52	.	.	PUNCT
hls-11323	13	1	tel	tel	PROPN
hls-11323	13	2	.	.	PUNCT
hls-11323	13	3	:	:	PUNCT
hls-11323	14	1	+20.01557709789	+20.01557709789	X
hls-11323	14	2	.	.	PUNCT
hls-11323	15	1	e	e	X
hls-11323	15	2	-	-	NOUN
hls-11323	15	3	mail	mail	NOUN
hls-11323	15	4	:	:	PUNCT
hls-11323	15	5	doctor.aj.2000@gmail.com	doctor.aj.2000@gmail.com	X
hls-11323	15	6	key	key	ADJ
hls-11323	15	7	wards	ward	NOUN
hls-11323	15	8	:	:	PUNCT
hls-11323	15	9	biochemical	biochemical	ADJ
hls-11323	15	10	markers	marker	NOUN
hls-11323	15	11	;	;	PUNCT
hls-11323	15	12	covid-19	covid-19	PROPN
hls-11323	15	13	;	;	PUNCT
hls-11323	15	14	cytokines	cytokine	NOUN
hls-11323	15	15	;	;	PUNCT
hls-11323	15	16	mortality	mortality	NOUN
hls-11323	15	17	.	.	PUNCT
hls-11323	16	1	contributions	contribution	NOUN
hls-11323	16	2	:	:	PUNCT
hls-11323	16	3	nrm	nrm	ADV
hls-11323	16	4	,	,	PUNCT
hls-11323	16	5	conceptualize	conceptualize	VERB
hls-11323	16	6	the	the	DET
hls-11323	16	7	idea	idea	NOUN
hls-11323	16	8	,	,	PUNCT
hls-11323	16	9	writing	write	VERB
hls-11323	16	10	and	and	CCONJ
hls-11323	16	11	editing	edit	VERB
hls-11323	16	12	the	the	DET
hls-11323	16	13	article	article	NOUN
hls-11323	16	14	;	;	PUNCT
hls-11323	16	15	aa	aa	PROPN
hls-11323	16	16	,	,	PUNCT
hls-11323	16	17	running	run	VERB
hls-11323	16	18	laboratory	laboratory	NOUN
hls-11323	16	19	blood	blood	NOUN
hls-11323	16	20	tests	test	NOUN
hls-11323	16	21	;	;	PUNCT
hls-11323	16	22	rme	rme	PROPN
hls-11323	16	23	,	,	PUNCT
hls-11323	16	24	data	datum	NOUN
hls-11323	16	25	collection	collection	NOUN
hls-11323	16	26	and	and	CCONJ
hls-11323	16	27	recruitment	recruitment	NOUN
hls-11323	16	28	of	of	ADP
hls-11323	16	29	cases	case	NOUN
hls-11323	16	30	;	;	PUNCT
hls-11323	16	31	mb	mb	X
hls-11323	16	32	,	,	PUNCT
hls-11323	16	33	data	datum	NOUN
hls-11323	16	34	collection	collection	NOUN
hls-11323	16	35	and	and	CCONJ
hls-11323	16	36	recruitment	recruitment	NOUN
hls-11323	16	37	and	and	CCONJ
hls-11323	16	38	follow	follow	NOUN
hls-11323	16	39	-	-	PUNCT
hls-11323	16	40	up	up	NOUN
hls-11323	16	41	of	of	ADP
hls-11323	16	42	cases	case	NOUN
hls-11323	16	43	.	.	PUNCT
hls-11323	17	1	conflict	conflict	NOUN
hls-11323	17	2	of	of	ADP
hls-11323	17	3	interest	interest	NOUN
hls-11323	17	4	:	:	PUNCT
hls-11323	17	5	the	the	DET
hls-11323	17	6	authors	author	NOUN
hls-11323	17	7	declare	declare	VERB
hls-11323	17	8	no	no	DET
hls-11323	17	9	conflict	conflict	NOUN
hls-11323	17	10	of	of	ADP
hls-11323	17	11	interest	interest	NOUN
hls-11323	17	12	.	.	PUNCT
hls-11323	18	1	ethics	ethic	NOUN
hls-11323	18	2	approval	approval	NOUN
hls-11323	18	3	and	and	CCONJ
hls-11323	18	4	consent	consent	NOUN
hls-11323	18	5	to	to	PART
hls-11323	18	6	participate	participate	VERB
hls-11323	18	7	:	:	PUNCT
hls-11323	18	8	the	the	DET
hls-11323	18	9	ethics	ethics	PROPN
hls-11323	18	10	committee	committee	PROPN
hls-11323	18	11	of	of	ADP
hls-11323	18	12	medical	medical	PROPN
hls-11323	18	13	research	research	PROPN
hls-11323	18	14	institute	institute	PROPN
hls-11323	18	15	approved	approve	VERB
hls-11323	18	16	this	this	DET
hls-11323	18	17	study	study	NOUN
hls-11323	18	18	(	(	PUNCT
hls-11323	18	19	e	e	NOUN
hls-11323	18	20	/	/	SYM
hls-11323	18	21	c.s	c.s	PROPN
hls-11323	18	22	/	/	SYM
hls-11323	18	23	n.r2/2023	n.r2/2023	PROPN
hls-11323	18	24	)	)	PUNCT
hls-11323	18	25	.	.	PUNCT
hls-11323	19	1	the	the	DET
hls-11323	19	2	study	study	NOUN
hls-11323	19	3	is	be	AUX
hls-11323	19	4	conformed	conform	VERB
hls-11323	19	5	with	with	ADP
hls-11323	19	6	the	the	DET
hls-11323	19	7	helsinki	helsinki	PROPN
hls-11323	19	8	declaration	declaration	NOUN
hls-11323	19	9	of	of	ADP
hls-11323	19	10	1964	1964	NUM
hls-11323	19	11	,	,	PUNCT
hls-11323	19	12	as	as	SCONJ
hls-11323	19	13	revised	revise	VERB
hls-11323	19	14	in	in	ADP
hls-11323	19	15	2013	2013	NUM
hls-11323	19	16	,	,	PUNCT
hls-11323	19	17	concerning	concern	VERB
hls-11323	19	18	human	human	ADJ
hls-11323	19	19	and	and	CCONJ
hls-11323	19	20	animal	animal	NOUN
hls-11323	19	21	rights	right	NOUN
hls-11323	19	22	.	.	PUNCT
hls-11323	20	1	informed	informed	ADJ
hls-11323	20	2	consent	consent	NOUN
hls-11323	20	3	:	:	PUNCT
hls-11323	20	4	all	all	DET
hls-11323	20	5	patients	patient	NOUN
hls-11323	20	6	participating	participate	VERB
hls-11323	20	7	in	in	ADP
hls-11323	20	8	this	this	DET
hls-11323	20	9	study	study	NOUN
hls-11323	20	10	signed	sign	VERB
hls-11323	20	11	a	a	DET
hls-11323	20	12	written	write	VERB
hls-11323	20	13	informed	inform	VERB
hls-11323	20	14	consent	consent	NOUN
hls-11323	20	15	form	form	NOUN
hls-11323	20	16	for	for	ADP
hls-11323	20	17	participating	participate	VERB
hls-11323	20	18	in	in	ADP
hls-11323	20	19	this	this	DET
hls-11323	20	20	study	study	NOUN
hls-11323	20	21	.	.	PUNCT
hls-11323	21	1	patient	patient	ADJ
hls-11323	21	2	consent	consent	NOUN
hls-11323	21	3	for	for	ADP
hls-11323	21	4	publication	publication	NOUN
hls-11323	21	5	:	:	PUNCT
hls-11323	21	6	written	write	VERB
hls-11323	21	7	informed	informed	ADJ
hls-11323	21	8	consent	consent	NOUN
hls-11323	21	9	was	be	AUX
hls-11323	21	10	obtained	obtain	VERB
hls-11323	21	11	from	from	ADP
hls-11323	21	12	a	a	DET
hls-11323	21	13	legally	legally	ADV
hls-11323	21	14	authorized	authorize	VERB
hls-11323	21	15	representative(s	representative(s	NOUN
hls-11323	21	16	)	)	PUNCT
hls-11323	21	17	for	for	ADP
hls-11323	21	18	anonymized	anonymize	VERB
hls-11323	21	19	patient	patient	ADJ
hls-11323	21	20	information	information	NOUN
hls-11323	21	21	to	to	PART
hls-11323	21	22	be	be	AUX
hls-11323	21	23	published	publish	VERB
hls-11323	21	24	in	in	ADP
hls-11323	21	25	this	this	DET
hls-11323	21	26	article	article	NOUN
hls-11323	21	27	.	.	PUNCT
hls-11323	22	1	availability	availability	NOUN
hls-11323	22	2	of	of	ADP
hls-11323	22	3	data	datum	NOUN
hls-11323	22	4	and	and	CCONJ
hls-11323	22	5	materials	material	NOUN
hls-11323	22	6	:	:	PUNCT
hls-11323	22	7	all	all	DET
hls-11323	22	8	data	datum	NOUN
hls-11323	22	9	generated	generate	VERB
hls-11323	22	10	or	or	CCONJ
hls-11323	22	11	analyzed	analyze	VERB
hls-11323	22	12	during	during	ADP
hls-11323	22	13	this	this	DET
hls-11323	22	14	study	study	NOUN
hls-11323	22	15	are	be	AUX
hls-11323	22	16	included	include	VERB
hls-11323	22	17	in	in	ADP
hls-11323	22	18	this	this	DET
hls-11323	22	19	published	publish	VERB
hls-11323	22	20	article	article	NOUN
hls-11323	22	21	.	.	PUNCT
hls-11323	23	1	received	receive	VERB
hls-11323	23	2	for	for	ADP
hls-11323	23	3	publication	publication	NOUN
hls-11323	23	4	:	:	PUNCT
hls-11323	23	5	18	18	NUM
hls-11323	23	6	march	march	NOUN
hls-11323	23	7	2023	2023	NUM
hls-11323	23	8	.	.	PUNCT
hls-11323	24	1	accepted	accept	VERB
hls-11323	24	2	for	for	ADP
hls-11323	24	3	publication	publication	NOUN
hls-11323	24	4	:	:	PUNCT
hls-11323	24	5	2	2	NUM
hls-11323	24	6	may	may	PROPN
hls-11323	24	7	2023	2023	NUM
hls-11323	24	8	.	.	PUNCT
hls-11323	25	1	conference	conference	NOUN
hls-11323	25	2	presentation	presentation	NOUN
hls-11323	25	3	:	:	PUNCT
hls-11323	25	4	part	part	NOUN
hls-11323	25	5	of	of	ADP
hls-11323	25	6	this	this	DET
hls-11323	25	7	paper	paper	NOUN
hls-11323	25	8	was	be	AUX
hls-11323	25	9	presented	present	VERB
hls-11323	25	10	at	at	ADP
hls-11323	25	11	the	the	DET
hls-11323	25	12	2nd	2nd	ADJ
hls-11323	25	13	international	international	ADJ
hls-11323	25	14	nursing	nursing	NOUN
hls-11323	25	15	and	and	CCONJ
hls-11323	25	16	health	health	NOUN
hls-11323	25	17	sciences	science	NOUN
hls-11323	25	18	symposium	symposium	NOUN
hls-11323	25	19	that	that	PRON
hls-11323	25	20	took	take	VERB
hls-11323	25	21	place	place	NOUN
hls-11323	25	22	at	at	ADP
hls-11323	25	23	the	the	DET
hls-11323	25	24	faculty	faculty	NOUN
hls-11323	25	25	of	of	ADP
hls-11323	25	26	medicine	medicine	NOUN
hls-11323	25	27	,	,	PUNCT
hls-11323	25	28	universitas	universita	NOUN
hls-11323	25	29	brawijaya	brawijaya	PROPN
hls-11323	25	30	,	,	PUNCT
hls-11323	25	31	malang	malang	PROPN
hls-11323	25	32	,	,	PUNCT
hls-11323	25	33	indonesia	indonesia	PROPN
hls-11323	25	34	.	.	PUNCT
hls-11323	26	1	this	this	DET
hls-11323	26	2	work	work	NOUN
hls-11323	26	3	is	be	AUX
hls-11323	26	4	licensed	license	VERB
hls-11323	26	5	under	under	ADP
hls-11323	26	6	a	a	DET
hls-11323	26	7	creative	creative	ADJ
hls-11323	26	8	commons	common	NOUN
hls-11323	26	9	attribution	attribution	NOUN
hls-11323	26	10	4.0	4.0	NUM
hls-11323	26	11	license	license	NOUN
hls-11323	26	12	(	(	PUNCT
hls-11323	26	13	by	by	ADP
hls-11323	26	14	-	-	PUNCT
hls-11323	26	15	nc	nc	PROPN
hls-11323	26	16	4.0	4.0	NUM
hls-11323	26	17	)	)	PUNCT
hls-11323	26	18	.	.	PUNCT
hls-11323	27	1	©	©	PROPN
hls-11323	27	2	copyright	copyright	NOUN
hls-11323	27	3	:	:	PUNCT
hls-11323	27	4	the	the	DET
hls-11323	27	5	author(s	author(s	PROPN
hls-11323	27	6	)	)	PUNCT
hls-11323	27	7	,	,	PUNCT
hls-11323	27	8	2023	2023	NUM
hls-11323	27	9	licensee	licensee	NOUN
hls-11323	27	10	pagepress	pagepress	NOUN
hls-11323	27	11	,	,	PUNCT
hls-11323	27	12	italy	italy	PROPN
hls-11323	27	13	healthcare	healthcare	PROPN
hls-11323	27	14	in	in	ADP
hls-11323	27	15	low	low	ADJ
hls-11323	27	16	-	-	PUNCT
hls-11323	27	17	resource	resource	NOUN
hls-11323	27	18	settings	setting	NOUN
hls-11323	27	19	2023	2023	NUM
hls-11323	27	20	;	;	PUNCT
hls-11323	27	21	11(s2):11323	11(s2):11323	NUM
hls-11323	27	22	doi:10.4081	doi:10.4081	ADJ
hls-11323	27	23	/	/	SYM
hls-11323	27	24	hls.2023.11323	hls.2023.11323	PROPN
hls-11323	27	25	publisher	publisher	NOUN
hls-11323	27	26	's	's	PART
hls-11323	27	27	note	note	NOUN
hls-11323	27	28	:	:	PUNCT
hls-11323	27	29	all	all	DET
hls-11323	27	30	claims	claim	NOUN
hls-11323	27	31	expressed	express	VERB
hls-11323	27	32	in	in	ADP
hls-11323	27	33	this	this	DET
hls-11323	27	34	article	article	NOUN
hls-11323	27	35	are	be	AUX
hls-11323	27	36	solely	solely	ADV
hls-11323	27	37	those	those	PRON
hls-11323	27	38	of	of	ADP
hls-11323	27	39	the	the	DET
hls-11323	27	40	authors	author	NOUN
hls-11323	27	41	and	and	CCONJ
hls-11323	27	42	do	do	AUX
hls-11323	27	43	not	not	PART
hls-11323	27	44	necessarily	necessarily	ADV
hls-11323	27	45	represent	represent	VERB
hls-11323	27	46	those	those	PRON
hls-11323	27	47	of	of	ADP
hls-11323	27	48	their	their	PRON
hls-11323	27	49	affiliated	affiliated	ADJ
hls-11323	27	50	organizations	organization	NOUN
hls-11323	27	51	,	,	PUNCT
hls-11323	27	52	or	or	CCONJ
hls-11323	27	53	those	those	PRON
hls-11323	27	54	of	of	ADP
hls-11323	27	55	the	the	DET
hls-11323	27	56	publisher	publisher	NOUN
hls-11323	27	57	,	,	PUNCT
hls-11323	27	58	the	the	DET
hls-11323	27	59	editors	editor	NOUN
hls-11323	27	60	and	and	CCONJ
hls-11323	27	61	the	the	DET
hls-11323	27	62	reviewers	reviewer	NOUN
hls-11323	27	63	.	.	PUNCT
hls-11323	28	1	any	any	DET
hls-11323	28	2	product	product	NOUN
hls-11323	28	3	that	that	PRON
hls-11323	28	4	may	may	AUX
hls-11323	28	5	be	be	AUX
hls-11323	28	6	evaluated	evaluate	VERB
hls-11323	28	7	in	in	ADP
hls-11323	28	8	this	this	DET
hls-11323	28	9	article	article	NOUN
hls-11323	28	10	or	or	CCONJ
hls-11323	28	11	claim	claim	NOUN
hls-11323	28	12	that	that	PRON
hls-11323	28	13	may	may	AUX
hls-11323	28	14	be	be	AUX
hls-11323	28	15	made	make	VERB
hls-11323	28	16	by	by	ADP
hls-11323	28	17	its	its	PRON
hls-11323	28	18	manufacturer	manufacturer	NOUN
hls-11323	28	19	is	be	AUX
hls-11323	28	20	not	not	PART
hls-11323	28	21	guaranteed	guarantee	VERB
hls-11323	28	22	or	or	CCONJ
hls-11323	28	23	endorsed	endorse	VERB
hls-11323	28	24	by	by	ADP
hls-11323	28	25	the	the	DET
hls-11323	28	26	publisher	publisher	NOUN
hls-11323	28	27	.	.	PUNCT
hls-11323	29	1	[	[	X
hls-11323	29	2	healthcare	healthcare	NOUN
hls-11323	29	3	in	in	ADP
hls-11323	29	4	low	low	ADJ
hls-11323	29	5	-	-	PUNCT
hls-11323	29	6	resource	resource	NOUN
hls-11323	29	7	settings	setting	NOUN
hls-11323	29	8	2023	2023	NUM
hls-11323	29	9	;	;	PUNCT
hls-11323	29	10	11(s2):11323	11(s2):11323	NUM
hls-11323	29	11	]	]	PUNCT
hls-11323	30	1	[	[	X
hls-11323	30	2	page	page	NOUN
hls-11323	30	3	1	1	NUM
hls-11323	30	4	]	]	X
hls-11323	30	5	non	non	ADJ
hls-11323	30	6	-co	-co	PROPN
hls-11323	30	7	mmerc	mmerc	PROPN
hls-11323	30	8	ial	ial	PROPN
hls-11323	30	9	us	us	PROPN
hls-11323	30	10	e	e	NOUN
hls-11323	30	11	o	o	NOUN
hls-11323	30	12	nly	nly	ADV
hls-11323	30	13	is	be	AUX
hls-11323	30	14	mandatory	mandatory	ADJ
hls-11323	30	15	in	in	ADP
hls-11323	30	16	those	those	PRON
hls-11323	30	17	patients.3	patients.3	VERB
hls-11323	30	18	a	a	DET
hls-11323	30	19	hyper	hyper	ADJ
hls-11323	30	20	-	-	ADJ
hls-11323	30	21	inflammatory	inflammatory	ADJ
hls-11323	30	22	state	state	NOUN
hls-11323	30	23	has	have	AUX
hls-11323	30	24	been	be	AUX
hls-11323	30	25	identified	identify	VERB
hls-11323	30	26	during	during	ADP
hls-11323	30	27	covid-19	covid-19	PROPN
hls-11323	30	28	infection	infection	NOUN
hls-11323	30	29	,	,	PUNCT
hls-11323	30	30	and	and	CCONJ
hls-11323	30	31	several	several	ADJ
hls-11323	30	32	biochemical	biochemical	ADJ
hls-11323	30	33	markers	marker	NOUN
hls-11323	30	34	can	can	AUX
hls-11323	30	35	differentiate	differentiate	VERB
hls-11323	30	36	between	between	ADP
hls-11323	30	37	severe	severe	ADJ
hls-11323	30	38	and	and	CCONJ
hls-11323	30	39	non	non	ADJ
hls-11323	30	40	-	-	ADJ
hls-11323	30	41	severe	severe	ADJ
hls-11323	30	42	outcomes	outcome	NOUN
hls-11323	30	43	.	.	PUNCT
hls-11323	31	1	these	these	DET
hls-11323	31	2	markers	marker	NOUN
hls-11323	31	3	can	can	AUX
hls-11323	31	4	also	also	ADV
hls-11323	31	5	predict	predict	VERB
hls-11323	31	6	the	the	DET
hls-11323	31	7	likelihood	likelihood	NOUN
hls-11323	31	8	of	of	ADP
hls-11323	31	9	complications	complication	NOUN
hls-11323	31	10	and	and	CCONJ
hls-11323	31	11	the	the	DET
hls-11323	31	12	course	course	NOUN
hls-11323	31	13	of	of	ADP
hls-11323	31	14	disease	disease	NOUN
hls-11323	31	15	,	,	PUNCT
hls-11323	31	16	thus	thus	ADV
hls-11323	31	17	helping	help	VERB
hls-11323	31	18	in	in	ADP
hls-11323	31	19	clinical	clinical	ADJ
hls-11323	31	20	decisionmaking.4	decisionmaking.4	SCONJ
hls-11323	31	21	to	to	PART
hls-11323	31	22	ensure	ensure	VERB
hls-11323	31	23	early	early	ADJ
hls-11323	31	24	and	and	CCONJ
hls-11323	31	25	effective	effective	ADJ
hls-11323	31	26	management	management	NOUN
hls-11323	31	27	of	of	ADP
hls-11323	31	28	the	the	DET
hls-11323	31	29	disease	disease	NOUN
hls-11323	31	30	,	,	PUNCT
hls-11323	31	31	various	various	ADJ
hls-11323	31	32	biochemical	biochemical	ADJ
hls-11323	31	33	markers	marker	NOUN
hls-11323	31	34	have	have	AUX
hls-11323	31	35	been	be	AUX
hls-11323	31	36	used	use	VERB
hls-11323	31	37	to	to	PART
hls-11323	31	38	predict	predict	VERB
hls-11323	31	39	the	the	DET
hls-11323	31	40	course	course	NOUN
hls-11323	31	41	of	of	ADP
hls-11323	31	42	the	the	DET
hls-11323	31	43	covid-19	covid-19	PROPN
hls-11323	31	44	,	,	PUNCT
hls-11323	31	45	differentiate	differentiate	VERB
hls-11323	31	46	between	between	ADP
hls-11323	31	47	severe	severe	ADJ
hls-11323	31	48	and	and	CCONJ
hls-11323	31	49	non	non	ADJ
hls-11323	31	50	-	-	ADJ
hls-11323	31	51	severe	severe	ADJ
hls-11323	31	52	cases	case	NOUN
hls-11323	31	53	,	,	PUNCT
hls-11323	31	54	and	and	CCONJ
hls-11323	31	55	determine	determine	VERB
hls-11323	31	56	the	the	DET
hls-11323	31	57	need	need	NOUN
hls-11323	31	58	for	for	ADP
hls-11323	31	59	more	more	ADV
hls-11323	31	60	advanced	advanced	ADJ
hls-11323	31	61	care.5	care.5	NOUN
hls-11323	31	62	recent	recent	ADJ
hls-11323	31	63	research	research	NOUN
hls-11323	31	64	has	have	AUX
hls-11323	31	65	focused	focus	VERB
hls-11323	31	66	on	on	ADP
hls-11323	31	67	identifying	identify	VERB
hls-11323	31	68	the	the	DET
hls-11323	31	69	most	most	ADV
hls-11323	31	70	specific	specific	ADJ
hls-11323	31	71	biochemical	biochemical	ADJ
hls-11323	31	72	markers	marker	NOUN
hls-11323	31	73	that	that	PRON
hls-11323	31	74	are	be	AUX
hls-11323	31	75	implicated	implicate	VERB
hls-11323	31	76	in	in	ADP
hls-11323	31	77	evolution	evolution	NOUN
hls-11323	31	78	of	of	ADP
hls-11323	31	79	the	the	DET
hls-11323	31	80	disease	disease	NOUN
hls-11323	31	81	.	.	PUNCT
hls-11323	32	1	materials	material	NOUN
hls-11323	32	2	and	and	CCONJ
hls-11323	32	3	methods	method	NOUN
hls-11323	32	4	this	this	DET
hls-11323	32	5	prospective	prospective	ADJ
hls-11323	32	6	cohort	cohort	NOUN
hls-11323	32	7	study	study	NOUN
hls-11323	32	8	was	be	AUX
hls-11323	32	9	conducted	conduct	VERB
hls-11323	32	10	on	on	ADP
hls-11323	32	11	patients	patient	NOUN
hls-11323	32	12	admitted	admit	VERB
hls-11323	32	13	to	to	ADP
hls-11323	32	14	alexandria	alexandria	PROPN
hls-11323	32	15	student	student	PROPN
hls-11323	32	16	university	university	PROPN
hls-11323	32	17	hospital	hospital	NOUN
hls-11323	32	18	,	,	PUNCT
hls-11323	32	19	egypt	egypt	PROPN
hls-11323	32	20	from	from	ADP
hls-11323	32	21	june	june	PROPN
hls-11323	32	22	2021	2021	NUM
hls-11323	32	23	to	to	ADP
hls-11323	32	24	december	december	PROPN
hls-11323	32	25	2021	2021	NUM
hls-11323	32	26	.	.	PUNCT
hls-11323	33	1	the	the	DET
hls-11323	33	2	study	study	NOUN
hls-11323	33	3	was	be	AUX
hls-11323	33	4	approved	approve	VERB
hls-11323	33	5	by	by	ADP
hls-11323	33	6	the	the	DET
hls-11323	33	7	ethics	ethic	NOUN
hls-11323	33	8	committee	committee	PROPN
hls-11323	33	9	of	of	ADP
hls-11323	33	10	alexandria	alexandria	PROPN
hls-11323	33	11	student	student	PROPN
hls-11323	33	12	university	university	PROPN
hls-11323	33	13	hospital	hospital	NOUN
hls-11323	33	14	in	in	ADP
hls-11323	33	15	egypt	egypt	PROPN
hls-11323	33	16	and	and	CCONJ
hls-11323	33	17	was	be	AUX
hls-11323	33	18	carried	carry	VERB
hls-11323	33	19	in	in	ADP
hls-11323	33	20	accordance	accordance	NOUN
hls-11323	33	21	with	with	ADP
hls-11323	33	22	the	the	DET
hls-11323	33	23	helsinki	helsinki	PROPN
hls-11323	33	24	declaration	declaration	PROPN
hls-11323	33	25	.	.	PUNCT
hls-11323	34	1	written	write	VERB
hls-11323	34	2	informed	informed	ADJ
hls-11323	34	3	consent	consent	NOUN
hls-11323	34	4	was	be	AUX
hls-11323	34	5	obtained	obtain	VERB
hls-11323	34	6	from	from	ADP
hls-11323	34	7	all	all	DET
hls-11323	34	8	the	the	DET
hls-11323	34	9	participants	participant	NOUN
hls-11323	34	10	.	.	PUNCT
hls-11323	35	1	inclusion	inclusion	NOUN
hls-11323	35	2	criteria	criterion	NOUN
hls-11323	35	3	a	a	DET
hls-11323	35	4	total	total	NOUN
hls-11323	35	5	of	of	ADP
hls-11323	35	6	140	140	NUM
hls-11323	35	7	adult	adult	NOUN
hls-11323	35	8	patients	patient	NOUN
hls-11323	35	9	with	with	ADP
hls-11323	35	10	confirmed	confirm	VERB
hls-11323	35	11	covid-19	covid-19	PROPN
hls-11323	35	12	infection	infection	NOUN
hls-11323	35	13	by	by	ADP
hls-11323	35	14	pcr	pcr	ADJ
hls-11323	35	15	throat	throat	NOUN
hls-11323	35	16	swab	swab	NOUN
hls-11323	35	17	testing6	testing6	NOUN
hls-11323	35	18	were	be	AUX
hls-11323	35	19	enrolled	enrol	VERB
hls-11323	35	20	in	in	ADP
hls-11323	35	21	the	the	DET
hls-11323	35	22	study	study	NOUN
hls-11323	35	23	.	.	PUNCT
hls-11323	36	1	exclusion	exclusion	NOUN
hls-11323	36	2	criteria	criterion	NOUN
hls-11323	36	3	bacterial	bacterial	ADJ
hls-11323	36	4	pneumonia	pneumonia	NOUN
hls-11323	36	5	,	,	PUNCT
hls-11323	36	6	bacterial	bacterial	ADJ
hls-11323	36	7	sepsis	sepsis	NOUN
hls-11323	36	8	,	,	PUNCT
hls-11323	36	9	asymptomatic	asymptomatic	ADJ
hls-11323	36	10	patients	patient	NOUN
hls-11323	36	11	who	who	PRON
hls-11323	36	12	tested	test	VERB
hls-11323	36	13	positive	positive	ADJ
hls-11323	36	14	for	for	ADP
hls-11323	36	15	the	the	DET
hls-11323	36	16	infection	infection	NOUN
hls-11323	36	17	but	but	CCONJ
hls-11323	36	18	did	do	AUX
hls-11323	36	19	not	not	PART
hls-11323	36	20	exhibit	exhibit	VERB
hls-11323	36	21	symptoms	symptom	NOUN
hls-11323	36	22	consistent	consistent	ADJ
hls-11323	36	23	with	with	ADP
hls-11323	36	24	covid-19	covid-19	PROPN
hls-11323	36	25	.	.	PUNCT
hls-11323	37	1	clinical	clinical	ADJ
hls-11323	37	2	data	datum	NOUN
hls-11323	37	3	included	include	VERB
hls-11323	37	4	:	:	PUNCT
hls-11323	37	5	i	i	PRON
hls-11323	37	6	)	)	PUNCT
hls-11323	37	7	demographic	demographic	ADJ
hls-11323	37	8	data	datum	NOUN
hls-11323	37	9	:	:	PUNCT
hls-11323	37	10	age	age	NOUN
hls-11323	37	11	and	and	CCONJ
hls-11323	37	12	gender	gender	NOUN
hls-11323	37	13	;	;	PUNCT
hls-11323	37	14	ii	ii	X
hls-11323	37	15	)	)	PUNCT
hls-11323	37	16	clinical	clinical	ADJ
hls-11323	37	17	data	datum	NOUN
hls-11323	37	18	:	:	PUNCT
hls-11323	37	19	time	time	NOUN
hls-11323	37	20	passed	pass	VERB
hls-11323	37	21	from	from	ADP
hls-11323	37	22	the	the	DET
hls-11323	37	23	onset	onset	NOUN
hls-11323	37	24	of	of	ADP
hls-11323	37	25	symptoms	symptom	NOUN
hls-11323	37	26	till	till	SCONJ
hls-11323	37	27	arriving	arrive	VERB
hls-11323	37	28	to	to	ADP
hls-11323	37	29	the	the	DET
hls-11323	37	30	hospital	hospital	NOUN
hls-11323	37	31	,	,	PUNCT
hls-11323	37	32	clinical	clinical	ADJ
hls-11323	37	33	symptoms	symptom	NOUN
hls-11323	37	34	including	include	VERB
hls-11323	37	35	cough	cough	NOUN
hls-11323	37	36	,	,	PUNCT
hls-11323	37	37	fever	fever	NOUN
hls-11323	37	38	,	,	PUNCT
hls-11323	37	39	headache	headache	NOUN
hls-11323	37	40	,	,	PUNCT
hls-11323	37	41	muscle	muscle	NOUN
hls-11323	37	42	aches	ache	VERB
hls-11323	37	43	,	,	PUNCT
hls-11323	37	44	vomiting	vomiting	NOUN
hls-11323	37	45	or	or	CCONJ
hls-11323	37	46	diarrhea	diarrhea	NOUN
hls-11323	37	47	,	,	PUNCT
hls-11323	37	48	with	with	ADP
hls-11323	37	49	or	or	CCONJ
hls-11323	37	50	without	without	ADP
hls-11323	37	51	respiratory	respiratory	ADJ
hls-11323	37	52	symptoms	symptom	NOUN
hls-11323	37	53	;	;	PUNCT
hls-11323	37	54	iii	iii	X
hls-11323	37	55	)	)	PUNCT
hls-11323	37	56	past	past	ADP
hls-11323	37	57	medical	medical	ADJ
hls-11323	37	58	history	history	NOUN
hls-11323	37	59	including	include	VERB
hls-11323	37	60	any	any	DET
hls-11323	37	61	cardiac	cardiac	ADJ
hls-11323	37	62	,	,	PUNCT
hls-11323	37	63	renal	renal	ADJ
hls-11323	37	64	,	,	PUNCT
hls-11323	37	65	hepatic	hepatic	ADJ
hls-11323	37	66	,	,	PUNCT
hls-11323	37	67	or	or	CCONJ
hls-11323	37	68	thyroid	thyroid	NOUN
hls-11323	37	69	diseases	disease	NOUN
hls-11323	37	70	,	,	PUNCT
hls-11323	37	71	and	and	CCONJ
hls-11323	37	72	presence	presence	NOUN
hls-11323	37	73	of	of	ADP
hls-11323	37	74	diabetes	diabetes	NOUN
hls-11323	37	75	mellitus	mellitus	NOUN
hls-11323	37	76	,	,	PUNCT
hls-11323	37	77	hypertension	hypertension	NOUN
hls-11323	37	78	or	or	CCONJ
hls-11323	37	79	any	any	DET
hls-11323	37	80	autoimmune	autoimmune	ADJ
hls-11323	37	81	diseases	disease	NOUN
hls-11323	37	82	.	.	PUNCT
hls-11323	38	1	biochemical	biochemical	ADJ
hls-11323	38	2	markers:7	markers:7	PUNCT
hls-11323	38	3	i	i	NOUN
hls-11323	38	4	)	)	PUNCT
hls-11323	38	5	routine	routine	ADJ
hls-11323	38	6	blood	blood	NOUN
hls-11323	38	7	tests	test	NOUN
hls-11323	38	8	were	be	AUX
hls-11323	38	9	done	do	VERB
hls-11323	38	10	including	include	VERB
hls-11323	38	11	cbc	cbc	NOUN
hls-11323	38	12	,	,	PUNCT
hls-11323	38	13	renal	renal	ADJ
hls-11323	38	14	function	function	NOUN
hls-11323	38	15	,	,	PUNCT
hls-11323	38	16	liver	liver	NOUN
hls-11323	38	17	function	function	NOUN
hls-11323	38	18	tests	test	NOUN
hls-11323	38	19	,	,	PUNCT
hls-11323	38	20	and	and	CCONJ
hls-11323	38	21	electrolytes	electrolyte	NOUN
hls-11323	38	22	;	;	PUNCT
hls-11323	38	23	ii	ii	X
hls-11323	38	24	)	)	PUNCT
hls-11323	38	25	inflammatory	inflammatory	ADJ
hls-11323	38	26	markers	marker	NOUN
hls-11323	38	27	including	include	VERB
hls-11323	38	28	crp	crp	PROPN
hls-11323	38	29	,	,	PUNCT
hls-11323	38	30	ferritin	ferritin	ADJ
hls-11323	38	31	,	,	PUNCT
hls-11323	38	32	ldh	ldh	PROPN
hls-11323	38	33	,	,	PUNCT
hls-11323	38	34	and	and	CCONJ
hls-11323	38	35	procalcitonin	procalcitonin	VERB
hls-11323	38	36	;	;	PUNCT
hls-11323	38	37	iii	iii	X
hls-11323	38	38	)	)	PUNCT
hls-11323	38	39	coagulation	coagulation	NOUN
hls-11323	38	40	markers	marker	NOUN
hls-11323	38	41	including	include	VERB
hls-11323	38	42	d	d	NOUN
hls-11323	38	43	-	-	PUNCT
hls-11323	38	44	dimer	dimer	ADJ
hls-11323	38	45	,	,	PUNCT
hls-11323	38	46	pt	pt	NOUN
hls-11323	38	47	,	,	PUNCT
hls-11323	38	48	aptt	aptt	ADJ
hls-11323	38	49	;	;	PUNCT
hls-11323	38	50	iv	iv	X
hls-11323	38	51	)	)	PUNCT
hls-11323	38	52	cardiovascular	cardiovascular	ADJ
hls-11323	38	53	markers	marker	NOUN
hls-11323	38	54	including	include	VERB
hls-11323	38	55	pro	pro	ADJ
hls-11323	38	56	-	-	ADJ
hls-11323	38	57	bnp	bnp	ADJ
hls-11323	38	58	.	.	PUNCT
hls-11323	38	59	definition	definition	NOUN
hls-11323	38	60	of	of	ADP
hls-11323	38	61	clinical	clinical	ADJ
hls-11323	38	62	outcome	outcome	NOUN
hls-11323	38	63	in	in	ADP
hls-11323	38	64	this	this	DET
hls-11323	38	65	study	study	NOUN
hls-11323	38	66	,	,	PUNCT
hls-11323	38	67	clinical	clinical	ADJ
hls-11323	38	68	outcome	outcome	NOUN
hls-11323	38	69	was	be	AUX
hls-11323	38	70	defined	define	VERB
hls-11323	38	71	as	as	ADP
hls-11323	38	72	discharge	discharge	NOUN
hls-11323	38	73	of	of	ADP
hls-11323	38	74	the	the	DET
hls-11323	38	75	patient	patient	NOUN
hls-11323	38	76	after	after	ADP
hls-11323	38	77	recovery	recovery	NOUN
hls-11323	38	78	or	or	CCONJ
hls-11323	38	79	death	death	NOUN
hls-11323	38	80	.	.	PUNCT
hls-11323	39	1	discharge	discharge	NOUN
hls-11323	39	2	was	be	AUX
hls-11323	39	3	considered	consider	VERB
hls-11323	39	4	when	when	SCONJ
hls-11323	39	5	the	the	DET
hls-11323	39	6	patient	patient	NOUN
hls-11323	39	7	was	be	AUX
hls-11323	39	8	free	free	ADJ
hls-11323	39	9	of	of	ADP
hls-11323	39	10	symptoms	symptom	NOUN
hls-11323	39	11	and	and	CCONJ
hls-11323	39	12	had	have	VERB
hls-11323	39	13	no	no	DET
hls-11323	39	14	fever	fever	NOUN
hls-11323	39	15	for	for	ADP
hls-11323	39	16	at	at	ADV
hls-11323	39	17	least	least	ADV
hls-11323	39	18	3	3	NUM
hls-11323	39	19	days	day	NOUN
hls-11323	39	20	,	,	PUNCT
hls-11323	39	21	and	and	CCONJ
hls-11323	39	22	had	have	VERB
hls-11323	39	23	two	two	NUM
hls-11323	39	24	consecutive	consecutive	ADJ
hls-11323	39	25	negative	negative	ADJ
hls-11323	39	26	pcr	pcr	ADJ
hls-11323	39	27	test	test	NOUN
hls-11323	39	28	results.8	results.8	ADJ
hls-11323	39	29	statistical	statistical	ADJ
hls-11323	39	30	analysis	analysis	NOUN
hls-11323	39	31	of	of	ADP
hls-11323	39	32	the	the	DET
hls-11323	39	33	data	data	NOUN
hls-11323	39	34	data	datum	NOUN
hls-11323	39	35	were	be	AUX
hls-11323	39	36	entered	enter	VERB
hls-11323	39	37	into	into	ADP
hls-11323	39	38	ibm	ibm	PROPN
hls-11323	39	39	spss	spss	PROPN
hls-11323	39	40	software	software	NOUN
hls-11323	39	41	package	package	NOUN
hls-11323	39	42	version	version	NOUN
hls-11323	39	43	20.0	20.0	NUM
hls-11323	39	44	.	.	PUNCT
hls-11323	40	1	(	(	PUNCT
hls-11323	40	2	armonk	armonk	PROPN
hls-11323	40	3	,	,	PUNCT
hls-11323	40	4	ny	ny	PROPN
hls-11323	40	5	:	:	PROPN
hls-11323	40	6	ibm	ibm	PROPN
hls-11323	40	7	corp	corp	PROPN
hls-11323	40	8	)	)	PUNCT
hls-11323	40	9	and	and	CCONJ
hls-11323	40	10	analyzed	analyze	VERB
hls-11323	40	11	using	use	VERB
hls-11323	40	12	appropriate	appropriate	ADJ
hls-11323	40	13	statistical	statistical	ADJ
hls-11323	40	14	tests	test	NOUN
hls-11323	40	15	.	.	PUNCT
hls-11323	41	1	categorical	categorical	ADJ
hls-11323	41	2	data	datum	NOUN
hls-11323	41	3	were	be	AUX
hls-11323	41	4	presented	present	VERB
hls-11323	41	5	as	as	ADP
hls-11323	41	6	numbers	number	NOUN
hls-11323	41	7	and	and	CCONJ
hls-11323	41	8	percentages	percentage	NOUN
hls-11323	41	9	.	.	PUNCT
hls-11323	42	1	chi	chi	ADJ
hls-11323	42	2	-	-	PUNCT
hls-11323	42	3	square	square	PROPN
hls-11323	42	4	test	test	NOUN
hls-11323	42	5	was	be	AUX
hls-11323	42	6	applied	apply	VERB
hls-11323	42	7	to	to	PART
hls-11323	42	8	investigate	investigate	VERB
hls-11323	42	9	the	the	DET
hls-11323	42	10	association	association	NOUN
hls-11323	42	11	between	between	ADP
hls-11323	42	12	the	the	DET
hls-11323	42	13	categorical	categorical	ADJ
hls-11323	42	14	variables	variable	NOUN
hls-11323	42	15	.	.	PUNCT
hls-11323	43	1	alternatively	alternatively	ADV
hls-11323	43	2	,	,	PUNCT
hls-11323	43	3	fisher	fisher	PROPN
hls-11323	43	4	exact	exact	ADJ
hls-11323	43	5	correction	correction	NOUN
hls-11323	43	6	test	test	NOUN
hls-11323	43	7	was	be	AUX
hls-11323	43	8	applied	apply	VERB
hls-11323	43	9	when	when	SCONJ
hls-11323	43	10	more	more	ADJ
hls-11323	43	11	than	than	ADP
hls-11323	43	12	20	20	NUM
hls-11323	43	13	%	%	NOUN
hls-11323	43	14	of	of	ADP
hls-11323	43	15	the	the	DET
hls-11323	43	16	cells	cell	NOUN
hls-11323	43	17	have	have	AUX
hls-11323	43	18	expected	expect	VERB
hls-11323	43	19	count	count	VERB
hls-11323	43	20	less	less	ADJ
hls-11323	43	21	than	than	ADP
hls-11323	43	22	5	5	NUM
hls-11323	43	23	.	.	PUNCT
hls-11323	43	24	for	for	ADP
hls-11323	43	25	continuous	continuous	ADJ
hls-11323	43	26	data	datum	NOUN
hls-11323	43	27	,	,	PUNCT
hls-11323	43	28	they	they	PRON
hls-11323	43	29	were	be	AUX
hls-11323	43	30	tested	test	VERB
hls-11323	43	31	for	for	ADP
hls-11323	43	32	normality	normality	NOUN
hls-11323	43	33	by	by	ADP
hls-11323	43	34	the	the	DET
hls-11323	43	35	kolmogorovsmirnov	kolmogorovsmirnov	PROPN
hls-11323	43	36	test	test	NOUN
hls-11323	43	37	and	and	CCONJ
hls-11323	43	38	shapiro	shapiro	NOUN
hls-11323	43	39	-	-	PUNCT
hls-11323	43	40	wilk	wilk	NOUN
hls-11323	43	41	test	test	NOUN
hls-11323	43	42	.	.	PUNCT
hls-11323	44	1	quantitative	quantitative	ADJ
hls-11323	44	2	data	datum	NOUN
hls-11323	44	3	were	be	AUX
hls-11323	44	4	expressed	express	VERB
hls-11323	44	5	mean	mean	ADJ
hls-11323	44	6	,	,	PUNCT
hls-11323	44	7	standard	standard	ADJ
hls-11323	44	8	deviation	deviation	NOUN
hls-11323	44	9	,	,	PUNCT
hls-11323	44	10	median	median	NOUN
hls-11323	44	11	and	and	CCONJ
hls-11323	44	12	range	range	NOUN
hls-11323	44	13	(	(	PUNCT
hls-11323	44	14	minimum	minimum	NOUN
hls-11323	44	15	and	and	CCONJ
hls-11323	44	16	maximum	maximum	ADJ
hls-11323	44	17	)	)	PUNCT
hls-11323	44	18	.	.	PUNCT
hls-11323	45	1	for	for	ADP
hls-11323	45	2	normally	normally	ADV
hls-11323	45	3	distributed	distribute	VERB
hls-11323	45	4	quantitative	quantitative	ADJ
hls-11323	45	5	variables	variable	NOUN
hls-11323	45	6	student	student	NOUN
hls-11323	45	7	t	t	PROPN
hls-11323	45	8	-	-	PUNCT
hls-11323	45	9	test	test	NOUN
hls-11323	45	10	was	be	AUX
hls-11323	45	11	used	use	VERB
hls-11323	45	12	to	to	PART
hls-11323	45	13	compare	compare	VERB
hls-11323	45	14	two	two	NUM
hls-11323	45	15	groups	group	NOUN
hls-11323	45	16	.	.	PUNCT
hls-11323	46	1	on	on	ADP
hls-11323	46	2	the	the	DET
hls-11323	46	3	other	other	ADJ
hls-11323	46	4	hand	hand	NOUN
hls-11323	46	5	for	for	ADP
hls-11323	46	6	not	not	PART
hls-11323	46	7	normally	normally	ADV
hls-11323	46	8	distributed	distribute	VERB
hls-11323	46	9	quantitative	quantitative	ADJ
hls-11323	46	10	variables	variable	NOUN
hls-11323	46	11	mann	mann	PROPN
hls-11323	46	12	whitney	whitney	PROPN
hls-11323	46	13	test	test	NOUN
hls-11323	46	14	was	be	AUX
hls-11323	46	15	used	use	VERB
hls-11323	46	16	to	to	PART
hls-11323	46	17	compare	compare	VERB
hls-11323	46	18	two	two	NUM
hls-11323	46	19	groups	group	NOUN
hls-11323	46	20	.	.	PUNCT
hls-11323	47	1	logistic	logistic	ADJ
hls-11323	47	2	regression	regression	NOUN
hls-11323	47	3	was	be	AUX
hls-11323	47	4	used	use	VERB
hls-11323	47	5	to	to	PART
hls-11323	47	6	detect	detect	VERB
hls-11323	47	7	the	the	DET
hls-11323	47	8	most	most	ADV
hls-11323	47	9	independent	independent	ADJ
hls-11323	47	10	factor	factor	NOUN
hls-11323	47	11	for	for	ADP
hls-11323	47	12	affecting	affect	VERB
hls-11323	47	13	deceased	deceased	ADJ
hls-11323	47	14	patients	patient	NOUN
hls-11323	47	15	.	.	PUNCT
hls-11323	48	1	the	the	DET
hls-11323	48	2	obtained	obtain	VERB
hls-11323	48	3	results	result	NOUN
hls-11323	48	4	were	be	AUX
hls-11323	48	5	judged	judge	VERB
hls-11323	48	6	at	at	ADP
hls-11323	48	7	the	the	DET
hls-11323	48	8	5	5	NUM
hls-11323	48	9	%	%	NOUN
hls-11323	48	10	level	level	NOUN
hls-11323	48	11	of	of	ADP
hls-11323	48	12	significance	significance	NOUN
hls-11323	48	13	.	.	PUNCT
hls-11323	49	1	results	result	NOUN
hls-11323	49	2	according	accord	VERB
hls-11323	49	3	to	to	ADP
hls-11323	49	4	the	the	DET
hls-11323	49	5	inclusion	inclusion	NOUN
hls-11323	49	6	/	/	SYM
hls-11323	49	7	exclusion	exclusion	NOUN
hls-11323	49	8	criteria	criterion	NOUN
hls-11323	49	9	mentioned	mention	VERB
hls-11323	49	10	earlier	early	ADV
hls-11323	49	11	,	,	PUNCT
hls-11323	49	12	a	a	DET
hls-11323	49	13	total	total	NOUN
hls-11323	49	14	of	of	ADP
hls-11323	49	15	140	140	NUM
hls-11323	49	16	patients	patient	NOUN
hls-11323	49	17	with	with	ADP
hls-11323	49	18	confirmed	confirm	VERB
hls-11323	49	19	covid-19	covid-19	PROPN
hls-11323	49	20	infection	infection	NOUN
hls-11323	49	21	were	be	AUX
hls-11323	49	22	involved	involve	VERB
hls-11323	49	23	in	in	ADP
hls-11323	49	24	the	the	DET
hls-11323	49	25	study	study	NOUN
hls-11323	49	26	,	,	PUNCT
hls-11323	49	27	out	out	ADP
hls-11323	49	28	of	of	ADP
hls-11323	49	29	these	these	DET
hls-11323	49	30	patients	patient	NOUN
hls-11323	49	31	,	,	PUNCT
hls-11323	49	32	100	100	NUM
hls-11323	49	33	patients	patient	NOUN
hls-11323	49	34	were	be	AUX
hls-11323	49	35	discharged	discharge	VERB
hls-11323	49	36	and	and	CCONJ
hls-11323	49	37	40	40	NUM
hls-11323	49	38	patients	patient	NOUN
hls-11323	49	39	passed	pass	VERB
hls-11323	49	40	away	away	ADV
hls-11323	49	41	.	.	PUNCT
hls-11323	50	1	the	the	DET
hls-11323	50	2	mean	mean	ADJ
hls-11323	50	3	age	age	NOUN
hls-11323	50	4	patients	patient	NOUN
hls-11323	50	5	with	with	ADP
hls-11323	50	6	covid019	covid019	PROPN
hls-11323	50	7	was	be	AUX
hls-11323	50	8	65.2±15.3	65.2±15.3	NUM
hls-11323	50	9	years	year	NOUN
hls-11323	50	10	.	.	PUNCT
hls-11323	51	1	the	the	DET
hls-11323	51	2	mean	mean	ADJ
hls-11323	51	3	age	age	NOUN
hls-11323	51	4	of	of	ADP
hls-11323	51	5	the	the	DET
hls-11323	51	6	discharged	discharge	VERB
hls-11323	51	7	patients	patient	NOUN
hls-11323	51	8	was	be	AUX
hls-11323	51	9	63.5±15.3	63.5±15.3	NUM
hls-11323	51	10	years	year	NOUN
hls-11323	51	11	,	,	PUNCT
hls-11323	51	12	whereas	whereas	SCONJ
hls-11323	51	13	the	the	DET
hls-11323	51	14	mean	mean	ADJ
hls-11323	51	15	age	age	NOUN
hls-11323	51	16	of	of	ADP
hls-11323	51	17	the	the	DET
hls-11323	51	18	deceased	deceased	ADJ
hls-11323	51	19	patients	patient	NOUN
hls-11323	51	20	was	be	AUX
hls-11323	51	21	69.7±14.8	69.7±14.8	NUM
hls-11323	51	22	years	year	NOUN
hls-11323	51	23	.	.	PUNCT
hls-11323	52	1	the	the	DET
hls-11323	52	2	age	age	NOUN
hls-11323	52	3	of	of	ADP
hls-11323	52	4	the	the	DET
hls-11323	52	5	deceased	deceased	ADJ
hls-11323	52	6	patients	patient	NOUN
hls-11323	52	7	was	be	AUX
hls-11323	52	8	significantly	significantly	ADV
hls-11323	52	9	higher	high	ADJ
hls-11323	52	10	than	than	ADP
hls-11323	52	11	that	that	PRON
hls-11323	52	12	of	of	ADP
hls-11323	52	13	the	the	DET
hls-11323	52	14	discharged	discharge	VERB
hls-11323	52	15	patients	patient	NOUN
hls-11323	52	16	,	,	PUNCT
hls-11323	52	17	p=0.031(table	p=0.031(table	NOUN
hls-11323	52	18	1	1	NUM
hls-11323	52	19	)	)	PUNCT
hls-11323	52	20	.	.	PUNCT
hls-11323	53	1	male	male	ADJ
hls-11323	53	2	patients	patient	NOUN
hls-11323	53	3	infected	infect	VERB
hls-11323	53	4	with	with	ADP
hls-11323	53	5	covid-19	covid-19	PROPN
hls-11323	53	6	were	be	AUX
hls-11323	53	7	86	86	NUM
hls-11323	53	8	(	(	PUNCT
hls-11323	53	9	61.4	61.4	NUM
hls-11323	53	10	%	%	NOUN
hls-11323	53	11	)	)	PUNCT
hls-11323	53	12	of	of	ADP
hls-11323	53	13	the	the	DET
hls-11323	53	14	study	study	NOUN
hls-11323	53	15	sample	sample	NOUN
hls-11323	53	16	,	,	PUNCT
hls-11323	53	17	the	the	DET
hls-11323	53	18	discharged	discharge	VERB
hls-11323	53	19	males	male	NOUN
hls-11323	53	20	were	be	AUX
hls-11323	53	21	57	57	NUM
hls-11323	53	22	(	(	PUNCT
hls-11323	53	23	57.0	57.0	NUM
hls-11323	53	24	%	%	NOUN
hls-11323	53	25	)	)	PUNCT
hls-11323	53	26	patients	patient	NOUN
hls-11323	53	27	,	,	PUNCT
hls-11323	53	28	and	and	CCONJ
hls-11323	53	29	the	the	DET
hls-11323	53	30	deceased	deceased	ADJ
hls-11323	53	31	males	male	NOUN
hls-11323	53	32	were	be	AUX
hls-11323	53	33	29	29	NUM
hls-11323	53	34	(	(	PUNCT
hls-11323	53	35	72.5	72.5	NUM
hls-11323	53	36	%	%	NOUN
hls-11323	53	37	)	)	PUNCT
hls-11323	53	38	patients	patient	NOUN
hls-11323	53	39	.	.	PUNCT
hls-11323	54	1	females	female	NOUN
hls-11323	54	2	infected	infect	VERB
hls-11323	54	3	with	with	ADP
hls-11323	54	4	covid-19	covid-19	PROPN
hls-11323	54	5	were	be	AUX
hls-11323	54	6	54	54	NUM
hls-11323	54	7	(	(	PUNCT
hls-11323	54	8	38.6	38.6	NUM
hls-11323	54	9	%	%	NOUN
hls-11323	54	10	)	)	PUNCT
hls-11323	54	11	patients	patient	NOUN
hls-11323	54	12	of	of	ADP
hls-11323	54	13	the	the	DET
hls-11323	54	14	study	study	NOUN
hls-11323	54	15	sample	sample	NOUN
hls-11323	54	16	,	,	PUNCT
hls-11323	54	17	the	the	DET
hls-11323	54	18	discharged	discharge	VERB
hls-11323	54	19	females	female	NOUN
hls-11323	54	20	were	be	AUX
hls-11323	54	21	43	43	NUM
hls-11323	54	22	(	(	PUNCT
hls-11323	54	23	43.0	43.0	NUM
hls-11323	54	24	%	%	NOUN
hls-11323	54	25	)	)	PUNCT
hls-11323	54	26	patients	patient	NOUN
hls-11323	54	27	,	,	PUNCT
hls-11323	54	28	and	and	CCONJ
hls-11323	54	29	the	the	DET
hls-11323	54	30	deceased	deceased	ADJ
hls-11323	54	31	females	female	NOUN
hls-11323	54	32	were	be	AUX
hls-11323	54	33	11	11	NUM
hls-11323	54	34	(	(	PUNCT
hls-11323	54	35	27.5	27.5	NUM
hls-11323	54	36	%	%	NOUN
hls-11323	54	37	)	)	PUNCT
hls-11323	54	38	patients	patient	NOUN
hls-11323	54	39	,	,	PUNCT
hls-11323	54	40	no	no	DET
hls-11323	54	41	significant	significant	ADJ
hls-11323	54	42	effect	effect	NOUN
hls-11323	54	43	of	of	ADP
hls-11323	54	44	gender	gender	NOUN
hls-11323	54	45	on	on	ADP
hls-11323	54	46	mortality	mortality	NOUN
hls-11323	54	47	in	in	ADP
hls-11323	54	48	covid-19	covid-19	PROPN
hls-11323	54	49	infection	infection	NOUN
hls-11323	54	50	,	,	PUNCT
hls-11323	54	51	p=0.089	p=0.089	PROPN
hls-11323	54	52	.	.	PUNCT
hls-11323	55	1	article	article	NOUN
hls-11323	55	2	table	table	VERB
hls-11323	55	3	1	1	NUM
hls-11323	55	4	.	.	PUNCT
hls-11323	56	1	comparison	comparison	NOUN
hls-11323	56	2	between	between	ADP
hls-11323	56	3	the	the	DET
hls-11323	56	4	two	two	NUM
hls-11323	56	5	studied	study	VERB
hls-11323	56	6	groups	group	NOUN
hls-11323	56	7	according	accord	VERB
hls-11323	56	8	to	to	ADP
hls-11323	56	9	demographic	demographic	ADJ
hls-11323	56	10	data	datum	NOUN
hls-11323	56	11	and	and	CCONJ
hls-11323	56	12	co	co	NOUN
hls-11323	56	13	-	-	NOUN
hls-11323	56	14	morbidity	morbidity	NOUN
hls-11323	56	15	.	.	PUNCT
hls-11323	57	1	total	total	ADJ
hls-11323	57	2	n=140	n=140	PROPN
hls-11323	57	3	(	(	PUNCT
hls-11323	57	4	%	%	INTJ
hls-11323	57	5	)	)	PUNCT
hls-11323	57	6	discharged	discharge	VERB
hls-11323	57	7	n=100	n=100	NUM
hls-11323	57	8	(	(	PUNCT
hls-11323	57	9	%	%	INTJ
hls-11323	57	10	)	)	PUNCT
hls-11323	57	11	deceased	deceased	ADJ
hls-11323	57	12	n=40	n=40	ADJ
hls-11323	57	13	(	(	PUNCT
hls-11323	57	14	%	%	INTJ
hls-11323	57	15	)	)	PUNCT
hls-11323	57	16	test	test	NOUN
hls-11323	57	17	of	of	ADP
hls-11323	57	18	sig	sig	NOUN
hls-11323	57	19	.	.	PUNCT
hls-11323	58	1	p	p	NOUN
hls-11323	58	2	age	age	NOUN
hls-11323	58	3	(	(	PUNCT
hls-11323	58	4	years	year	NOUN
hls-11323	58	5	)	)	PUNCT
hls-11323	58	6	mean±sd	mean±sd	ADP
hls-11323	58	7	.	.	PUNCT
hls-11323	59	1	65.2±15.3	65.2±15.3	NUM
hls-11323	59	2	63.5±15.3	63.5±15.3	NOUN
hls-11323	59	3	69.7±14.8	69.7±14.8	VERB
hls-11323	59	4	t=	t=	NOUN
hls-11323	59	5	2.179	2.179	NUM
hls-11323	59	6	*	*	NOUN
hls-11323	59	7	0.031	0.031	NUM
hls-11323	59	8	*	*	ADJ
hls-11323	59	9	median	median	PROPN
hls-11323	59	10	(	(	PUNCT
hls-11323	59	11	min.–max	min.–max	NOUN
hls-11323	59	12	.	.	PUNCT
hls-11323	59	13	)	)	PUNCT
hls-11323	60	1	65	65	NUM
hls-11323	60	2	(	(	PUNCT
hls-11323	60	3	30–98	30–98	NUM
hls-11323	60	4	)	)	PUNCT
hls-11323	60	5	64	64	NUM
hls-11323	60	6	(	(	PUNCT
hls-11323	60	7	30–91	30–91	NUM
hls-11323	60	8	)	)	PUNCT
hls-11323	60	9	73	73	NUM
hls-11323	60	10	(	(	PUNCT
hls-11323	60	11	36–98	36–98	NUM
hls-11323	60	12	)	)	PUNCT
hls-11323	60	13	gender	gender	NOUN
hls-11323	60	14	male	male	NOUN
hls-11323	60	15	86	86	NUM
hls-11323	60	16	(	(	PUNCT
hls-11323	60	17	61.4	61.4	NUM
hls-11323	60	18	)	)	PUNCT
hls-11323	60	19	57	57	NUM
hls-11323	60	20	(	(	PUNCT
hls-11323	60	21	57.0	57.0	NUM
hls-11323	60	22	)	)	PUNCT
hls-11323	60	23	29	29	NUM
hls-11323	60	24	(	(	PUNCT
hls-11323	60	25	72.5	72.5	NUM
hls-11323	60	26	)	)	PUNCT
hls-11323	60	27	χχ2=	χχ2=	PROPN
hls-11323	60	28	2.897	2.897	NUM
hls-11323	60	29	0.089	0.089	NUM
hls-11323	60	30	female	female	ADJ
hls-11323	60	31	54	54	NUM
hls-11323	60	32	(	(	PUNCT
hls-11323	60	33	38.6	38.6	NUM
hls-11323	60	34	)	)	PUNCT
hls-11323	60	35	43	43	NUM
hls-11323	60	36	(	(	PUNCT
hls-11323	60	37	43.0	43.0	NUM
hls-11323	60	38	)	)	PUNCT
hls-11323	60	39	11	11	NUM
hls-11323	60	40	(	(	PUNCT
hls-11323	60	41	27.5	27.5	NUM
hls-11323	60	42	)	)	PUNCT
hls-11323	61	1	dm	dm	PROPN
hls-11323	61	2	63	63	NUM
hls-11323	61	3	(	(	PUNCT
hls-11323	61	4	45.0	45.0	NUM
hls-11323	61	5	)	)	PUNCT
hls-11323	61	6	44	44	NUM
hls-11323	61	7	(	(	PUNCT
hls-11323	61	8	44.0	44.0	NUM
hls-11323	61	9	)	)	PUNCT
hls-11323	61	10	19	19	NUM
hls-11323	61	11	(	(	PUNCT
hls-11323	61	12	47.5	47.5	NUM
hls-11323	61	13	)	)	PUNCT
hls-11323	61	14	χ2=0.141	χ2=0.141	NUM
hls-11323	61	15	0.707	0.707	NUM
hls-11323	61	16	dyslipidemia	dyslipidemia	NOUN
hls-11323	61	17	48	48	NUM
hls-11323	61	18	(	(	PUNCT
hls-11323	61	19	34.3	34.3	NUM
hls-11323	61	20	)	)	PUNCT
hls-11323	61	21	33	33	NUM
hls-11323	61	22	(	(	PUNCT
hls-11323	61	23	33	33	NUM
hls-11323	61	24	)	)	SYM
hls-11323	61	25	15	15	NUM
hls-11323	61	26	(	(	PUNCT
hls-11323	61	27	37.5	37.5	NUM
hls-11323	61	28	)	)	PUNCT
hls-11323	61	29	χ2=0.257	χ2=0.257	X
hls-11323	61	30	0.612	0.612	NUM
hls-11323	61	31	htn	htn	NOUN
hls-11323	61	32	55	55	NUM
hls-11323	61	33	(	(	PUNCT
hls-11323	61	34	39.3	39.3	NUM
hls-11323	61	35	)	)	PUNCT
hls-11323	61	36	41	41	NUM
hls-11323	61	37	(	(	PUNCT
hls-11323	61	38	41	41	NUM
hls-11323	61	39	)	)	PUNCT
hls-11323	61	40	14	14	NUM
hls-11323	61	41	(	(	PUNCT
hls-11323	61	42	35	35	NUM
hls-11323	61	43	)	)	PUNCT
hls-11323	61	44	χχ2=0.431	χχ2=0.431	VERB
hls-11323	61	45	0.511	0.511	NUM
hls-11323	61	46	anemia	anemia	NOUN
hls-11323	61	47	14	14	NUM
hls-11323	61	48	(	(	PUNCT
hls-11323	61	49	10	10	NUM
hls-11323	61	50	)	)	PUNCT
hls-11323	61	51	7	7	NUM
hls-11323	61	52	(	(	PUNCT
hls-11323	61	53	7	7	NUM
hls-11323	61	54	)	)	PUNCT
hls-11323	61	55	7	7	NUM
hls-11323	61	56	(	(	PUNCT
hls-11323	61	57	17.5	17.5	NUM
hls-11323	61	58	)	)	PUNCT
hls-11323	61	59	χχ2=3.500	χχ2=3.500	NOUN
hls-11323	61	60	fep=0.114	fep=0.114	NOUN
hls-11323	61	61	ischemic	ischemic	ADJ
hls-11323	61	62	heart	heart	NOUN
hls-11323	61	63	disease	disease	NOUN
hls-11323	61	64	13	13	NUM
hls-11323	61	65	(	(	PUNCT
hls-11323	61	66	9.3	9.3	NUM
hls-11323	61	67	)	)	PUNCT
hls-11323	61	68	10	10	NUM
hls-11323	61	69	(	(	PUNCT
hls-11323	61	70	10	10	NUM
hls-11323	61	71	)	)	PUNCT
hls-11323	61	72	3	3	NUM
hls-11323	61	73	(	(	PUNCT
hls-11323	61	74	7.5	7.5	NUM
hls-11323	61	75	)	)	PUNCT
hls-11323	61	76	χ2=0.212	χ2=0.212	PROPN
hls-11323	62	1	fep=0.758	fep=0.758	PROPN
hls-11323	62	2	thyroid	thyroid	NOUN
hls-11323	62	3	13	13	NUM
hls-11323	62	4	(	(	PUNCT
hls-11323	62	5	9.3	9.3	NUM
hls-11323	62	6	)	)	PUNCT
hls-11323	62	7	9	9	NUM
hls-11323	62	8	(	(	PUNCT
hls-11323	62	9	9	9	NUM
hls-11323	62	10	)	)	SYM
hls-11323	62	11	4	4	NUM
hls-11323	62	12	(	(	PUNCT
hls-11323	62	13	10	10	NUM
hls-11323	62	14	)	)	PUNCT
hls-11323	62	15	χ2=0.034	χ2=0.034	X
hls-11323	62	16	fep=1.000	fep=1.000	NOUN
hls-11323	62	17	sd	sd	NOUN
hls-11323	62	18	,	,	PUNCT
hls-11323	62	19	standard	standard	ADJ
hls-11323	62	20	deviation	deviation	NOUN
hls-11323	62	21	;	;	PUNCT
hls-11323	62	22	t	t	PROPN
hls-11323	62	23	,	,	PUNCT
hls-11323	62	24	student	student	NOUN
hls-11323	62	25	t	t	PROPN
hls-11323	62	26	-	-	PUNCT
hls-11323	62	27	test	test	NOUN
hls-11323	62	28	;	;	PUNCT
hls-11323	62	29	χ2	χ2	PROPN
hls-11323	62	30	,	,	PUNCT
hls-11323	62	31	chi	chi	PROPN
hls-11323	62	32	square	square	PROPN
hls-11323	62	33	test	test	NOUN
hls-11323	62	34	;	;	PUNCT
hls-11323	62	35	fe	fe	X
hls-11323	62	36	,	,	PUNCT
hls-11323	62	37	fisher	fisher	PROPN
hls-11323	62	38	exact	exact	NOUN
hls-11323	62	39	;	;	PUNCT
hls-11323	62	40	p	p	X
hls-11323	62	41	,	,	PUNCT
hls-11323	62	42	p	p	NOUN
hls-11323	62	43	value	value	NOUN
hls-11323	62	44	for	for	ADP
hls-11323	62	45	comparing	compare	VERB
hls-11323	62	46	between	between	ADP
hls-11323	62	47	the	the	DET
hls-11323	62	48	studied	study	VERB
hls-11323	62	49	groups	group	NOUN
hls-11323	62	50	.	.	PUNCT
hls-11323	63	1	*	*	PUNCT
hls-11323	63	2	statistically	statistically	ADV
hls-11323	63	3	significant	significant	ADJ
hls-11323	63	4	at	at	ADP
hls-11323	63	5	p≤0.05	p≤0.05	NOUN
hls-11323	63	6	.	.	PUNCT
hls-11323	64	1	[	[	X
hls-11323	64	2	page	page	NOUN
hls-11323	64	3	2	2	NUM
hls-11323	64	4	]	]	PUNCT
hls-11323	64	5	[	[	X
hls-11323	64	6	healthcare	healthcare	NOUN
hls-11323	64	7	in	in	ADP
hls-11323	64	8	low	low	ADJ
hls-11323	64	9	-	-	PUNCT
hls-11323	64	10	resource	resource	NOUN
hls-11323	64	11	settings	setting	NOUN
hls-11323	64	12	2023	2023	NUM
hls-11323	64	13	;	;	PUNCT
hls-11323	64	14	11(s2):11323	11(s2):11323	NUM
hls-11323	64	15	]	]	X
hls-11323	64	16	non	non	ADJ
hls-11323	64	17	-co	-co	PROPN
hls-11323	64	18	mmerc	mmerc	PROPN
hls-11323	64	19	ial	ial	PROPN
hls-11323	64	20	us	us	PROPN
hls-11323	64	21	e	e	NOUN
hls-11323	64	22	o	o	NOUN
hls-11323	64	23	nly	nly	ADV
hls-11323	64	24	patients	patient	NOUN
hls-11323	64	25	infected	infect	VERB
hls-11323	64	26	with	with	ADP
hls-11323	64	27	covid-19	covid-19	PROPN
hls-11323	64	28	had	have	VERB
hls-11323	64	29	multiple	multiple	ADJ
hls-11323	64	30	comorbidities	comorbiditie	NOUN
hls-11323	64	31	,	,	PUNCT
hls-11323	64	32	including	include	VERB
hls-11323	64	33	dm	dm	NUM
hls-11323	64	34	in	in	ADP
hls-11323	64	35	63	63	NUM
hls-11323	64	36	(	(	PUNCT
hls-11323	64	37	45.0	45.0	NUM
hls-11323	64	38	%	%	NOUN
hls-11323	64	39	)	)	PUNCT
hls-11323	64	40	patients	patient	NOUN
hls-11323	64	41	,	,	PUNCT
hls-11323	64	42	44	44	NUM
hls-11323	64	43	(	(	PUNCT
hls-11323	64	44	44.0	44.0	NUM
hls-11323	64	45	%	%	NOUN
hls-11323	64	46	)	)	PUNCT
hls-11323	64	47	patients	patient	NOUN
hls-11323	64	48	were	be	AUX
hls-11323	64	49	discharged	discharge	VERB
hls-11323	64	50	and	and	CCONJ
hls-11323	64	51	19	19	NUM
hls-11323	64	52	(	(	PUNCT
hls-11323	64	53	47.5	47.5	NUM
hls-11323	64	54	%	%	NOUN
hls-11323	64	55	)	)	PUNCT
hls-11323	64	56	patients	patient	NOUN
hls-11323	64	57	were	be	AUX
hls-11323	64	58	deceased	deceased	ADJ
hls-11323	64	59	,	,	PUNCT
hls-11323	64	60	p=0.707	p=0.707	NOUN
hls-11323	64	61	.	.	PUNCT
hls-11323	65	1	(	(	PUNCT
hls-11323	65	2	table	table	NOUN
hls-11323	65	3	1	1	NUM
hls-11323	65	4	)	)	PUNCT
hls-11323	65	5	.	.	PUNCT
hls-11323	66	1	dyslipidemia	dyslipidemia	NOUN
hls-11323	66	2	in	in	ADP
hls-11323	66	3	48	48	NUM
hls-11323	66	4	(	(	PUNCT
hls-11323	66	5	34.3	34.3	NUM
hls-11323	66	6	%	%	NOUN
hls-11323	66	7	)	)	PUNCT
hls-11323	66	8	patients	patient	NOUN
hls-11323	66	9	,	,	PUNCT
hls-11323	66	10	33	33	NUM
hls-11323	66	11	(	(	PUNCT
hls-11323	66	12	33	33	NUM
hls-11323	66	13	%	%	NOUN
hls-11323	66	14	)	)	PUNCT
hls-11323	66	15	patients	patient	NOUN
hls-11323	66	16	were	be	AUX
hls-11323	66	17	discharged	discharge	VERB
hls-11323	66	18	and	and	CCONJ
hls-11323	66	19	15	15	NUM
hls-11323	66	20	(	(	PUNCT
hls-11323	66	21	37.5	37.5	NUM
hls-11323	66	22	%	%	NOUN
hls-11323	66	23	)	)	PUNCT
hls-11323	67	1	patients	patient	NOUN
hls-11323	67	2	were	be	AUX
hls-11323	67	3	deceased	deceased	ADJ
hls-11323	67	4	,	,	PUNCT
hls-11323	67	5	p=0.612	p=0.612	PROPN
hls-11323	67	6	.	.	PUNCT
hls-11323	68	1	htn	htn	PROPN
hls-11323	68	2	in	in	ADP
hls-11323	68	3	55	55	NUM
hls-11323	68	4	(	(	PUNCT
hls-11323	68	5	39.3	39.3	NUM
hls-11323	68	6	%	%	NOUN
hls-11323	68	7	)	)	PUNCT
hls-11323	68	8	patients	patient	NOUN
hls-11323	68	9	,	,	PUNCT
hls-11323	68	10	41	41	NUM
hls-11323	68	11	(	(	PUNCT
hls-11323	68	12	41	41	NUM
hls-11323	68	13	%	%	NOUN
hls-11323	68	14	)	)	PUNCT
hls-11323	69	1	patients	patient	NOUN
hls-11323	69	2	were	be	AUX
hls-11323	69	3	discharged	discharge	VERB
hls-11323	69	4	and	and	CCONJ
hls-11323	69	5	14	14	NUM
hls-11323	69	6	(	(	PUNCT
hls-11323	69	7	35	35	NUM
hls-11323	69	8	%	%	NOUN
hls-11323	69	9	)	)	PUNCT
hls-11323	69	10	patients	patient	NOUN
hls-11323	69	11	were	be	AUX
hls-11323	69	12	deceased	deceased	ADJ
hls-11323	69	13	,	,	PUNCT
hls-11323	69	14	p=0.511	p=0.511	NOUN
hls-11323	69	15	.	.	PUNCT
hls-11323	70	1	anemia	anemia	NOUN
hls-11323	70	2	in	in	ADP
hls-11323	70	3	14	14	NUM
hls-11323	70	4	(	(	PUNCT
hls-11323	70	5	10	10	NUM
hls-11323	70	6	%	%	NOUN
hls-11323	70	7	)	)	PUNCT
hls-11323	70	8	patients	patient	NOUN
hls-11323	70	9	,	,	PUNCT
hls-11323	70	10	7	7	NUM
hls-11323	70	11	(	(	PUNCT
hls-11323	70	12	7	7	NUM
hls-11323	70	13	%	%	NOUN
hls-11323	70	14	)	)	PUNCT
hls-11323	70	15	patients	patient	NOUN
hls-11323	70	16	were	be	AUX
hls-11323	70	17	discharged	discharge	VERB
hls-11323	70	18	and	and	CCONJ
hls-11323	70	19	7	7	NUM
hls-11323	70	20	(	(	PUNCT
hls-11323	70	21	17.5	17.5	NUM
hls-11323	70	22	%	%	NOUN
hls-11323	70	23	)	)	PUNCT
hls-11323	70	24	patients	patient	NOUN
hls-11323	70	25	were	be	AUX
hls-11323	70	26	deceased	deceased	ADJ
hls-11323	70	27	,	,	PUNCT
hls-11323	70	28	p=0.114	p=0.114	X
hls-11323	70	29	.	.	PUNCT
hls-11323	71	1	ischemic	ischemic	ADJ
hls-11323	71	2	heart	heart	NOUN
hls-11323	71	3	disease	disease	NOUN
hls-11323	71	4	in	in	ADP
hls-11323	71	5	13	13	NUM
hls-11323	71	6	(	(	PUNCT
hls-11323	71	7	9.3	9.3	NUM
hls-11323	71	8	%	%	NOUN
hls-11323	71	9	)	)	PUNCT
hls-11323	71	10	patients	patient	NOUN
hls-11323	71	11	,	,	PUNCT
hls-11323	71	12	10	10	NUM
hls-11323	71	13	(	(	PUNCT
hls-11323	71	14	10	10	NUM
hls-11323	71	15	%	%	NOUN
hls-11323	71	16	)	)	PUNCT
hls-11323	71	17	patients	patient	NOUN
hls-11323	71	18	were	be	AUX
hls-11323	71	19	discharged	discharge	VERB
hls-11323	71	20	and	and	CCONJ
hls-11323	71	21	3	3	NUM
hls-11323	71	22	(	(	PUNCT
hls-11323	71	23	7.5	7.5	NUM
hls-11323	71	24	%	%	NOUN
hls-11323	71	25	)	)	PUNCT
hls-11323	71	26	patients	patient	NOUN
hls-11323	71	27	were	be	AUX
hls-11323	71	28	deceased	deceased	ADJ
hls-11323	71	29	,	,	PUNCT
hls-11323	71	30	p=0.758	p=0.758	NOUN
hls-11323	71	31	.	.	PUNCT
hls-11323	72	1	thyroid	thyroid	NOUN
hls-11323	72	2	disease	disease	NOUN
hls-11323	72	3	in	in	ADP
hls-11323	72	4	13	13	NUM
hls-11323	72	5	(	(	PUNCT
hls-11323	72	6	9.3	9.3	NUM
hls-11323	72	7	%	%	NOUN
hls-11323	72	8	)	)	PUNCT
hls-11323	72	9	patients	patient	NOUN
hls-11323	72	10	,	,	PUNCT
hls-11323	72	11	9	9	NUM
hls-11323	72	12	(	(	PUNCT
hls-11323	72	13	9	9	NUM
hls-11323	72	14	%	%	NOUN
hls-11323	72	15	)	)	PUNCT
hls-11323	72	16	patients	patient	NOUN
hls-11323	72	17	were	be	AUX
hls-11323	72	18	discharged	discharge	VERB
hls-11323	72	19	and	and	CCONJ
hls-11323	72	20	4	4	NUM
hls-11323	72	21	(	(	PUNCT
hls-11323	72	22	10	10	NUM
hls-11323	72	23	%	%	NOUN
hls-11323	72	24	)	)	PUNCT
hls-11323	72	25	patients	patient	NOUN
hls-11323	72	26	were	be	AUX
hls-11323	72	27	deceased	deceased	ADJ
hls-11323	72	28	,	,	PUNCT
hls-11323	72	29	p=1.000	p=1.000	NOUN
hls-11323	72	30	.	.	PUNCT
hls-11323	73	1	none	none	NOUN
hls-11323	73	2	of	of	ADP
hls-11323	73	3	them	they	PRON
hls-11323	73	4	significantly	significantly	ADV
hls-11323	73	5	affects	affect	VERB
hls-11323	73	6	the	the	DET
hls-11323	73	7	outcome	outcome	NOUN
hls-11323	73	8	of	of	ADP
hls-11323	73	9	the	the	DET
hls-11323	73	10	disease	disease	NOUN
hls-11323	73	11	.	.	PUNCT
hls-11323	74	1	many	many	ADJ
hls-11323	74	2	laboratory	laboratory	NOUN
hls-11323	74	3	investigations	investigation	NOUN
hls-11323	74	4	were	be	AUX
hls-11323	74	5	conducted	conduct	VERB
hls-11323	74	6	and	and	CCONJ
hls-11323	74	7	their	their	PRON
hls-11323	74	8	relation	relation	NOUN
hls-11323	74	9	to	to	ADP
hls-11323	74	10	the	the	DET
hls-11323	74	11	outcome	outcome	NOUN
hls-11323	74	12	of	of	ADP
hls-11323	74	13	the	the	DET
hls-11323	74	14	disease	disease	NOUN
hls-11323	74	15	were	be	AUX
hls-11323	74	16	recorded	record	VERB
hls-11323	74	17	.	.	PUNCT
hls-11323	75	1	crp	crp	PROPN
hls-11323	75	2	showed	show	VERB
hls-11323	75	3	mean	mean	ADJ
hls-11323	75	4	value	value	NOUN
hls-11323	75	5	of	of	ADP
hls-11323	75	6	17.7±16.3	17.7±16.3	NUM
hls-11323	75	7	mg	mg	PROPN
hls-11323	75	8	/	/	SYM
hls-11323	75	9	l	l	NOUN
hls-11323	75	10	in	in	ADP
hls-11323	75	11	all	all	DET
hls-11323	75	12	covid-19	covid-19	PROPN
hls-11323	75	13	infected	infected	ADJ
hls-11323	75	14	patients	patient	NOUN
hls-11323	75	15	,	,	PUNCT
hls-11323	75	16	with	with	ADP
hls-11323	75	17	a	a	DET
hls-11323	75	18	mean	mean	NOUN
hls-11323	75	19	of	of	ADP
hls-11323	75	20	11.4±8.3	11.4±8.3	NUM
hls-11323	75	21	mg	mg	PROPN
hls-11323	75	22	/	/	SYM
hls-11323	75	23	l	l	NOUN
hls-11323	75	24	in	in	ADP
hls-11323	75	25	discharged	discharge	VERB
hls-11323	75	26	patients	patient	NOUN
hls-11323	75	27	,	,	PUNCT
hls-11323	75	28	and	and	CCONJ
hls-11323	75	29	a	a	DET
hls-11323	75	30	mean	mean	NOUN
hls-11323	75	31	of	of	ADP
hls-11323	75	32	33.4±20.4	33.4±20.4	NUM
hls-11323	75	33	mg	mg	PROPN
hls-11323	75	34	/	/	SYM
hls-11323	75	35	l	l	NOUN
hls-11323	75	36	in	in	ADP
hls-11323	75	37	deceased	deceased	ADJ
hls-11323	75	38	patients	patient	NOUN
hls-11323	75	39	.	.	PUNCT
hls-11323	76	1	crp	crp	PROPN
hls-11323	76	2	also	also	ADV
hls-11323	76	3	showed	show	VERB
hls-11323	76	4	high	high	ADJ
hls-11323	76	5	significant	significant	ADJ
hls-11323	76	6	increase	increase	NOUN
hls-11323	76	7	in	in	ADP
hls-11323	76	8	deceased	deceased	ADJ
hls-11323	76	9	patients	patient	NOUN
hls-11323	76	10	more	more	ADV
hls-11323	76	11	than	than	ADP
hls-11323	76	12	discharged	discharge	VERB
hls-11323	76	13	patients	patient	NOUN
hls-11323	76	14	,	,	PUNCT
hls-11323	76	15	p<0.001	p<0.001	X
hls-11323	76	16	(	(	PUNCT
hls-11323	76	17	table	table	NOUN
hls-11323	76	18	2	2	NUM
hls-11323	76	19	)	)	PUNCT
hls-11323	76	20	.	.	PUNCT
hls-11323	77	1	ferritin	ferritin	PROPN
hls-11323	77	2	showed	show	VERB
hls-11323	77	3	mean	mean	ADJ
hls-11323	77	4	value	value	NOUN
hls-11323	77	5	of	of	ADP
hls-11323	77	6	1308±2006	1308±2006	PROPN
hls-11323	77	7	ng	ng	PROPN
hls-11323	77	8	/	/	SYM
hls-11323	77	9	ml	ml	X
hls-11323	77	10	in	in	ADP
hls-11323	77	11	all	all	DET
hls-11323	77	12	covid-19	covid-19	PROPN
hls-11323	77	13	infected	infected	ADJ
hls-11323	77	14	patients	patient	NOUN
hls-11323	77	15	,	,	PUNCT
hls-11323	77	16	with	with	ADP
hls-11323	77	17	a	a	DET
hls-11323	77	18	mean	mean	NOUN
hls-11323	77	19	of	of	ADP
hls-11323	77	20	715.8±1188.6	715.8±1188.6	NUM
hls-11323	77	21	ng	ng	NOUN
hls-11323	77	22	/	/	SYM
hls-11323	77	23	ml	ml	PROPN
hls-11323	77	24	in	in	ADP
hls-11323	77	25	discharged	discharge	VERB
hls-11323	77	26	patients	patient	NOUN
hls-11323	77	27	,	,	PUNCT
hls-11323	77	28	and	and	CCONJ
hls-11323	77	29	a	a	DET
hls-11323	77	30	mean	mean	NOUN
hls-11323	77	31	of	of	ADP
hls-11323	77	32	2788.8±2758.5	2788.8±2758.5	NUM
hls-11323	77	33	ng	ng	PROPN
hls-11323	77	34	/	/	SYM
hls-11323	77	35	ml	ml	X
hls-11323	77	36	in	in	ADP
hls-11323	77	37	deceased	deceased	ADJ
hls-11323	77	38	patients	patient	NOUN
hls-11323	77	39	,	,	PUNCT
hls-11323	77	40	the	the	DET
hls-11323	77	41	increase	increase	NOUN
hls-11323	77	42	in	in	ADP
hls-11323	77	43	ferritin	ferritin	ADJ
hls-11323	77	44	level	level	NOUN
hls-11323	77	45	was	be	AUX
hls-11323	77	46	highly	highly	ADV
hls-11323	77	47	significant	significant	ADJ
hls-11323	77	48	in	in	ADP
hls-11323	77	49	deceased	deceased	ADJ
hls-11323	77	50	patients	patient	NOUN
hls-11323	77	51	in	in	ADP
hls-11323	77	52	comparison	comparison	NOUN
hls-11323	77	53	to	to	ADP
hls-11323	77	54	discharged	discharge	VERB
hls-11323	77	55	patients	patient	NOUN
hls-11323	77	56	,	,	PUNCT
hls-11323	77	57	p<0.001	p<0.001	X
hls-11323	77	58	(	(	PUNCT
hls-11323	77	59	table	table	NOUN
hls-11323	77	60	2	2	NUM
hls-11323	77	61	,	,	PUNCT
hls-11323	77	62	figure	figure	NOUN
hls-11323	77	63	1	1	NUM
hls-11323	77	64	)	)	PUNCT
hls-11323	77	65	.	.	PUNCT
hls-11323	78	1	ldh	ldh	PROPN
hls-11323	78	2	showed	show	VERB
hls-11323	78	3	mean	mean	ADJ
hls-11323	78	4	value	value	NOUN
hls-11323	78	5	of	of	ADP
hls-11323	78	6	585±590	585±590	NUM
hls-11323	78	7	iu	iu	NOUN
hls-11323	78	8	/	/	SYM
hls-11323	78	9	l	l	NOUN
hls-11323	78	10	in	in	ADP
hls-11323	78	11	all	all	DET
hls-11323	78	12	covid-19	covid-19	PROPN
hls-11323	78	13	infected	infected	ADJ
hls-11323	78	14	patients	patient	NOUN
hls-11323	78	15	,	,	PUNCT
hls-11323	78	16	with	with	ADP
hls-11323	78	17	a	a	DET
hls-11323	78	18	mean	mean	NOUN
hls-11323	78	19	of	of	ADP
hls-11323	78	20	380.7±246.7	380.7±246.7	NUM
hls-11323	78	21	iu	iu	NOUN
hls-11323	78	22	/	/	SYM
hls-11323	78	23	l	l	NOUN
hls-11323	78	24	in	in	ADP
hls-11323	78	25	discharged	discharge	VERB
hls-11323	78	26	patients	patient	NOUN
hls-11323	78	27	,	,	PUNCT
hls-11323	78	28	and	and	CCONJ
hls-11323	78	29	a	a	DET
hls-11323	78	30	mean	mean	NOUN
hls-11323	78	31	of	of	ADP
hls-11323	78	32	1095.9±843.5	1095.9±843.5	NUM
hls-11323	78	33	iu	iu	NOUN
hls-11323	78	34	/	/	SYM
hls-11323	78	35	l	l	NOUN
hls-11323	78	36	in	in	ADP
hls-11323	78	37	deceased	deceased	ADJ
hls-11323	78	38	patients	patient	NOUN
hls-11323	78	39	,	,	PUNCT
hls-11323	78	40	there	there	PRON
hls-11323	78	41	was	be	VERB
hls-11323	78	42	a	a	DET
hls-11323	78	43	high	high	ADJ
hls-11323	78	44	significant	significant	ADJ
hls-11323	78	45	increase	increase	NOUN
hls-11323	78	46	of	of	ADP
hls-11323	78	47	ldh	ldh	NOUN
hls-11323	78	48	in	in	ADP
hls-11323	78	49	deceased	deceased	ADJ
hls-11323	78	50	patients	patient	NOUN
hls-11323	78	51	article	article	NOUN
hls-11323	78	52	table	table	NOUN
hls-11323	78	53	2	2	NUM
hls-11323	78	54	.	.	PUNCT
hls-11323	78	55	comparison	comparison	NOUN
hls-11323	78	56	between	between	ADP
hls-11323	78	57	the	the	DET
hls-11323	78	58	two	two	NUM
hls-11323	78	59	studied	study	VERB
hls-11323	78	60	groups	group	NOUN
hls-11323	78	61	according	accord	VERB
hls-11323	78	62	to	to	ADP
hls-11323	78	63	laboratory	laboratory	NOUN
hls-11323	78	64	investigations	investigation	NOUN
hls-11323	78	65	.	.	PUNCT
hls-11323	79	1	total	total	ADJ
hls-11323	79	2	n=140	n=140	PROPN
hls-11323	79	3	(	(	PUNCT
hls-11323	79	4	%	%	INTJ
hls-11323	79	5	)	)	PUNCT
hls-11323	79	6	discharged	discharge	VERB
hls-11323	79	7	n=100	n=100	NUM
hls-11323	79	8	(	(	PUNCT
hls-11323	79	9	%	%	INTJ
hls-11323	79	10	)	)	PUNCT
hls-11323	79	11	deceased	deceased	ADJ
hls-11323	79	12	n=40	n=40	ADJ
hls-11323	79	13	(	(	PUNCT
hls-11323	79	14	%	%	INTJ
hls-11323	79	15	)	)	PUNCT
hls-11323	79	16	u	u	NOUN
hls-11323	79	17	p	p	PROPN
hls-11323	79	18	crp	crp	PROPN
hls-11323	79	19	(	(	PUNCT
hls-11323	79	20	mg	mg	PROPN
hls-11323	79	21	/	/	SYM
hls-11323	79	22	l	l	NOUN
hls-11323	79	23	)	)	PUNCT
hls-11323	79	24	mean±sd	mean±sd	PROPN
hls-11323	79	25	.	.	PUNCT
hls-11323	80	1	17.7±16.3	17.7±16.3	NUM
hls-11323	80	2	11.4±8.3	11.4±8.3	NUM
hls-11323	80	3	33.4±20.4	33.4±20.4	NUM
hls-11323	80	4	543.0	543.0	NUM
hls-11323	80	5	*	*	PUNCT
hls-11323	80	6	<	<	X
hls-11323	80	7	0.001	0.001	NUM
hls-11323	80	8	*	*	ADJ
hls-11323	80	9	median	median	PROPN
hls-11323	80	10	(	(	PUNCT
hls-11323	80	11	min.–max	min.–max	NOUN
hls-11323	80	12	.	.	PUNCT
hls-11323	80	13	)	)	PUNCT
hls-11323	81	1	14.5	14.5	NUM
hls-11323	81	2	(	(	PUNCT
hls-11323	81	3	0.3–71	0.3–71	NOUN
hls-11323	81	4	)	)	PUNCT
hls-11323	81	5	8.6	8.6	NUM
hls-11323	81	6	(	(	PUNCT
hls-11323	81	7	0.3–36	0.3–36	NUM
hls-11323	81	8	)	)	PUNCT
hls-11323	81	9	28	28	NUM
hls-11323	81	10	(	(	PUNCT
hls-11323	81	11	10–71	10–71	NUM
hls-11323	81	12	)	)	PUNCT
hls-11323	81	13	ferritin	ferritin	NOUN
hls-11323	81	14	(	(	PUNCT
hls-11323	81	15	ng	ng	NOUN
hls-11323	81	16	/	/	SYM
hls-11323	81	17	ml	ml	NOUN
hls-11323	81	18	)	)	PUNCT
hls-11323	81	19	mean±sd	mean±sd	PROPN
hls-11323	81	20	.	.	PUNCT
hls-11323	82	1	1308±2006.1	1308±2006.1	NUM
hls-11323	82	2	715.8±1188.6	715.8±1188.6	NUM
hls-11323	82	3	2788.8±2758.5	2788.8±2758.5	NUM
hls-11323	83	1	774.0	774.0	NUM
hls-11323	83	2	*	*	PUNCT
hls-11323	83	3	<	<	X
hls-11323	83	4	0.001	0.001	NUM
hls-11323	83	5	*	*	ADJ
hls-11323	83	6	median	median	PROPN
hls-11323	83	7	(	(	PUNCT
hls-11323	83	8	min.–max	min.–max	NOUN
hls-11323	83	9	.	.	PUNCT
hls-11323	83	10	)	)	PUNCT
hls-11323	84	1	642.5	642.5	NUM
hls-11323	84	2	(	(	PUNCT
hls-11323	84	3	14–10105	14–10105	NUM
hls-11323	84	4	)	)	PUNCT
hls-11323	84	5	354.5	354.5	NUM
hls-11323	84	6	(	(	PUNCT
hls-11323	84	7	14–7006	14–7006	NUM
hls-11323	84	8	)	)	PUNCT
hls-11323	84	9	1588	1588	NUM
hls-11323	84	10	(	(	PUNCT
hls-11323	84	11	21–10105	21–10105	NUM
hls-11323	84	12	)	)	PUNCT
hls-11323	84	13	ldh	ldh	NOUN
hls-11323	84	14	(	(	PUNCT
hls-11323	84	15	iu	iu	PROPN
hls-11323	84	16	/	/	SYM
hls-11323	84	17	l	l	NOUN
hls-11323	84	18	)	)	PUNCT
hls-11323	84	19	mean±sd	mean±sd	PROPN
hls-11323	84	20	.	.	PUNCT
hls-11323	85	1	585±590	585±590	NUM
hls-11323	85	2	380.7±246.7	380.7±246.7	NUM
hls-11323	85	3	1095.9±843.5	1095.9±843.5	NUM
hls-11323	85	4	336.50	336.50	NUM
hls-11323	85	5	*	*	PUNCT
hls-11323	86	1	<	<	X
hls-11323	86	2	0.001	0.001	NUM
hls-11323	86	3	*	*	ADJ
hls-11323	86	4	median	median	PROPN
hls-11323	86	5	(	(	PUNCT
hls-11323	86	6	min.–max	min.–max	NOUN
hls-11323	86	7	.	.	PUNCT
hls-11323	86	8	)	)	PUNCT
hls-11323	86	9	444	444	NUM
hls-11323	86	10	(	(	PUNCT
hls-11323	86	11	134–3894	134–3894	NUM
hls-11323	86	12	)	)	PUNCT
hls-11323	86	13	290.5	290.5	NUM
hls-11323	86	14	(	(	PUNCT
hls-11323	86	15	134–966	134–966	NUM
hls-11323	86	16	)	)	PUNCT
hls-11323	86	17	874.5	874.5	NUM
hls-11323	86	18	(	(	PUNCT
hls-11323	86	19	500–3894	500–3894	NUM
hls-11323	86	20	)	)	PUNCT
hls-11323	86	21	d	d	NOUN
hls-11323	86	22	-	-	PUNCT
hls-11323	86	23	dimer	dimer	NOUN
hls-11323	86	24	(	(	PUNCT
hls-11323	86	25	ng	ng	NOUN
hls-11323	86	26	/	/	SYM
hls-11323	86	27	ml	ml	NOUN
hls-11323	86	28	)	)	PUNCT
hls-11323	86	29	mean±sd	mean±sd	PROPN
hls-11323	86	30	.	.	PUNCT
hls-11323	87	1	4442±4943.2	4442±4943.2	NUM
hls-11323	88	1	2902.5±2873.8	2902.5±2873.8	NUM
hls-11323	88	2	8290.8±6697.2	8290.8±6697.2	NUM
hls-11323	88	3	677.0	677.0	NUM
hls-11323	88	4	*	*	PUNCT
hls-11323	88	5	<	<	X
hls-11323	88	6	0.001	0.001	NUM
hls-11323	88	7	*	*	ADJ
hls-11323	88	8	median	median	PROPN
hls-11323	88	9	(	(	PUNCT
hls-11323	88	10	min.–max	min.–max	NOUN
hls-11323	88	11	.	.	PUNCT
hls-11323	88	12	)	)	PUNCT
hls-11323	89	1	2427	2427	NUM
hls-11323	89	2	(	(	PUNCT
hls-11323	89	3	331–28809	331–28809	NUM
hls-11323	89	4	)	)	PUNCT
hls-11323	89	5	1581.8	1581.8	NUM
hls-11323	89	6	(	(	PUNCT
hls-11323	89	7	331–10177	331–10177	NUM
hls-11323	89	8	)	)	PUNCT
hls-11323	89	9	8524.5(1255–28809	8524.5(1255–28809	NUM
hls-11323	89	10	)	)	PUNCT
hls-11323	89	11	alt	alt	VERB
hls-11323	89	12	(	(	PUNCT
hls-11323	89	13	iu	iu	PROPN
hls-11323	89	14	/	/	SYM
hls-11323	89	15	l	l	NOUN
hls-11323	89	16	)	)	PUNCT
hls-11323	89	17	mean±sd	mean±sd	PROPN
hls-11323	89	18	.	.	PUNCT
hls-11323	89	19	91.2±230.2	91.2±230.2	NUM
hls-11323	90	1	42.5±32.7	42.5±32.7	NUM
hls-11323	90	2	212.9±406	212.9±406	NUM
hls-11323	90	3	1258.50	1258.50	NUM
hls-11323	90	4	*	*	SYM
hls-11323	90	5	0.001	0.001	NUM
hls-11323	90	6	*	*	NOUN
hls-11323	90	7	median	median	PROPN
hls-11323	90	8	(	(	PUNCT
hls-11323	90	9	min.–max	min.–max	NOUN
hls-11323	90	10	.	.	PUNCT
hls-11323	90	11	)	)	PUNCT
hls-11323	91	1	41	41	NUM
hls-11323	91	2	(	(	PUNCT
hls-11323	91	3	9–1577	9–1577	NOUN
hls-11323	91	4	)	)	PUNCT
hls-11323	91	5	35.5	35.5	NUM
hls-11323	91	6	(	(	PUNCT
hls-11323	91	7	9–148	9–148	NUM
hls-11323	91	8	)	)	PUNCT
hls-11323	91	9	91	91	NUM
hls-11323	91	10	(	(	PUNCT
hls-11323	91	11	11–1577	11–1577	NUM
hls-11323	91	12	)	)	PUNCT
hls-11323	91	13	ast	ast	NOUN
hls-11323	91	14	(	(	PUNCT
hls-11323	91	15	iu	iu	PROPN
hls-11323	91	16	/	/	SYM
hls-11323	91	17	l	l	NOUN
hls-11323	91	18	)	)	PUNCT
hls-11323	91	19	mean±sd	mean±sd	PROPN
hls-11323	91	20	.	.	PROPN
hls-11323	91	21	129.5±276.2	129.5±276.2	PROPN
hls-11323	91	22	54.2±51	54.2±51	NUM
hls-11323	91	23	318±462.9	318±462.9	NUM
hls-11323	91	24	727.0	727.0	NUM
hls-11323	91	25	*	*	PUNCT
hls-11323	91	26	<	<	X
hls-11323	91	27	0.001	0.001	NUM
hls-11323	91	28	*	*	ADJ
hls-11323	91	29	median	median	PROPN
hls-11323	91	30	(	(	PUNCT
hls-11323	91	31	min.–max	min.–max	NOUN
hls-11323	91	32	.	.	PUNCT
hls-11323	91	33	)	)	PUNCT
hls-11323	92	1	45.5	45.5	NUM
hls-11323	92	2	(	(	PUNCT
hls-11323	92	3	15–1692	15–1692	NUM
hls-11323	92	4	)	)	PUNCT
hls-11323	92	5	34	34	NUM
hls-11323	92	6	(	(	PUNCT
hls-11323	92	7	15–284	15–284	NUM
hls-11323	92	8	)	)	PUNCT
hls-11323	92	9	98.5	98.5	NUM
hls-11323	92	10	(	(	PUNCT
hls-11323	92	11	30–1692	30–1692	NUM
hls-11323	92	12	)	)	PUNCT
hls-11323	92	13	pt	pt	NOUN
hls-11323	92	14	(	(	PUNCT
hls-11323	92	15	seconds	second	NOUN
hls-11323	92	16	)	)	PUNCT
hls-11323	92	17	mean±sd	mean±sd	NOUN
hls-11323	92	18	.	.	NOUN
hls-11323	92	19	17.6±5.5	17.6±5.5	NUM
hls-11323	92	20	16.4±5.2	16.4±5.2	NUM
hls-11323	92	21	20.5±5.2	20.5±5.2	NUM
hls-11323	92	22	1042.0	1042.0	NUM
hls-11323	92	23	*	*	PUNCT
hls-11323	92	24	<	<	X
hls-11323	92	25	0.001	0.001	NUM
hls-11323	92	26	*	*	ADJ
hls-11323	92	27	median	median	PROPN
hls-11323	92	28	(	(	PUNCT
hls-11323	92	29	min.–max	min.–max	NOUN
hls-11323	92	30	.	.	PUNCT
hls-11323	92	31	)	)	PUNCT
hls-11323	92	32	16	16	NUM
hls-11323	92	33	(	(	PUNCT
hls-11323	92	34	1–33	1–33	NOUN
hls-11323	92	35	)	)	PUNCT
hls-11323	92	36	15.7	15.7	NUM
hls-11323	92	37	(	(	PUNCT
hls-11323	92	38	1–33	1–33	NOUN
hls-11323	92	39	)	)	PUNCT
hls-11323	92	40	18.1	18.1	NUM
hls-11323	92	41	(	(	PUNCT
hls-11323	92	42	15–32	15–32	NUM
hls-11323	92	43	)	)	PUNCT
hls-11323	92	44	aptt	aptt	PROPN
hls-11323	92	45	mean±sd	mean±sd	PROPN
hls-11323	92	46	.	.	PUNCT
hls-11323	93	1	41.4±13.5	41.4±13.5	NUM
hls-11323	93	2	39.7±13.7	39.7±13.7	NUM
hls-11323	93	3	45.5±12.2	45.5±12.2	NUM
hls-11323	93	4	1376.50	1376.50	NUM
hls-11323	93	5	*	*	NOUN
hls-11323	93	6	0.004	0.004	NUM
hls-11323	93	7	*	*	PUNCT
hls-11323	93	8	median	median	PROPN
hls-11323	93	9	(	(	PUNCT
hls-11323	93	10	min.–max	min.–max	NOUN
hls-11323	93	11	.	.	PUNCT
hls-11323	93	12	)	)	PUNCT
hls-11323	94	1	37.4	37.4	NUM
hls-11323	94	2	(	(	PUNCT
hls-11323	94	3	20–78	20–78	NUM
hls-11323	94	4	)	)	PUNCT
hls-11323	94	5	35	35	NUM
hls-11323	94	6	(	(	PUNCT
hls-11323	94	7	20–78	20–78	NUM
hls-11323	94	8	)	)	PUNCT
hls-11323	94	9	43	43	NUM
hls-11323	94	10	(	(	PUNCT
hls-11323	94	11	25–77	25–77	NUM
hls-11323	94	12	)	)	PUNCT
hls-11323	94	13	procalcitonin	procalcitonin	PROPN
hls-11323	94	14	(	(	PUNCT
hls-11323	94	15	ng	ng	PROPN
hls-11323	94	16	/	/	SYM
hls-11323	94	17	ml	ml	NOUN
hls-11323	94	18	)	)	PUNCT
hls-11323	94	19	mean±sd	mean±sd	PROPN
hls-11323	94	20	.	.	PUNCT
hls-11323	95	1	4.4±8.3	4.4±8.3	NUM
hls-11323	95	2	1.7±3.8	1.7±3.8	NUM
hls-11323	95	3	11.0±12.2	11.0±12.2	NUM
hls-11323	95	4	457.0	457.0	NUM
hls-11323	95	5	*	*	PUNCT
hls-11323	95	6	<	<	X
hls-11323	95	7	0.001	0.001	NUM
hls-11323	95	8	*	*	ADJ
hls-11323	95	9	median	median	PROPN
hls-11323	95	10	(	(	PUNCT
hls-11323	95	11	min.–max	min.–max	NOUN
hls-11323	95	12	.	.	PUNCT
hls-11323	95	13	)	)	PUNCT
hls-11323	96	1	1.2	1.2	NUM
hls-11323	96	2	(	(	PUNCT
hls-11323	96	3	0.03–45.0	0.03–45.0	PROPN
hls-11323	96	4	)	)	PUNCT
hls-11323	96	5	0.6	0.6	NUM
hls-11323	96	6	(	(	PUNCT
hls-11323	96	7	0.03–23.0	0.03–23.0	PROPN
hls-11323	96	8	)	)	PUNCT
hls-11323	96	9	5.9	5.9	NUM
hls-11323	96	10	(	(	PUNCT
hls-11323	96	11	0.2–45.0	0.2–45.0	NOUN
hls-11323	96	12	)	)	PUNCT
hls-11323	96	13	pro	pro	ADJ
hls-11323	96	14	-	-	ADJ
hls-11323	96	15	bnp	bnp	ADJ
hls-11323	96	16	(	(	PUNCT
hls-11323	96	17	pg	pg	NOUN
hls-11323	96	18	/	/	SYM
hls-11323	96	19	ml	ml	NOUN
hls-11323	96	20	)	)	PUNCT
hls-11323	96	21	mean±sd	mean±sd	PROPN
hls-11323	96	22	.	.	PROPN
hls-11323	96	23	4219.3±9446	4219.3±9446	PROPN
hls-11323	97	1	1121.8±1601.1	1121.8±1601.1	NUM
hls-11323	97	2	11963.1±15013.3	11963.1±15013.3	NUM
hls-11323	97	3	486.50	486.50	NUM
hls-11323	97	4	*	*	PUNCT
hls-11323	97	5	<	<	X
hls-11323	97	6	0.001	0.001	NUM
hls-11323	97	7	*	*	ADJ
hls-11323	97	8	median	median	PROPN
hls-11323	97	9	(	(	PUNCT
hls-11323	97	10	min.–max	min.–max	NOUN
hls-11323	97	11	.	.	PUNCT
hls-11323	97	12	)	)	PUNCT
hls-11323	98	1	784.5	784.5	NUM
hls-11323	99	1	(	(	PUNCT
hls-11323	99	2	43–45908	43–45908	NUM
hls-11323	99	3	)	)	PUNCT
hls-11323	99	4	556.5	556.5	NUM
hls-11323	99	5	(	(	PUNCT
hls-11323	99	6	43–8084	43–8084	NUM
hls-11323	99	7	)	)	PUNCT
hls-11323	99	8	6547.5	6547.5	NUM
hls-11323	99	9	(	(	PUNCT
hls-11323	99	10	300–45908	300–45908	NUM
hls-11323	99	11	)	)	PUNCT
hls-11323	99	12	sd	sd	NOUN
hls-11323	99	13	,	,	PUNCT
hls-11323	99	14	standard	standard	ADJ
hls-11323	99	15	deviation	deviation	NOUN
hls-11323	99	16	;	;	PUNCT
hls-11323	99	17	u	u	NOUN
hls-11323	99	18	,	,	PUNCT
hls-11323	99	19	mann	mann	PROPN
hls-11323	99	20	whitney	whitney	PROPN
hls-11323	99	21	test	test	NOUN
hls-11323	99	22	;	;	PUNCT
hls-11323	99	23	p	p	X
hls-11323	99	24	,	,	PUNCT
hls-11323	99	25	value	value	NOUN
hls-11323	99	26	for	for	ADP
hls-11323	99	27	comparing	compare	VERB
hls-11323	99	28	between	between	ADP
hls-11323	99	29	the	the	DET
hls-11323	99	30	studied	study	VERB
hls-11323	99	31	groups	group	NOUN
hls-11323	99	32	.	.	PUNCT
hls-11323	100	1	*	*	PUNCT
hls-11323	100	2	statistically	statistically	ADV
hls-11323	100	3	significant	significant	ADJ
hls-11323	100	4	at	at	ADP
hls-11323	100	5	p≤0.05	p≤0.05	PROPN
hls-11323	100	6	.	.	PUNCT
hls-11323	101	1	figure	figure	NOUN
hls-11323	101	2	1	1	NUM
hls-11323	101	3	.	.	NOUN
hls-11323	101	4	error	error	NOUN
hls-11323	101	5	bar	bar	NOUN
hls-11323	101	6	showing	show	VERB
hls-11323	101	7	differences	difference	NOUN
hls-11323	101	8	in	in	ADP
hls-11323	101	9	three	three	NUM
hls-11323	101	10	markers	marker	NOUN
hls-11323	101	11	between	between	ADP
hls-11323	101	12	discharged	discharge	VERB
hls-11323	101	13	and	and	CCONJ
hls-11323	101	14	deceased	deceased	ADJ
hls-11323	101	15	patients	patient	NOUN
hls-11323	101	16	.	.	PUNCT
hls-11323	102	1	[	[	X
hls-11323	102	2	healthcare	healthcare	NOUN
hls-11323	102	3	in	in	ADP
hls-11323	102	4	low	low	ADJ
hls-11323	102	5	-	-	PUNCT
hls-11323	102	6	resource	resource	NOUN
hls-11323	102	7	settings	setting	NOUN
hls-11323	102	8	2023	2023	NUM
hls-11323	102	9	;	;	PUNCT
hls-11323	102	10	11(s2):11323	11(s2):11323	NUM
hls-11323	102	11	]	]	PUNCT
hls-11323	103	1	[	[	X
hls-11323	103	2	page	page	NOUN
hls-11323	103	3	3	3	NUM
hls-11323	103	4	]	]	X
hls-11323	103	5	non	non	ADJ
hls-11323	103	6	-co	-co	PROPN
hls-11323	103	7	mmerc	mmerc	PROPN
hls-11323	103	8	ial	ial	PROPN
hls-11323	103	9	us	us	PROPN
hls-11323	103	10	e	e	NOUN
hls-11323	103	11	o	o	NOUN
hls-11323	103	12	nly	nly	ADV
hls-11323	103	13	more	more	ADV
hls-11323	103	14	than	than	ADP
hls-11323	103	15	discharged	discharge	VERB
hls-11323	103	16	patients	patient	NOUN
hls-11323	103	17	,	,	PUNCT
hls-11323	103	18	p<0.001	p<0.001	ADJ
hls-11323	103	19	.	.	PUNCT
hls-11323	104	1	d	d	X
hls-11323	104	2	-	-	PUNCT
hls-11323	104	3	dimer	dimer	NOUN
hls-11323	104	4	showed	show	VERB
hls-11323	104	5	mean	mean	ADJ
hls-11323	104	6	value	value	NOUN
hls-11323	104	7	of	of	ADP
hls-11323	104	8	4442±4943.2	4442±4943.2	NUM
hls-11323	104	9	ng	ng	NOUN
hls-11323	104	10	/	/	SYM
hls-11323	104	11	ml	ml	X
hls-11323	104	12	in	in	ADP
hls-11323	104	13	all	all	DET
hls-11323	104	14	covid-19	covid-19	PROPN
hls-11323	104	15	infected	infected	ADJ
hls-11323	104	16	patients	patient	NOUN
hls-11323	104	17	,	,	PUNCT
hls-11323	104	18	with	with	ADP
hls-11323	104	19	a	a	DET
hls-11323	104	20	mean	mean	NOUN
hls-11323	104	21	of	of	ADP
hls-11323	104	22	2902.5±2873.8	2902.5±2873.8	PROPN
hls-11323	104	23	ng	ng	PROPN
hls-11323	104	24	/	/	SYM
hls-11323	104	25	ml	ml	PROPN
hls-11323	104	26	in	in	ADP
hls-11323	104	27	discharged	discharge	VERB
hls-11323	104	28	patients	patient	NOUN
hls-11323	104	29	,	,	PUNCT
hls-11323	104	30	and	and	CCONJ
hls-11323	104	31	a	a	DET
hls-11323	104	32	mean	mean	NOUN
hls-11323	104	33	of	of	ADP
hls-11323	104	34	8290.8±6697.2	8290.8±6697.2	NUM
hls-11323	104	35	ng	ng	NOUN
hls-11323	104	36	/	/	SYM
hls-11323	104	37	ml	ml	X
hls-11323	104	38	in	in	ADP
hls-11323	104	39	deceased	deceased	ADJ
hls-11323	104	40	patients	patient	NOUN
hls-11323	104	41	,	,	PUNCT
hls-11323	104	42	the	the	DET
hls-11323	104	43	increase	increase	NOUN
hls-11323	104	44	in	in	ADP
hls-11323	104	45	d	d	NOUN
hls-11323	104	46	-	-	PUNCT
hls-11323	104	47	dimer	dimer	NOUN
hls-11323	104	48	was	be	AUX
hls-11323	104	49	highly	highly	ADV
hls-11323	104	50	significant	significant	ADJ
hls-11323	104	51	in	in	ADP
hls-11323	104	52	deceased	deceased	ADJ
hls-11323	104	53	patients	patient	NOUN
hls-11323	104	54	,	,	PUNCT
hls-11323	104	55	p<0.001	p<0.001	PROPN
hls-11323	104	56	.	.	PUNCT
hls-11323	105	1	alt	alt	PROPN
hls-11323	105	2	showed	show	VERB
hls-11323	105	3	mean	mean	ADJ
hls-11323	105	4	value	value	NOUN
hls-11323	105	5	of	of	ADP
hls-11323	105	6	91.2±230.2	91.2±230.2	NOUN
hls-11323	105	7	iu	iu	NOUN
hls-11323	105	8	/	/	SYM
hls-11323	105	9	l	l	NOUN
hls-11323	105	10	in	in	ADP
hls-11323	105	11	all	all	DET
hls-11323	105	12	covid-19	covid-19	PROPN
hls-11323	105	13	infected	infected	ADJ
hls-11323	105	14	patients	patient	NOUN
hls-11323	105	15	,	,	PUNCT
hls-11323	105	16	with	with	ADP
hls-11323	105	17	a	a	DET
hls-11323	105	18	mean	mean	NOUN
hls-11323	105	19	of	of	ADP
hls-11323	105	20	42.5±32.7	42.5±32.7	NUM
hls-11323	105	21	iu	iu	NOUN
hls-11323	105	22	/	/	SYM
hls-11323	105	23	l	l	NOUN
hls-11323	105	24	in	in	ADP
hls-11323	105	25	discharged	discharge	VERB
hls-11323	105	26	patients	patient	NOUN
hls-11323	105	27	,	,	PUNCT
hls-11323	105	28	and	and	CCONJ
hls-11323	105	29	a	a	DET
hls-11323	105	30	mean	mean	NOUN
hls-11323	105	31	of	of	ADP
hls-11323	105	32	212.9±406	212.9±406	NUM
hls-11323	105	33	iu	iu	NOUN
hls-11323	105	34	/	/	SYM
hls-11323	105	35	l	l	NOUN
hls-11323	105	36	in	in	ADP
hls-11323	105	37	deceased	deceased	ADJ
hls-11323	105	38	patients	patient	NOUN
hls-11323	105	39	,	,	PUNCT
hls-11323	105	40	there	there	PRON
hls-11323	105	41	was	be	VERB
hls-11323	105	42	a	a	DET
hls-11323	105	43	significant	significant	ADJ
hls-11323	105	44	increase	increase	NOUN
hls-11323	105	45	of	of	ADP
hls-11323	105	46	alt	alt	NOUN
hls-11323	105	47	in	in	ADP
hls-11323	105	48	deceased	deceased	ADJ
hls-11323	105	49	patients	patient	NOUN
hls-11323	105	50	more	more	ADV
hls-11323	105	51	than	than	ADP
hls-11323	105	52	discharged	discharge	VERB
hls-11323	105	53	patients	patient	NOUN
hls-11323	105	54	,	,	PUNCT
hls-11323	105	55	p=0.001	p=0.001	PROPN
hls-11323	105	56	.	.	PUNCT
hls-11323	106	1	ast	ast	PROPN
hls-11323	106	2	showed	show	VERB
hls-11323	106	3	mean	mean	ADJ
hls-11323	106	4	value	value	NOUN
hls-11323	106	5	of	of	ADP
hls-11323	106	6	129.5±276.2	129.5±276.2	PROPN
hls-11323	106	7	iu	iu	PROPN
hls-11323	106	8	/	/	SYM
hls-11323	106	9	l	l	NOUN
hls-11323	106	10	in	in	ADP
hls-11323	106	11	all	all	DET
hls-11323	106	12	covid19	covid19	NOUN
hls-11323	106	13	infected	infect	VERB
hls-11323	106	14	patients	patient	NOUN
hls-11323	106	15	,	,	PUNCT
hls-11323	106	16	with	with	ADP
hls-11323	106	17	a	a	DET
hls-11323	106	18	mean	mean	NOUN
hls-11323	106	19	of	of	ADP
hls-11323	106	20	54.2±51	54.2±51	NUM
hls-11323	106	21	iu	iu	NOUN
hls-11323	106	22	/	/	SYM
hls-11323	106	23	l	l	NOUN
hls-11323	106	24	in	in	ADP
hls-11323	106	25	discharged	discharge	VERB
hls-11323	106	26	patients	patient	NOUN
hls-11323	106	27	,	,	PUNCT
hls-11323	106	28	and	and	CCONJ
hls-11323	106	29	a	a	DET
hls-11323	106	30	mean	mean	NOUN
hls-11323	106	31	of	of	ADP
hls-11323	106	32	318±462.9	318±462.9	NUM
hls-11323	106	33	iu	iu	NOUN
hls-11323	106	34	/	/	SYM
hls-11323	106	35	l	l	NOUN
hls-11323	106	36	in	in	ADP
hls-11323	106	37	deceased	deceased	ADJ
hls-11323	106	38	patients	patient	NOUN
hls-11323	106	39	,	,	PUNCT
hls-11323	106	40	there	there	PRON
hls-11323	106	41	was	be	VERB
hls-11323	106	42	a	a	DET
hls-11323	106	43	significant	significant	ADJ
hls-11323	106	44	increase	increase	NOUN
hls-11323	106	45	of	of	ADP
hls-11323	106	46	ast	ast	NOUN
hls-11323	106	47	in	in	ADP
hls-11323	106	48	deceased	deceased	ADJ
hls-11323	106	49	patients	patient	NOUN
hls-11323	106	50	more	more	ADV
hls-11323	106	51	than	than	ADP
hls-11323	106	52	discharged	discharge	VERB
hls-11323	106	53	patients	patient	NOUN
hls-11323	106	54	,	,	PUNCT
hls-11323	106	55	p<0.001	p<0.001	PROPN
hls-11323	106	56	.	.	PUNCT
hls-11323	107	1	pt	pt	PROPN
hls-11323	107	2	showed	show	VERB
hls-11323	107	3	mean	mean	ADJ
hls-11323	107	4	value	value	NOUN
hls-11323	107	5	of	of	ADP
hls-11323	107	6	17.6±5.5	17.6±5.5	NUM
hls-11323	107	7	seconds	second	NOUN
hls-11323	107	8	in	in	ADP
hls-11323	107	9	all	all	DET
hls-11323	107	10	covid-19	covid-19	PROPN
hls-11323	107	11	infected	infected	ADJ
hls-11323	107	12	patients	patient	NOUN
hls-11323	107	13	,	,	PUNCT
hls-11323	107	14	with	with	ADP
hls-11323	107	15	a	a	DET
hls-11323	107	16	mean	mean	NOUN
hls-11323	107	17	of	of	ADP
hls-11323	107	18	16.4±5.2	16.4±5.2	NUM
hls-11323	107	19	seconds	second	NOUN
hls-11323	107	20	in	in	ADP
hls-11323	107	21	discharged	discharge	VERB
hls-11323	107	22	patients	patient	NOUN
hls-11323	107	23	,	,	PUNCT
hls-11323	107	24	and	and	CCONJ
hls-11323	107	25	a	a	DET
hls-11323	107	26	mean	mean	NOUN
hls-11323	107	27	of	of	ADP
hls-11323	107	28	20.5±5.2	20.5±5.2	NUM
hls-11323	107	29	seconds	second	NOUN
hls-11323	107	30	in	in	ADP
hls-11323	107	31	deceased	deceased	ADJ
hls-11323	107	32	patients	patient	NOUN
hls-11323	107	33	,	,	PUNCT
hls-11323	107	34	pt	pt	PROPN
hls-11323	107	35	showed	show	VERB
hls-11323	107	36	high	high	ADJ
hls-11323	107	37	significant	significant	ADJ
hls-11323	107	38	increase	increase	NOUN
hls-11323	107	39	in	in	ADP
hls-11323	107	40	deceased	deceased	ADJ
hls-11323	107	41	patients	patient	NOUN
hls-11323	107	42	more	more	ADV
hls-11323	107	43	than	than	ADP
hls-11323	107	44	discharged	discharge	VERB
hls-11323	107	45	patients	patient	NOUN
hls-11323	107	46	,	,	PUNCT
hls-11323	107	47	p<0.001	p<0.001	PROPN
hls-11323	107	48	.	.	PUNCT
hls-11323	108	1	aptt	aptt	PROPN
hls-11323	108	2	showed	show	VERB
hls-11323	108	3	mean	mean	ADJ
hls-11323	108	4	value	value	NOUN
hls-11323	108	5	of	of	ADP
hls-11323	108	6	41.4±13.5	41.4±13.5	NUM
hls-11323	108	7	seconds	second	NOUN
hls-11323	108	8	in	in	ADP
hls-11323	108	9	all	all	DET
hls-11323	108	10	covid19	covid19	NOUN
hls-11323	108	11	infected	infect	VERB
hls-11323	108	12	patients	patient	NOUN
hls-11323	108	13	,	,	PUNCT
hls-11323	108	14	with	with	ADP
hls-11323	108	15	a	a	DET
hls-11323	108	16	mean	mean	NOUN
hls-11323	108	17	of	of	ADP
hls-11323	108	18	39.7±13.7	39.7±13.7	NUM
hls-11323	108	19	seconds	second	NOUN
hls-11323	108	20	in	in	ADP
hls-11323	108	21	discharged	discharge	VERB
hls-11323	108	22	patients	patient	NOUN
hls-11323	108	23	,	,	PUNCT
hls-11323	108	24	and	and	CCONJ
hls-11323	108	25	a	a	DET
hls-11323	108	26	mean	mean	NOUN
hls-11323	108	27	of	of	ADP
hls-11323	108	28	45.5±12.2	45.5±12.2	NUM
hls-11323	108	29	seconds	second	NOUN
hls-11323	108	30	in	in	ADP
hls-11323	108	31	deceased	deceased	ADJ
hls-11323	108	32	patients	patient	NOUN
hls-11323	108	33	,	,	PUNCT
hls-11323	108	34	aptt	aptt	PROPN
hls-11323	108	35	showed	show	VERB
hls-11323	108	36	significant	significant	ADJ
hls-11323	108	37	increase	increase	NOUN
hls-11323	108	38	in	in	ADP
hls-11323	108	39	deceased	deceased	ADJ
hls-11323	108	40	patients	patient	NOUN
hls-11323	108	41	more	more	ADV
hls-11323	108	42	than	than	ADP
hls-11323	108	43	discharged	discharge	VERB
hls-11323	108	44	patients	patient	NOUN
hls-11323	108	45	,	,	PUNCT
hls-11323	108	46	p<0.004	p<0.004	NOUN
hls-11323	108	47	.	.	PUNCT
hls-11323	109	1	pct	pct	NOUN
hls-11323	109	2	showed	show	VERB
hls-11323	109	3	mean	mean	ADJ
hls-11323	109	4	value	value	NOUN
hls-11323	109	5	of	of	ADP
hls-11323	109	6	4.4±8.3	4.4±8.3	PROPN
hls-11323	109	7	ng	ng	PROPN
hls-11323	109	8	/	/	SYM
hls-11323	109	9	ml	ml	NOUN
hls-11323	109	10	in	in	ADP
hls-11323	109	11	all	all	DET
hls-11323	109	12	covid-19	covid-19	PROPN
hls-11323	109	13	infected	infected	ADJ
hls-11323	109	14	patients	patient	NOUN
hls-11323	109	15	,	,	PUNCT
hls-11323	109	16	with	with	ADP
hls-11323	109	17	a	a	DET
hls-11323	109	18	mean	mean	NOUN
hls-11323	109	19	of	of	ADP
hls-11323	109	20	1.7±3.8	1.7±3.8	NUM
hls-11323	109	21	ng	ng	NOUN
hls-11323	109	22	/	/	SYM
hls-11323	109	23	ml	ml	PROPN
hls-11323	109	24	in	in	ADP
hls-11323	109	25	discharged	discharge	VERB
hls-11323	109	26	patients	patient	NOUN
hls-11323	109	27	,	,	PUNCT
hls-11323	109	28	and	and	CCONJ
hls-11323	109	29	a	a	DET
hls-11323	109	30	mean	mean	NOUN
hls-11323	109	31	of	of	ADP
hls-11323	109	32	11.0±12.2	11.0±12.2	PROPN
hls-11323	109	33	ng	ng	PROPN
hls-11323	109	34	/	/	SYM
hls-11323	109	35	ml	ml	X
hls-11323	109	36	in	in	ADP
hls-11323	109	37	deceased	deceased	ADJ
hls-11323	109	38	patients	patient	NOUN
hls-11323	109	39	,	,	PUNCT
hls-11323	109	40	pct	pct	NOUN
hls-11323	109	41	showed	show	VERB
hls-11323	109	42	highly	highly	ADV
hls-11323	109	43	significant	significant	ADJ
hls-11323	109	44	increase	increase	NOUN
hls-11323	109	45	in	in	ADP
hls-11323	109	46	deceased	deceased	ADJ
hls-11323	109	47	patients	patient	NOUN
hls-11323	109	48	more	more	ADV
hls-11323	109	49	than	than	ADP
hls-11323	109	50	discharged	discharge	VERB
hls-11323	109	51	patients	patient	NOUN
hls-11323	109	52	,	,	PUNCT
hls-11323	109	53	p<0.001	p<0.001	ADJ
hls-11323	109	54	.	.	PUNCT
hls-11323	110	1	pro	pro	ADJ
hls-11323	110	2	-	-	ADJ
hls-11323	110	3	bnp	bnp	PROPN
hls-11323	110	4	showed	show	VERB
hls-11323	110	5	mean	mean	ADJ
hls-11323	110	6	value	value	NOUN
hls-11323	110	7	of	of	ADP
hls-11323	110	8	4219.3±9446	4219.3±9446	NOUN
hls-11323	110	9	pg	pg	AUX
hls-11323	110	10	/	/	SYM
hls-11323	110	11	ml	ml	X
hls-11323	110	12	in	in	ADP
hls-11323	110	13	all	all	DET
hls-11323	110	14	covid-19	covid-19	PROPN
hls-11323	110	15	infected	infected	ADJ
hls-11323	110	16	patients	patient	NOUN
hls-11323	110	17	,	,	PUNCT
hls-11323	110	18	with	with	ADP
hls-11323	110	19	a	a	DET
hls-11323	110	20	mean	mean	NOUN
hls-11323	110	21	of	of	ADP
hls-11323	110	22	1121.8±1601.1	1121.8±1601.1	NUM
hls-11323	110	23	pg	pg	NOUN
hls-11323	110	24	/	/	SYM
hls-11323	110	25	ml	ml	PROPN
hls-11323	110	26	in	in	ADP
hls-11323	110	27	discharged	discharge	VERB
hls-11323	110	28	patients	patient	NOUN
hls-11323	110	29	,	,	PUNCT
hls-11323	110	30	and	and	CCONJ
hls-11323	110	31	a	a	DET
hls-11323	110	32	mean	mean	NOUN
hls-11323	110	33	of	of	ADP
hls-11323	110	34	11963.1±15013.3	11963.1±15013.3	NUM
hls-11323	110	35	pg	pg	NOUN
hls-11323	110	36	/	/	SYM
hls-11323	110	37	ml	ml	X
hls-11323	110	38	in	in	ADP
hls-11323	110	39	deceased	deceased	ADJ
hls-11323	110	40	patients	patient	NOUN
hls-11323	110	41	,	,	PUNCT
hls-11323	110	42	there	there	PRON
hls-11323	110	43	was	be	VERB
hls-11323	110	44	a	a	DET
hls-11323	110	45	high	high	ADJ
hls-11323	110	46	significant	significant	ADJ
hls-11323	110	47	increase	increase	NOUN
hls-11323	110	48	of	of	ADP
hls-11323	110	49	pro	pro	ADJ
hls-11323	110	50	-	-	ADJ
hls-11323	110	51	bnp	bnp	ADJ
hls-11323	110	52	in	in	ADP
hls-11323	110	53	deceased	deceased	ADJ
hls-11323	110	54	patients	patient	NOUN
hls-11323	110	55	more	more	ADV
hls-11323	110	56	than	than	ADP
hls-11323	110	57	discharged	discharge	VERB
hls-11323	110	58	patients	patient	NOUN
hls-11323	110	59	,	,	PUNCT
hls-11323	110	60	p<0.001	p<0.001	PROPN
hls-11323	110	61	.	.	PUNCT
hls-11323	111	1	to	to	PART
hls-11323	111	2	detect	detect	VERB
hls-11323	111	3	if	if	SCONJ
hls-11323	111	4	the	the	DET
hls-11323	111	5	previous	previous	ADJ
hls-11323	111	6	laboratory	laboratory	NOUN
hls-11323	111	7	investigations	investigation	NOUN
hls-11323	111	8	were	be	AUX
hls-11323	111	9	accurate	accurate	ADJ
hls-11323	111	10	in	in	ADP
hls-11323	111	11	predicting	predict	VERB
hls-11323	111	12	mortality	mortality	NOUN
hls-11323	111	13	,	,	PUNCT
hls-11323	111	14	we	we	PRON
hls-11323	111	15	used	use	VERB
hls-11323	111	16	the	the	DET
hls-11323	111	17	area	area	NOUN
hls-11323	111	18	under	under	ADP
hls-11323	111	19	the	the	DET
hls-11323	111	20	curve	curve	NOUN
hls-11323	111	21	(	(	PUNCT
hls-11323	111	22	auc	auc	NOUN
hls-11323	111	23	)	)	PUNCT
hls-11323	111	24	and	and	CCONJ
hls-11323	111	25	95	95	NUM
hls-11323	111	26	%	%	NOUN
hls-11323	111	27	ci	ci	NOUN
hls-11323	111	28	of	of	ADP
hls-11323	111	29	the	the	DET
hls-11323	111	30	receiver	receiver	ADJ
hls-11323	111	31	operator	operator	NOUN
hls-11323	111	32	characteristic	characteristic	ADJ
hls-11323	111	33	(	(	PUNCT
hls-11323	111	34	roc	roc	PROPN
hls-11323	111	35	)	)	PUNCT
hls-11323	111	36	curve	curve	NOUN
hls-11323	111	37	.	.	PUNCT
hls-11323	112	1	we	we	PRON
hls-11323	112	2	found	find	VERB
hls-11323	112	3	that	that	SCONJ
hls-11323	112	4	there	there	PRON
hls-11323	112	5	was	be	VERB
hls-11323	112	6	significant	significant	ADJ
hls-11323	112	7	prognostic	prognostic	ADJ
hls-11323	112	8	performance	performance	NOUN
hls-11323	112	9	of	of	ADP
hls-11323	112	10	crp	crp	PROPN
hls-11323	112	11	,	,	PUNCT
hls-11323	112	12	ferritin	ferritin	PROPN
hls-11323	112	13	,	,	PUNCT
hls-11323	112	14	ldh	ldh	PROPN
hls-11323	112	15	,	,	PUNCT
hls-11323	112	16	d	d	NOUN
hls-11323	112	17	-	-	PUNCT
hls-11323	112	18	dimer	dimer	ADJ
hls-11323	112	19	,	,	PUNCT
hls-11323	112	20	pcct	pcct	NOUN
hls-11323	112	21	and	and	CCONJ
hls-11323	112	22	pro	pro	ADJ
hls-11323	112	23	-	-	ADJ
hls-11323	112	24	bnp	bnp	ADJ
hls-11323	112	25	with	with	ADP
hls-11323	112	26	mortality	mortality	NOUN
hls-11323	112	27	,	,	PUNCT
hls-11323	112	28	and	and	CCONJ
hls-11323	112	29	the	the	DET
hls-11323	112	30	highest	high	ADJ
hls-11323	112	31	performance	performance	NOUN
hls-11323	112	32	of	of	ADP
hls-11323	112	33	variables	variable	NOUN
hls-11323	112	34	were	be	AUX
hls-11323	112	35	,	,	PUNCT
hls-11323	112	36	ldh	ldh	VERB
hls-11323	112	37	>	>	X
hls-11323	112	38	pct	pct	NOUN
hls-11323	112	39	>	>	X
hls-11323	112	40	pro	pro	ADJ
hls-11323	112	41	-	-	ADJ
hls-11323	112	42	bnp	bnp	ADJ
hls-11323	112	43	>	>	SYM
hls-11323	112	44	crp	crp	PROPN
hls-11323	112	45	,	,	PUNCT
hls-11323	112	46	and	and	CCONJ
hls-11323	112	47	the	the	DET
hls-11323	112	48	least	least	ADJ
hls-11323	112	49	was	be	AUX
hls-11323	112	50	d	d	NOUN
hls-11323	112	51	-	-	PUNCT
hls-11323	112	52	dimer	dimer	NOUN
hls-11323	112	53	and	and	CCONJ
hls-11323	112	54	ferritin	ferritin	NOUN
hls-11323	112	55	.	.	PUNCT
hls-11323	113	1	the	the	DET
hls-11323	113	2	cut	cut	VERB
hls-11323	113	3	off	off	ADP
hls-11323	113	4	value	value	NOUN
hls-11323	113	5	for	for	ADP
hls-11323	113	6	ldh	ldh	PROPN
hls-11323	113	7	was	be	AUX
hls-11323	113	8	>	>	X
hls-11323	113	9	500	500	NUM
hls-11323	113	10	iu	iu	PROPN
hls-11323	113	11	/	/	SYM
hls-11323	113	12	l	l	NOUN
hls-11323	113	13	,	,	PUNCT
hls-11323	113	14	for	for	ADP
hls-11323	113	15	pct	pct	NOUN
hls-11323	113	16	was	be	AUX
hls-11323	113	17	>	>	X
hls-11323	113	18	2.09	2.09	NUM
hls-11323	113	19	ng	ng	NOUN
hls-11323	113	20	/	/	SYM
hls-11323	113	21	ml	ml	PROPN
hls-11323	113	22	,	,	PUNCT
hls-11323	113	23	for	for	ADP
hls-11323	113	24	probnp	probnp	NOUN
hls-11323	113	25	was	be	AUX
hls-11323	113	26	>	>	X
hls-11323	113	27	1755	1755	NUM
hls-11323	113	28	pg	pg	NOUN
hls-11323	113	29	/	/	SYM
hls-11323	113	30	ml	ml	ADP
hls-11323	113	31	,	,	PUNCT
hls-11323	113	32	and	and	CCONJ
hls-11323	113	33	for	for	ADP
hls-11323	113	34	crp	crp	PROPN
hls-11323	113	35	>	>	X
hls-11323	113	36	15.4	15.4	NUM
hls-11323	113	37	mg	mg	PROPN
hls-11323	113	38	/	/	SYM
hls-11323	113	39	l.	l.	PROPN
hls-11323	113	40	(	(	PUNCT
hls-11323	113	41	table	table	NOUN
hls-11323	113	42	3	3	NUM
hls-11323	113	43	,	,	PUNCT
hls-11323	113	44	figure	figure	NOUN
hls-11323	113	45	2	2	NUM
hls-11323	113	46	)	)	PUNCT
hls-11323	113	47	.	.	PUNCT
hls-11323	114	1	univariate	univariate	ADJ
hls-11323	114	2	analysis	analysis	NOUN
hls-11323	114	3	showed	show	VERB
hls-11323	114	4	that	that	SCONJ
hls-11323	114	5	each	each	DET
hls-11323	114	6	one	one	NUM
hls-11323	114	7	of	of	ADP
hls-11323	114	8	the	the	DET
hls-11323	114	9	variables	variable	NOUN
hls-11323	114	10	was	be	AUX
hls-11323	114	11	associated	associate	VERB
hls-11323	114	12	with	with	ADP
hls-11323	114	13	mortality	mortality	NOUN
hls-11323	114	14	after	after	ADP
hls-11323	114	15	adjustment	adjustment	NOUN
hls-11323	114	16	with	with	ADP
hls-11323	114	17	alt	alt	ADJ
hls-11323	114	18	,	,	PUNCT
hls-11323	114	19	ast	ast	PROPN
hls-11323	114	20	,	,	PUNCT
hls-11323	114	21	pt	pt	PROPN
hls-11323	114	22	,	,	PUNCT
hls-11323	114	23	article	article	NOUN
hls-11323	114	24	table	table	NOUN
hls-11323	114	25	3	3	NUM
hls-11323	114	26	.	.	PUNCT
hls-11323	114	27	prognostic	prognostic	ADJ
hls-11323	114	28	performance	performance	NOUN
hls-11323	114	29	for	for	ADP
hls-11323	114	30	crp	crp	PROPN
hls-11323	114	31	,	,	PUNCT
hls-11323	114	32	ferritin	ferritin	PROPN
hls-11323	114	33	,	,	PUNCT
hls-11323	114	34	ldh	ldh	PROPN
hls-11323	114	35	,	,	PUNCT
hls-11323	114	36	d.	d.	PROPN
hls-11323	114	37	dimer	dimer	PROPN
hls-11323	114	38	,	,	PUNCT
hls-11323	114	39	procalcitonin	procalcitonin	ADJ
hls-11323	114	40	and	and	CCONJ
hls-11323	114	41	pro	pro	ADJ
hls-11323	114	42	-	-	ADJ
hls-11323	114	43	bnp	bnp	ADJ
hls-11323	114	44	to	to	PART
hls-11323	114	45	predict	predict	VERB
hls-11323	114	46	mortality	mortality	NOUN
hls-11323	114	47	(	(	PUNCT
hls-11323	114	48	n=40	n=40	PROPN
hls-11323	114	49	)	)	PUNCT
hls-11323	114	50	from	from	ADP
hls-11323	114	51	discharged	discharge	VERB
hls-11323	114	52	(	(	PUNCT
hls-11323	114	53	n=100	n=100	NUM
hls-11323	114	54	)	)	PUNCT
hls-11323	114	55	.	.	PUNCT
hls-11323	115	1	auc	auc	VERB
hls-11323	115	2	p	p	PRON
hls-11323	116	1	95	95	NUM
hls-11323	116	2	%	%	NOUN
hls-11323	116	3	c.i	c.i	NOUN
hls-11323	116	4	cut	cut	VERB
hls-11323	116	5	off	off	ADP
hls-11323	116	6	sensitivity	sensitivity	NOUN
hls-11323	116	7	specificity	specificity	NOUN
hls-11323	116	8	ppv	ppv	NOUN
hls-11323	116	9	npv	npv	PROPN
hls-11323	116	10	crp	crp	PROPN
hls-11323	116	11	0.864	0.864	NUM
hls-11323	116	12	<	<	X
hls-11323	116	13	0.001	0.001	NUM
hls-11323	116	14	*	*	SYM
hls-11323	116	15	0.803–0.926	0.803–0.926	NUM
hls-11323	116	16	>	>	PUNCT
hls-11323	116	17	15.4	15.4	NUM
hls-11323	116	18	80.0	80.0	NUM
hls-11323	116	19	69.0	69.0	NUM
hls-11323	116	20	50.8	50.8	NUM
hls-11323	116	21	89.6	89.6	NUM
hls-11323	116	22	ferritin	ferritin	ADJ
hls-11323	116	23	0.807	0.807	NUM
hls-11323	116	24	<	<	NOUN
hls-11323	116	25	0.001	0.001	NUM
hls-11323	116	26	*	*	PUNCT
hls-11323	116	27	0.718–0.895	0.718–0.895	NOUN
hls-11323	116	28	>	>	X
hls-11323	116	29	677	677	NUM
hls-11323	116	30	#	#	NOUN
hls-11323	116	31	87.50	87.50	NUM
hls-11323	116	32	70.0	70.0	NUM
hls-11323	116	33	53.8	53.8	NUM
hls-11323	116	34	93.3	93.3	NUM
hls-11323	116	35	ldh	ldh	NOUN
hls-11323	116	36	0.916	0.916	NUM
hls-11323	116	37	<	<	X
hls-11323	116	38	0.001	0.001	NUM
hls-11323	116	39	*	*	PUNCT
hls-11323	116	40	0.872–0.960	0.872–0.960	NUM
hls-11323	116	41	>	>	PUNCT
hls-11323	117	1	500	500	NUM
hls-11323	117	2	97.50	97.50	NUM
hls-11323	117	3	78.0	78.0	NUM
hls-11323	117	4	63.9	63.9	NUM
hls-11323	117	5	98.7	98.7	NUM
hls-11323	117	6	d.	d.	PROPN
hls-11323	117	7	dimer	dimer	NOUN
hls-11323	117	8	0.831	0.831	NUM
hls-11323	117	9	<	<	X
hls-11323	117	10	0.001	0.001	NUM
hls-11323	117	11	*	*	SYM
hls-11323	117	12	0.761–0.900	0.761–0.900	PROPN
hls-11323	117	13	>	>	PUNCT
hls-11323	117	14	2188	2188	NUM
hls-11323	117	15	#	#	NOUN
hls-11323	117	16	92.50	92.50	NUM
hls-11323	117	17	63.0	63.0	NUM
hls-11323	117	18	50.0	50.0	NUM
hls-11323	117	19	95.5	95.5	NUM
hls-11323	117	20	procalcitonin	procalcitonin	VERB
hls-11323	117	21	0.886	0.886	NUM
hls-11323	117	22	<	<	NOUN
hls-11323	117	23	0.001	0.001	NUM
hls-11323	117	24	*	*	PUNCT
hls-11323	117	25	0.815–0.957	0.815–0.957	NOUN
hls-11323	117	26	>	>	X
hls-11323	117	27	2.09	2.09	NUM
hls-11323	117	28	90.0	90.0	NUM
hls-11323	117	29	79.0	79.0	NUM
hls-11323	117	30	63.2	63.2	NUM
hls-11323	117	31	95.2	95.2	NUM
hls-11323	117	32	pro	pro	ADJ
hls-11323	117	33	-	-	ADJ
hls-11323	117	34	bnp	bnp	ADJ
hls-11323	117	35	0.878	0.878	NUM
hls-11323	117	36	<	<	NOUN
hls-11323	117	37	0.001	0.001	NUM
hls-11323	117	38	*	*	NOUN
hls-11323	117	39	0.806–0.950	0.806–0.950	NOUN
hls-11323	117	40	>	>	X
hls-11323	117	41	1755	1755	NUM
hls-11323	117	42	#	#	NOUN
hls-11323	117	43	85.0	85.0	NUM
hls-11323	117	44	84.0	84.0	NUM
hls-11323	117	45	68.0	68.0	NUM
hls-11323	117	46	93.3	93.3	NUM
hls-11323	117	47	auc	auc	NOUN
hls-11323	117	48	,	,	PUNCT
hls-11323	117	49	area	area	NOUN
hls-11323	117	50	under	under	ADP
hls-11323	117	51	a	a	DET
hls-11323	117	52	curve	curve	NOUN
hls-11323	117	53	;	;	PUNCT
hls-11323	117	54	p	p	NOUN
hls-11323	117	55	value	value	NOUN
hls-11323	117	56	:	:	PUNCT
hls-11323	117	57	probability	probability	NOUN
hls-11323	117	58	value	value	NOUN
hls-11323	117	59	;	;	PUNCT
hls-11323	117	60	ci	ci	NOUN
hls-11323	117	61	,	,	PUNCT
hls-11323	117	62	confidence	confidence	NOUN
hls-11323	117	63	intervals	interval	NOUN
hls-11323	117	64	;	;	PUNCT
hls-11323	117	65	npv	npv	NOUN
hls-11323	117	66	,	,	PUNCT
hls-11323	117	67	negative	negative	ADJ
hls-11323	117	68	predictive	predictive	ADJ
hls-11323	117	69	value	value	NOUN
hls-11323	117	70	;	;	PUNCT
hls-11323	117	71	ppv	ppv	NOUN
hls-11323	117	72	,	,	PUNCT
hls-11323	117	73	positive	positive	ADJ
hls-11323	117	74	predictive	predictive	ADJ
hls-11323	117	75	value	value	NOUN
hls-11323	117	76	.	.	PUNCT
hls-11323	118	1	*	*	PUNCT
hls-11323	118	2	statistically	statistically	ADV
hls-11323	118	3	significant	significant	ADJ
hls-11323	118	4	at	at	ADP
hls-11323	118	5	p≤0.05	p≤0.05	NOUN
hls-11323	118	6	.	.	PUNCT
hls-11323	119	1	#	#	ADJ
hls-11323	119	2	cut	cut	VERB
hls-11323	119	3	off	off	ADP
hls-11323	119	4	was	be	AUX
hls-11323	119	5	choose	choose	ADJ
hls-11323	119	6	according	accord	VERB
hls-11323	119	7	to	to	ADP
hls-11323	119	8	youden	youden	PROPN
hls-11323	119	9	index	index	NOUN
hls-11323	119	10	.	.	PUNCT
hls-11323	120	1	table	table	NOUN
hls-11323	120	2	4	4	NUM
hls-11323	120	3	.	.	PUNCT
hls-11323	120	4	univariate	univariate	ADJ
hls-11323	120	5	and	and	CCONJ
hls-11323	120	6	multivariate	multivariate	VERB
hls-11323	120	7	logistic	logistic	ADJ
hls-11323	120	8	regression	regression	NOUN
hls-11323	120	9	analysis	analysis	NOUN
hls-11323	120	10	for	for	ADP
hls-11323	120	11	the	the	DET
hls-11323	120	12	parameters	parameter	NOUN
hls-11323	120	13	affecting	affect	VERB
hls-11323	120	14	deceased	deceased	ADJ
hls-11323	120	15	patients	patient	NOUN
hls-11323	120	16	(	(	PUNCT
hls-11323	120	17	n=40	n=40	X
hls-11323	120	18	vs.	vs.	X
hls-11323	120	19	100	100	NUM
hls-11323	120	20	)	)	PUNCT
hls-11323	120	21	.	.	PUNCT
hls-11323	121	1	univariate	univariate	ADJ
hls-11323	121	2	model	model	NOUN
hls-11323	121	3	1	1	NUM
hls-11323	121	4	model	model	NOUN
hls-11323	121	5	2	2	NUM
hls-11323	121	6	p	p	NOUN
hls-11323	121	7	or	or	CCONJ
hls-11323	121	8	(	(	PUNCT
hls-11323	121	9	95%c.i	95%c.i	NUM
hls-11323	121	10	)	)	PUNCT
hls-11323	121	11	(	(	PUNCT
hls-11323	121	12	ll	ll	NOUN
hls-11323	121	13	-	-	PUNCT
hls-11323	121	14	ul	ul	NOUN
hls-11323	121	15	)	)	PUNCT
hls-11323	121	16	p	p	NOUN
hls-11323	121	17	or	or	CCONJ
hls-11323	121	18	(	(	PUNCT
hls-11323	121	19	95%c.i	95%c.i	NUM
hls-11323	121	20	)	)	PUNCT
hls-11323	121	21	(	(	PUNCT
hls-11323	121	22	ll	ll	NOUN
hls-11323	121	23	-	-	PUNCT
hls-11323	121	24	ul	ul	NOUN
hls-11323	121	25	)	)	PUNCT
hls-11323	121	26	p	p	NOUN
hls-11323	121	27	or	or	CCONJ
hls-11323	121	28	(	(	PUNCT
hls-11323	121	29	95%c.i	95%c.i	NUM
hls-11323	121	30	)	)	PUNCT
hls-11323	121	31	(	(	PUNCT
hls-11323	121	32	ll	ll	NOUN
hls-11323	121	33	-	-	PUNCT
hls-11323	121	34	ul	ul	NOUN
hls-11323	121	35	)	)	PUNCT
hls-11323	121	36	crp	crp	PROPN
hls-11323	121	37	(	(	PUNCT
hls-11323	121	38	>	>	NOUN
hls-11323	121	39	15.4	15.4	NUM
hls-11323	121	40	)	)	PUNCT
hls-11323	121	41	<	<	X
hls-11323	121	42	0.001	0.001	NUM
hls-11323	121	43	*	*	SYM
hls-11323	121	44	8.90	8.90	NUM
hls-11323	121	45	(	(	PUNCT
hls-11323	121	46	3.68–21.53	3.68–21.53	NUM
hls-11323	121	47	)	)	PUNCT
hls-11323	121	48	<	<	X
hls-11323	121	49	0.001	0.001	NUM
hls-11323	121	50	*	*	NUM
hls-11323	121	51	11.41(3.11–41.86	11.41(3.11–41.86	NUM
hls-11323	121	52	)	)	PUNCT
hls-11323	121	53	0.073	0.073	NUM
hls-11323	121	54	3.96	3.96	NUM
hls-11323	121	55	(	(	PUNCT
hls-11323	121	56	0.88–17.79	0.88–17.79	PROPN
hls-11323	121	57	)	)	PUNCT
hls-11323	121	58	ferritin	ferritin	VERB
hls-11323	121	59	(	(	PUNCT
hls-11323	121	60	>	>	NOUN
hls-11323	121	61	677	677	NUM
hls-11323	121	62	)	)	PUNCT
hls-11323	121	63	<	<	X
hls-11323	121	64	0.001	0.001	NUM
hls-11323	121	65	*	*	SYM
hls-11323	121	66	16.33	16.33	NUM
hls-11323	121	67	(	(	PUNCT
hls-11323	121	68	5.83–45.75	5.83–45.75	NUM
hls-11323	121	69	)	)	PUNCT
hls-11323	121	70	<	<	X
hls-11323	121	71	0.001	0.001	NUM
hls-11323	121	72	*	*	SYM
hls-11323	121	73	18.40	18.40	NUM
hls-11323	121	74	(	(	PUNCT
hls-11323	121	75	4.60–73.72	4.60–73.72	NUM
hls-11323	121	76	)	)	PUNCT
hls-11323	121	77	0.018	0.018	NUM
hls-11323	121	78	*	*	SYM
hls-11323	121	79	10.95	10.95	NUM
hls-11323	121	80	(	(	PUNCT
hls-11323	121	81	1.51–79.25	1.51–79.25	NUM
hls-11323	121	82	)	)	PUNCT
hls-11323	121	83	ldh	ldh	NOUN
hls-11323	121	84	(	(	PUNCT
hls-11323	121	85	>	>	NOUN
hls-11323	121	86	500	500	NUM
hls-11323	121	87	)	)	PUNCT
hls-11323	121	88	<	<	X
hls-11323	121	89	0.001	0.001	NUM
hls-11323	121	90	*	*	SYM
hls-11323	121	91	138.3	138.3	NUM
hls-11323	121	92	(	(	PUNCT
hls-11323	121	93	17.97–106	17.97–106	NUM
hls-11323	121	94	)	)	PUNCT
hls-11323	121	95	0.005	0.005	NUM
hls-11323	121	96	*	*	SYM
hls-11323	121	97	608(14.3–2588727	608(14.3–2588727	NUM
hls-11323	121	98	)	)	PUNCT
hls-11323	121	99	0.003	0.003	NUM
hls-11323	121	100	*	*	SYM
hls-11323	121	101	34.72	34.72	NUM
hls-11323	121	102	(	(	PUNCT
hls-11323	121	103	3.23–373.7	3.23–373.7	NOUN
hls-11323	121	104	)	)	PUNCT
hls-11323	121	105	d.	d.	PROPN
hls-11323	121	106	dimer	dimer	PROPN
hls-11323	121	107	(	(	PUNCT
hls-11323	121	108	>	>	X
hls-11323	121	109	2188	2188	NUM
hls-11323	121	110	)	)	PUNCT
hls-11323	121	111	<	<	X
hls-11323	121	112	0.001	0.001	NUM
hls-11323	121	113	*	*	SYM
hls-11323	121	114	21.0	21.0	NUM
hls-11323	121	115	(	(	PUNCT
hls-11323	121	116	6.05–72.91	6.05–72.91	NOUN
hls-11323	121	117	)	)	PUNCT
hls-11323	121	118	<	<	X
hls-11323	121	119	0.001	0.001	NUM
hls-11323	121	120	*	*	NUM
hls-11323	121	121	15.27(3.53–66.09	15.27(3.53–66.09	NUM
hls-11323	121	122	)	)	PUNCT
hls-11323	121	123	0.573	0.573	NUM
hls-11323	121	124	2.64	2.64	NUM
hls-11323	121	125	(	(	PUNCT
hls-11323	121	126	0.09–77.02	0.09–77.02	NUM
hls-11323	121	127	)	)	PUNCT
hls-11323	121	128	procalcitonin(>2.09	procalcitonin(>2.09	NOUN
hls-11323	121	129	)	)	PUNCT
hls-11323	121	130	<	<	X
hls-11323	121	131	0.001	0.001	NUM
hls-11323	121	132	*	*	SYM
hls-11323	121	133	33.86	33.86	NUM
hls-11323	121	134	(	(	PUNCT
hls-11323	121	135	10.83–105.8	10.83–105.8	NUM
hls-11323	121	136	)	)	PUNCT
hls-11323	121	137	<	<	X
hls-11323	121	138	0.001	0.001	NUM
hls-11323	121	139	*	*	NUM
hls-11323	121	140	27.12(6.95–105.9	27.12(6.95–105.9	NUM
hls-11323	121	141	)	)	PUNCT
hls-11323	121	142	0.003	0.003	NUM
hls-11323	121	143	*	*	SYM
hls-11323	121	144	11.82	11.82	NUM
hls-11323	121	145	(	(	PUNCT
hls-11323	121	146	2.26–61.86	2.26–61.86	NUM
hls-11323	121	147	)	)	PUNCT
hls-11323	121	148	pro	pro	ADJ
hls-11323	121	149	-	-	ADJ
hls-11323	121	150	bnp	bnp	ADJ
hls-11323	121	151	(	(	PUNCT
hls-11323	121	152	>	>	NOUN
hls-11323	121	153	1755	1755	NUM
hls-11323	121	154	)	)	PUNCT
hls-11323	121	155	<	<	X
hls-11323	121	156	0.001	0.001	NUM
hls-11323	121	157	*	*	SYM
hls-11323	121	158	29.75	29.75	NUM
hls-11323	121	159	(	(	PUNCT
hls-11323	121	160	10.74–82.45	10.74–82.45	NUM
hls-11323	121	161	)	)	PUNCT
hls-11323	121	162	<	<	X
hls-11323	121	163	0.001	0.001	NUM
hls-11323	121	164	*	*	SYM
hls-11323	121	165	28.21	28.21	NUM
hls-11323	121	166	(	(	PUNCT
hls-11323	121	167	7.07–112.6	7.07–112.6	NUM
hls-11323	121	168	)	)	PUNCT
hls-11323	121	169	0.014	0.014	NUM
hls-11323	121	170	*	*	SYM
hls-11323	121	171	7.73	7.73	NUM
hls-11323	121	172	(	(	PUNCT
hls-11323	121	173	1.50–39.80	1.50–39.80	NUM
hls-11323	121	174	)	)	PUNCT
hls-11323	121	175	or	or	CCONJ
hls-11323	121	176	,	,	PUNCT
hls-11323	121	177	odd	odd	ADJ
hls-11323	121	178	’s	’s	PART
hls-11323	121	179	ratio	ratio	NOUN
hls-11323	121	180	;	;	PUNCT
hls-11323	121	181	ci	ci	NOUN
hls-11323	121	182	:	:	PUNCT
hls-11323	121	183	confidence	confidence	NOUN
hls-11323	121	184	interval	interval	NOUN
hls-11323	121	185	;	;	PUNCT
hls-11323	121	186	ll	ll	AUX
hls-11323	121	187	,	,	PUNCT
hls-11323	121	188	lower	low	ADJ
hls-11323	121	189	limit	limit	NOUN
hls-11323	121	190	;	;	PUNCT
hls-11323	121	191	ul	ul	INTJ
hls-11323	121	192	,	,	PUNCT
hls-11323	121	193	upper	upper	ADJ
hls-11323	121	194	limit	limit	NOUN
hls-11323	121	195	;	;	PUNCT
hls-11323	121	196	model	model	NOUN
hls-11323	121	197	1	1	NUM
hls-11323	121	198	,	,	PUNCT
hls-11323	121	199	each	each	DET
hls-11323	121	200	marker	marker	NOUN
hls-11323	121	201	was	be	AUX
hls-11323	121	202	adjusted	adjust	VERB
hls-11323	121	203	by	by	ADP
hls-11323	121	204	other	other	ADJ
hls-11323	121	205	significant	significant	ADJ
hls-11323	121	206	variables	variable	NOUN
hls-11323	121	207	(	(	PUNCT
hls-11323	121	208	alt	alt	ADJ
hls-11323	121	209	,	,	PUNCT
hls-11323	121	210	ast	ast	PROPN
hls-11323	121	211	,	,	PUNCT
hls-11323	121	212	pt	pt	NOUN
hls-11323	121	213	,	,	PUNCT
hls-11323	121	214	appt	appt	NOUN
hls-11323	121	215	and	and	CCONJ
hls-11323	121	216	age	age	NOUN
hls-11323	121	217	)	)	PUNCT
hls-11323	121	218	;	;	PUNCT
hls-11323	121	219	model	model	NOUN
hls-11323	121	220	2	2	NUM
hls-11323	121	221	,	,	PUNCT
hls-11323	121	222	multivariate	multivariate	NOUN
hls-11323	121	223	regression	regression	NOUN
hls-11323	121	224	for	for	ADP
hls-11323	121	225	the	the	DET
hls-11323	121	226	six	six	NUM
hls-11323	121	227	markers	marker	NOUN
hls-11323	121	228	.	.	PUNCT
hls-11323	122	1	*	*	PUNCT
hls-11323	122	2	statistically	statistically	ADV
hls-11323	122	3	significant	significant	ADJ
hls-11323	122	4	at	at	ADP
hls-11323	122	5	p	p	NOUN
hls-11323	122	6	≤	≤	NUM
hls-11323	122	7	0.05	0.05	NUM
hls-11323	122	8	.	.	PUNCT
hls-11323	123	1	[	[	X
hls-11323	123	2	page	page	NOUN
hls-11323	123	3	4	4	NUM
hls-11323	123	4	]	]	PUNCT
hls-11323	124	1	[	[	X
hls-11323	124	2	healthcare	healthcare	NOUN
hls-11323	124	3	in	in	ADP
hls-11323	124	4	low	low	ADJ
hls-11323	124	5	-	-	PUNCT
hls-11323	124	6	resource	resource	NOUN
hls-11323	124	7	settings	setting	NOUN
hls-11323	124	8	2023	2023	NUM
hls-11323	124	9	;	;	PUNCT
hls-11323	124	10	11(s2):11323	11(s2):11323	NUM
hls-11323	124	11	]	]	PUNCT
hls-11323	124	12	figure	figure	NOUN
hls-11323	124	13	2	2	NUM
hls-11323	124	14	.	.	PUNCT
hls-11323	124	15	roc	roc	PROPN
hls-11323	124	16	for	for	ADP
hls-11323	124	17	crp	crp	PROPN
hls-11323	124	18	,	,	PUNCT
hls-11323	124	19	ferritin	ferritin	PROPN
hls-11323	124	20	,	,	PUNCT
hls-11323	124	21	ldh	ldh	PROPN
hls-11323	124	22	,	,	PUNCT
hls-11323	124	23	d.	d.	PROPN
hls-11323	124	24	dimer	dimer	PROPN
hls-11323	124	25	,	,	PUNCT
hls-11323	124	26	pct	pct	NOUN
hls-11323	124	27	and	and	CCONJ
hls-11323	124	28	probnp	probnp	VERB
hls-11323	124	29	to	to	PART
hls-11323	124	30	predict	predict	VERB
hls-11323	124	31	mortality	mortality	NOUN
hls-11323	124	32	.	.	PUNCT
hls-11323	125	1	non	non	ADJ
hls-11323	126	1	-co	-co	PROPN
hls-11323	126	2	mmerc	mmerc	PROPN
hls-11323	126	3	ial	ial	PROPN
hls-11323	126	4	us	us	PROPN
hls-11323	126	5	e	e	NOUN
hls-11323	126	6	o	o	X
hls-11323	126	7	nly	nly	ADV
hls-11323	126	8	aptt	aptt	ADJ
hls-11323	126	9	,	,	PUNCT
hls-11323	126	10	and	and	CCONJ
hls-11323	126	11	age	age	NOUN
hls-11323	126	12	,	,	PUNCT
hls-11323	126	13	model	model	NOUN
hls-11323	126	14	i	i	PRON
hls-11323	126	15	showed	show	VERB
hls-11323	126	16	that	that	SCONJ
hls-11323	126	17	they	they	PRON
hls-11323	126	18	were	be	AUX
hls-11323	126	19	statistically	statistically	ADV
hls-11323	126	20	significant	significant	ADJ
hls-11323	126	21	,	,	PUNCT
hls-11323	126	22	and	and	CCONJ
hls-11323	126	23	after	after	ADP
hls-11323	126	24	performing	perform	VERB
hls-11323	126	25	multivariate	multivariate	NOUN
hls-11323	126	26	analysis	analysis	NOUN
hls-11323	126	27	(	(	PUNCT
hls-11323	126	28	model	model	NOUN
hls-11323	126	29	ii	ii	PROPN
hls-11323	126	30	)	)	PUNCT
hls-11323	126	31	we	we	PRON
hls-11323	126	32	found	find	VERB
hls-11323	126	33	that	that	SCONJ
hls-11323	126	34	ferritin	ferritin	VERB
hls-11323	126	35	>	>	X
hls-11323	126	36	677	677	NUM
hls-11323	126	37	ng	ng	PROPN
hls-11323	126	38	/	/	SYM
hls-11323	126	39	ml	ml	PROPN
hls-11323	126	40	,	,	PUNCT
hls-11323	126	41	ldh	ldh	X
hls-11323	126	42	>	>	X
hls-11323	126	43	500	500	NUM
hls-11323	126	44	iu	iu	PROPN
hls-11323	126	45	/	/	SYM
hls-11323	126	46	l	l	NOUN
hls-11323	126	47	,	,	PUNCT
hls-11323	126	48	pct	pct	NOUN
hls-11323	126	49	>	>	X
hls-11323	126	50	2.09	2.09	NUM
hls-11323	126	51	ng	ng	PROPN
hls-11323	126	52	/	/	SYM
hls-11323	126	53	ml	ml	PROPN
hls-11323	126	54	,	,	PUNCT
hls-11323	126	55	and	and	CCONJ
hls-11323	126	56	pro	pro	ADJ
hls-11323	126	57	-	-	ADJ
hls-11323	126	58	bnp	bnp	ADJ
hls-11323	126	59	>	>	X
hls-11323	126	60	1755	1755	NUM
hls-11323	126	61	pg	pg	NOUN
hls-11323	126	62	/	/	SYM
hls-11323	126	63	ml	ml	NOUN
hls-11323	126	64	were	be	AUX
hls-11323	126	65	still	still	ADV
hls-11323	126	66	independently	independently	ADV
hls-11323	126	67	significant	significant	ADJ
hls-11323	126	68	for	for	ADP
hls-11323	126	69	predicting	predict	VERB
hls-11323	126	70	mortality	mortality	NOUN
hls-11323	126	71	(	(	PUNCT
hls-11323	126	72	table	table	NOUN
hls-11323	126	73	4	4	NUM
hls-11323	126	74	,	,	PUNCT
hls-11323	126	75	figure	figure	VERB
hls-11323	126	76	3	3	NUM
hls-11323	126	77	)	)	PUNCT
hls-11323	126	78	.	.	PUNCT
hls-11323	127	1	discussion	discussion	NOUN
hls-11323	127	2	numerous	numerous	ADJ
hls-11323	127	3	studies	study	NOUN
hls-11323	127	4	have	have	AUX
hls-11323	127	5	confirmed	confirm	VERB
hls-11323	127	6	that	that	SCONJ
hls-11323	127	7	increasing	increase	VERB
hls-11323	127	8	age	age	NOUN
hls-11323	127	9	and	and	CCONJ
hls-11323	127	10	presence	presence	NOUN
hls-11323	127	11	of	of	ADP
hls-11323	127	12	chronic	chronic	ADJ
hls-11323	127	13	illness	illness	NOUN
hls-11323	127	14	are	be	AUX
hls-11323	127	15	significant	significant	ADJ
hls-11323	127	16	risk	risk	NOUN
hls-11323	127	17	factors	factor	NOUN
hls-11323	127	18	in	in	ADP
hls-11323	127	19	covid19	covid19	NOUN
hls-11323	127	20	infection	infection	NOUN
hls-11323	127	21	,	,	PUNCT
hls-11323	127	22	leading	lead	VERB
hls-11323	127	23	to	to	ADP
hls-11323	127	24	extended	extend	VERB
hls-11323	127	25	hospitalization	hospitalization	NOUN
hls-11323	127	26	periods	period	NOUN
hls-11323	127	27	and	and	CCONJ
hls-11323	127	28	increase	increase	VERB
hls-11323	127	29	mortality	mortality	NOUN
hls-11323	127	30	.	.	PUNCT
hls-11323	128	1	for	for	ADP
hls-11323	128	2	instance	instance	NOUN
hls-11323	128	3	,	,	PUNCT
hls-11323	128	4	a	a	DET
hls-11323	128	5	retrospective	retrospective	ADJ
hls-11323	128	6	study	study	NOUN
hls-11323	128	7	conducted	conduct	VERB
hls-11323	128	8	on	on	ADP
hls-11323	128	9	older	old	ADJ
hls-11323	128	10	patients	patient	NOUN
hls-11323	128	11	infected	infect	VERB
hls-11323	128	12	with	with	ADP
hls-11323	128	13	covid-19	covid-19	PROPN
hls-11323	128	14	at	at	ADP
hls-11323	128	15	zhongnan	zhongnan	PROPN
hls-11323	128	16	hospital	hospital	PROPN
hls-11323	128	17	of	of	ADP
hls-11323	128	18	wuhan	wuhan	PROPN
hls-11323	128	19	university	university	PROPN
hls-11323	128	20	found	find	VERB
hls-11323	128	21	that	that	SCONJ
hls-11323	128	22	the	the	DET
hls-11323	128	23	mortality	mortality	NOUN
hls-11323	128	24	rate	rate	NOUN
hls-11323	128	25	was	be	AUX
hls-11323	128	26	significantly	significantly	ADV
hls-11323	128	27	higher	high	ADJ
hls-11323	128	28	among	among	ADP
hls-11323	128	29	patients	patient	NOUN
hls-11323	128	30	aged	age	VERB
hls-11323	128	31	over	over	ADP
hls-11323	128	32	65	65	NUM
hls-11323	128	33	years	year	NOUN
hls-11323	128	34	(	(	PUNCT
hls-11323	128	35	34.5	34.5	NUM
hls-11323	128	36	%	%	NOUN
hls-11323	128	37	)	)	PUNCT
hls-11323	128	38	than	than	ADP
hls-11323	128	39	in	in	ADP
hls-11323	128	40	younger	young	ADJ
hls-11323	128	41	patients	patient	NOUN
hls-11323	128	42	(	(	PUNCT
hls-11323	128	43	4.7%).9	4.7%).9	NOUN
hls-11323	128	44	another	another	DET
hls-11323	128	45	study	study	NOUN
hls-11323	128	46	conducted	conduct	VERB
hls-11323	128	47	in	in	ADP
hls-11323	128	48	hyderabad	hyderabad	PROPN
hls-11323	128	49	,	,	PUNCT
hls-11323	128	50	telangana	telangana	PROPN
hls-11323	128	51	,	,	PUNCT
hls-11323	128	52	india	india	PROPN
hls-11323	128	53	revealed	reveal	VERB
hls-11323	128	54	the	the	DET
hls-11323	128	55	impact	impact	NOUN
hls-11323	128	56	of	of	ADP
hls-11323	128	57	preexisting	preexist	VERB
hls-11323	128	58	comorbidities	comorbiditie	NOUN
hls-11323	128	59	on	on	ADP
hls-11323	128	60	disease	disease	NOUN
hls-11323	128	61	outcome	outcome	NOUN
hls-11323	128	62	,	,	PUNCT
hls-11323	128	63	including	include	VERB
hls-11323	128	64	diabetes	diabetes	NOUN
hls-11323	128	65	mellitus	mellitus	NOUN
hls-11323	128	66	,	,	PUNCT
hls-11323	128	67	hypertension	hypertension	NOUN
hls-11323	128	68	,	,	PUNCT
hls-11323	128	69	coronary	coronary	ADJ
hls-11323	128	70	artery	artery	NOUN
hls-11323	128	71	disease	disease	NOUN
hls-11323	128	72	,	,	PUNCT
hls-11323	128	73	and	and	CCONJ
hls-11323	128	74	chronic	chronic	ADJ
hls-11323	128	75	kidney	kidney	NOUN
hls-11323	128	76	disease	disease	NOUN
hls-11323	128	77	,	,	PUNCT
hls-11323	128	78	either	either	CCONJ
hls-11323	128	79	individually	individually	ADV
hls-11323	128	80	or	or	CCONJ
hls-11323	128	81	in	in	ADP
hls-11323	128	82	combination	combination	NOUN
hls-11323	128	83	.	.	PUNCT
hls-11323	129	1	the	the	DET
hls-11323	129	2	study	study	NOUN
hls-11323	129	3	found	find	VERB
hls-11323	129	4	that	that	SCONJ
hls-11323	129	5	preexisting	preexist	VERB
hls-11323	129	6	comorbidities	comorbiditie	NOUN
hls-11323	129	7	were	be	AUX
hls-11323	129	8	significant	significant	ADJ
hls-11323	129	9	contributing	contribute	VERB
hls-11323	129	10	factor	factor	NOUN
hls-11323	129	11	in	in	ADP
hls-11323	129	12	increasing	increase	VERB
hls-11323	129	13	mortality	mortality	NOUN
hls-11323	129	14	,	,	PUNCT
hls-11323	129	15	especially	especially	ADV
hls-11323	129	16	when	when	SCONJ
hls-11323	129	17	diabetes	diabetes	NOUN
hls-11323	129	18	mellitus	mellitus	NOUN
hls-11323	129	19	and	and	CCONJ
hls-11323	129	20	hypertension	hypertension	NOUN
hls-11323	129	21	occurred	occur	VERB
hls-11323	129	22	together.10	together.10	ADP
hls-11323	129	23	moreover	moreover	ADV
hls-11323	129	24	,	,	PUNCT
hls-11323	129	25	a	a	DET
hls-11323	129	26	multivariate	multivariate	NOUN
hls-11323	129	27	retrospective	retrospective	ADJ
hls-11323	129	28	cohort	cohort	NOUN
hls-11323	129	29	conducted	conduct	VERB
hls-11323	129	30	in	in	ADP
hls-11323	129	31	bangladesh	bangladesh	NOUN
hls-11323	129	32	assessed	assess	VERB
hls-11323	129	33	the	the	DET
hls-11323	129	34	effect	effect	NOUN
hls-11323	129	35	of	of	ADP
hls-11323	129	36	sociodemographic	sociodemographic	ADJ
hls-11323	129	37	factors	factor	NOUN
hls-11323	129	38	,	,	PUNCT
hls-11323	129	39	comorbidities	comorbiditie	NOUN
hls-11323	129	40	,	,	PUNCT
hls-11323	129	41	symptoms	symptom	NOUN
hls-11323	129	42	,	,	PUNCT
hls-11323	129	43	charlson	charlson	NOUN
hls-11323	129	44	comorbidity	comorbidity	PROPN
hls-11323	129	45	index	index	NOUN
hls-11323	129	46	,	,	PUNCT
hls-11323	129	47	and	and	CCONJ
hls-11323	129	48	access	access	NOUN
hls-11323	129	49	to	to	ADP
hls-11323	129	50	health	health	NOUN
hls-11323	129	51	facilities	facility	NOUN
hls-11323	129	52	on	on	ADP
hls-11323	129	53	disease	disease	NOUN
hls-11323	129	54	outcomes	outcome	NOUN
hls-11323	129	55	.	.	PUNCT
hls-11323	130	1	the	the	DET
hls-11323	130	2	study	study	NOUN
hls-11323	130	3	reported	report	VERB
hls-11323	130	4	that	that	SCONJ
hls-11323	130	5	increased	increase	VERB
hls-11323	130	6	age	age	NOUN
hls-11323	130	7	,	,	PUNCT
hls-11323	130	8	the	the	DET
hls-11323	130	9	presence	presence	NOUN
hls-11323	130	10	of	of	ADP
hls-11323	130	11	more	more	ADJ
hls-11323	130	12	than	than	ADP
hls-11323	130	13	3	3	NUM
hls-11323	130	14	symptoms	symptom	NOUN
hls-11323	130	15	,	,	PUNCT
hls-11323	130	16	and	and	CCONJ
hls-11323	130	17	multiple	multiple	ADJ
hls-11323	130	18	comorbidities	comorbiditie	NOUN
hls-11323	130	19	,	,	PUNCT
hls-11323	130	20	were	be	AUX
hls-11323	130	21	associated	associate	VERB
hls-11323	130	22	with	with	ADP
hls-11323	130	23	higher	high	ADJ
hls-11323	130	24	morbidity	morbidity	NOUN
hls-11323	130	25	and	and	CCONJ
hls-11323	130	26	mortality	mortality	NOUN
hls-11323	130	27	in	in	ADP
hls-11323	130	28	covid-19	covid-19	PROPN
hls-11323	130	29	patients.11	patients.11	NOUN
hls-11323	130	30	in	in	ADP
hls-11323	130	31	our	our	PRON
hls-11323	130	32	study	study	NOUN
hls-11323	130	33	,	,	PUNCT
hls-11323	130	34	we	we	PRON
hls-11323	130	35	also	also	ADV
hls-11323	130	36	observed	observe	VERB
hls-11323	130	37	that	that	SCONJ
hls-11323	130	38	the	the	DET
hls-11323	130	39	age	age	NOUN
hls-11323	130	40	had	have	VERB
hls-11323	130	41	a	a	DET
hls-11323	130	42	significant	significant	ADJ
hls-11323	130	43	impact	impact	NOUN
hls-11323	130	44	on	on	ADP
hls-11323	130	45	covid-19	covid-19	PROPN
hls-11323	130	46	mortality	mortality	NOUN
hls-11323	130	47	rates	rate	NOUN
hls-11323	130	48	,	,	PUNCT
hls-11323	130	49	with	with	ADP
hls-11323	130	50	higher	high	ADJ
hls-11323	130	51	mortality	mortality	NOUN
hls-11323	130	52	rates	rate	NOUN
hls-11323	130	53	observed	observe	VERB
hls-11323	130	54	in	in	ADP
hls-11323	130	55	patients	patient	NOUN
hls-11323	130	56	aged	age	VERB
hls-11323	130	57	over	over	ADP
hls-11323	130	58	65	65	NUM
hls-11323	130	59	years	year	NOUN
hls-11323	130	60	.	.	PUNCT
hls-11323	131	1	however	however	ADV
hls-11323	131	2	,	,	PUNCT
hls-11323	131	3	we	we	PRON
hls-11323	131	4	did	do	AUX
hls-11323	131	5	not	not	PART
hls-11323	131	6	observe	observe	VERB
hls-11323	131	7	any	any	DET
hls-11323	131	8	significant	significant	ADJ
hls-11323	131	9	effect	effect	NOUN
hls-11323	131	10	of	of	ADP
hls-11323	131	11	other	other	ADJ
hls-11323	131	12	comorbidities	comorbiditie	NOUN
hls-11323	131	13	on	on	ADP
hls-11323	131	14	covid-19	covid-19	PROPN
hls-11323	131	15	mortality	mortality	NOUN
hls-11323	131	16	rates	rate	NOUN
hls-11323	131	17	.	.	PUNCT
hls-11323	132	1	one	one	NUM
hls-11323	132	2	of	of	ADP
hls-11323	132	3	the	the	DET
hls-11323	132	4	frequently	frequently	ADV
hls-11323	132	5	studied	study	VERB
hls-11323	132	6	aspects	aspect	NOUN
hls-11323	132	7	of	of	ADP
hls-11323	132	8	covid-19	covid-19	PROPN
hls-11323	132	9	infection	infection	NOUN
hls-11323	132	10	is	be	AUX
hls-11323	132	11	its	its	PRON
hls-11323	132	12	relation	relation	NOUN
hls-11323	132	13	to	to	PART
hls-11323	132	14	patient	patient	VERB
hls-11323	132	15	sex	sex	NOUN
hls-11323	132	16	,	,	PUNCT
hls-11323	132	17	and	and	CCONJ
hls-11323	132	18	its	its	PRON
hls-11323	132	19	effect	effect	NOUN
hls-11323	132	20	on	on	ADP
hls-11323	132	21	the	the	DET
hls-11323	132	22	rate	rate	NOUN
hls-11323	132	23	of	of	ADP
hls-11323	132	24	infection	infection	NOUN
hls-11323	132	25	and	and	CCONJ
hls-11323	132	26	the	the	DET
hls-11323	132	27	outcome	outcome	NOUN
hls-11323	132	28	of	of	ADP
hls-11323	132	29	the	the	DET
hls-11323	132	30	disease	disease	NOUN
hls-11323	132	31	.	.	PUNCT
hls-11323	133	1	according	accord	VERB
hls-11323	133	2	to	to	ADP
hls-11323	133	3	data	datum	NOUN
hls-11323	133	4	reported	report	VERB
hls-11323	133	5	on	on	ADP
hls-11323	133	6	239,709	239,709	NUM
hls-11323	133	7	patients	patient	NOUN
hls-11323	133	8	in	in	ADP
hls-11323	133	9	italy	italy	PROPN
hls-11323	133	10	,	,	PUNCT
hls-11323	133	11	mortality	mortality	NOUN
hls-11323	133	12	is	be	AUX
hls-11323	133	13	17.7	17.7	NUM
hls-11323	133	14	%	%	NOUN
hls-11323	133	15	in	in	ADP
hls-11323	133	16	men	man	NOUN
hls-11323	133	17	and	and	CCONJ
hls-11323	133	18	10.8	10.8	NUM
hls-11323	133	19	%	%	NOUN
hls-11323	133	20	in	in	ADP
hls-11323	133	21	women	woman	NOUN
hls-11323	133	22	,	,	PUNCT
hls-11323	133	23	with	with	ADP
hls-11323	133	24	59	59	NUM
hls-11323	133	25	%	%	NOUN
hls-11323	133	26	of	of	ADP
hls-11323	133	27	total	total	ADJ
hls-11323	133	28	deaths	death	NOUN
hls-11323	133	29	were	be	AUX
hls-11323	133	30	in	in	ADP
hls-11323	133	31	males	male	NOUN
hls-11323	133	32	.	.	PUNCT
hls-11323	134	1	even	even	ADV
hls-11323	134	2	though	though	SCONJ
hls-11323	134	3	the	the	DET
hls-11323	134	4	rate	rate	NOUN
hls-11323	134	5	of	of	ADP
hls-11323	134	6	infection	infection	NOUN
hls-11323	134	7	was	be	AUX
hls-11323	134	8	lower	low	ADJ
hls-11323	134	9	in	in	ADP
hls-11323	134	10	males	male	NOUN
hls-11323	134	11	than	than	ADP
hls-11323	134	12	in	in	ADP
hls-11323	134	13	females	female	NOUN
hls-11323	134	14	,	,	PUNCT
hls-11323	134	15	with	with	ADP
hls-11323	134	16	45.8	45.8	NUM
hls-11323	134	17	%	%	NOUN
hls-11323	134	18	and	and	CCONJ
hls-11323	134	19	54.2	54.2	NUM
hls-11323	134	20	%	%	NOUN
hls-11323	134	21	respectively	respectively	ADV
hls-11323	134	22	,	,	PUNCT
hls-11323	134	23	indicating	indicate	VERB
hls-11323	134	24	that	that	SCONJ
hls-11323	134	25	evolution	evolution	NOUN
hls-11323	134	26	of	of	ADP
hls-11323	134	27	the	the	DET
hls-11323	134	28	disease	disease	NOUN
hls-11323	134	29	may	may	AUX
hls-11323	134	30	be	be	AUX
hls-11323	134	31	affected	affect	VERB
hls-11323	134	32	by	by	ADP
hls-11323	134	33	gender.12	gender.12	PROPN
hls-11323	134	34	in	in	ADP
hls-11323	134	35	contrast	contrast	NOUN
hls-11323	134	36	,	,	PUNCT
hls-11323	134	37	another	another	DET
hls-11323	134	38	study	study	NOUN
hls-11323	134	39	found	find	VERB
hls-11323	134	40	higher	high	ADJ
hls-11323	134	41	infection	infection	NOUN
hls-11323	134	42	risks	risk	NOUN
hls-11323	134	43	among	among	ADP
hls-11323	134	44	females	female	NOUN
hls-11323	134	45	than	than	ADP
hls-11323	134	46	males	male	NOUN
hls-11323	134	47	at	at	ADP
hls-11323	134	48	working	working	NOUN
hls-11323	134	49	ages	age	NOUN
hls-11323	134	50	,	,	PUNCT
hls-11323	134	51	but	but	CCONJ
hls-11323	134	52	the	the	DET
hls-11323	134	53	opposite	opposite	ADJ
hls-11323	134	54	trend	trend	NOUN
hls-11323	134	55	was	be	AUX
hls-11323	134	56	observed	observe	VERB
hls-11323	134	57	at	at	ADP
hls-11323	134	58	older	old	ADJ
hls-11323	134	59	age	age	NOUN
hls-11323	134	60	,	,	PUNCT
hls-11323	134	61	and	and	CCONJ
hls-11323	134	62	across	across	ADP
hls-11323	134	63	all	all	DET
hls-11323	134	64	age	age	NOUN
hls-11323	134	65	groups	group	NOUN
hls-11323	134	66	,	,	PUNCT
hls-11323	134	67	mortality	mortality	NOUN
hls-11323	134	68	rate	rate	NOUN
hls-11323	134	69	in	in	ADP
hls-11323	134	70	males	male	NOUN
hls-11323	134	71	was	be	AUX
hls-11323	134	72	double	double	ADJ
hls-11323	134	73	that	that	PRON
hls-11323	134	74	in	in	ADP
hls-11323	134	75	females.13	females.13	NOUN
hls-11323	134	76	however	however	ADV
hls-11323	134	77	,	,	PUNCT
hls-11323	134	78	in	in	ADP
hls-11323	134	79	our	our	PRON
hls-11323	134	80	study	study	NOUN
hls-11323	134	81	,	,	PUNCT
hls-11323	134	82	there	there	PRON
hls-11323	134	83	was	be	VERB
hls-11323	134	84	no	no	DET
hls-11323	134	85	significant	significant	ADJ
hls-11323	134	86	effect	effect	NOUN
hls-11323	134	87	of	of	ADP
hls-11323	134	88	gender	gender	NOUN
hls-11323	134	89	on	on	ADP
hls-11323	134	90	mortality	mortality	NOUN
hls-11323	134	91	in	in	ADP
hls-11323	134	92	covid-19	covid-19	PROPN
hls-11323	134	93	infection	infection	NOUN
hls-11323	134	94	.	.	PUNCT
hls-11323	135	1	laboratory	laboratory	NOUN
hls-11323	135	2	investigations	investigation	NOUN
hls-11323	135	3	are	be	AUX
hls-11323	135	4	crucial	crucial	ADJ
hls-11323	135	5	for	for	ADP
hls-11323	135	6	the	the	DET
hls-11323	135	7	detection	detection	NOUN
hls-11323	135	8	of	of	ADP
hls-11323	135	9	covid-19	covid-19	PROPN
hls-11323	135	10	infection	infection	NOUN
hls-11323	135	11	and	and	CCONJ
hls-11323	135	12	monitoring	monitor	VERB
hls-11323	135	13	evolution	evolution	NOUN
hls-11323	135	14	of	of	ADP
hls-11323	135	15	the	the	DET
hls-11323	135	16	disease	disease	NOUN
hls-11323	135	17	.	.	PUNCT
hls-11323	136	1	crp	crp	PROPN
hls-11323	136	2	is	be	AUX
hls-11323	136	3	an	an	DET
hls-11323	136	4	acute	acute	ADJ
hls-11323	136	5	-	-	PUNCT
hls-11323	136	6	phase	phase	NOUN
hls-11323	136	7	protein	protein	NOUN
hls-11323	136	8	synthesized	synthesize	VERB
hls-11323	136	9	by	by	ADP
hls-11323	136	10	the	the	DET
hls-11323	136	11	liver	liver	NOUN
hls-11323	136	12	,	,	PUNCT
hls-11323	136	13	and	and	CCONJ
hls-11323	136	14	elevated	elevate	VERB
hls-11323	136	15	in	in	ADP
hls-11323	136	16	response	response	NOUN
hls-11323	136	17	to	to	ADP
hls-11323	136	18	bacterial	bacterial	ADJ
hls-11323	136	19	infection	infection	NOUN
hls-11323	136	20	,	,	PUNCT
hls-11323	136	21	which	which	PRON
hls-11323	136	22	is	be	AUX
hls-11323	136	23	usually	usually	ADV
hls-11323	136	24	used	use	VERB
hls-11323	136	25	in	in	ADP
hls-11323	136	26	the	the	DET
hls-11323	136	27	diagnosis	diagnosis	NOUN
hls-11323	136	28	of	of	ADP
hls-11323	136	29	pneumonia.14	pneumonia.14	NOUN
hls-11323	136	30	a	a	DET
hls-11323	136	31	retrospective	retrospective	ADJ
hls-11323	136	32	study	study	NOUN
hls-11323	136	33	conducted	conduct	VERB
hls-11323	136	34	in	in	ADP
hls-11323	136	35	china	china	PROPN
hls-11323	136	36	involving	involve	VERB
hls-11323	136	37	76	76	NUM
hls-11323	136	38	patients	patient	NOUN
hls-11323	136	39	with	with	ADP
hls-11323	136	40	confirmed	confirm	VERB
hls-11323	136	41	covid-19	covid-19	PROPN
hls-11323	136	42	infection	infection	NOUN
hls-11323	136	43	,	,	PUNCT
hls-11323	136	44	found	find	VERB
hls-11323	136	45	that	that	SCONJ
hls-11323	136	46	crp	crp	PROPN
hls-11323	136	47	≥	≥	NUM
hls-11323	136	48	52.14mg	52.14mg	NUM
hls-11323	136	49	/	/	SYM
hls-11323	136	50	l	l	NOUN
hls-11323	136	51	was	be	AUX
hls-11323	136	52	correlated	correlate	VERB
hls-11323	136	53	with	with	ADP
hls-11323	136	54	the	the	DET
hls-11323	136	55	severity	severity	NOUN
hls-11323	136	56	of	of	ADP
hls-11323	136	57	infection	infection	NOUN
hls-11323	136	58	,	,	PUNCT
hls-11323	136	59	and	and	CCONJ
hls-11323	136	60	had	have	VERB
hls-11323	136	61	prognostic	prognostic	ADJ
hls-11323	136	62	value	value	NOUN
hls-11323	136	63	for	for	ADP
hls-11323	136	64	mortality.15	mortality.15	NOUN
hls-11323	136	65	additionally	additionally	ADV
hls-11323	136	66	,	,	PUNCT
hls-11323	136	67	another	another	DET
hls-11323	136	68	study	study	NOUN
hls-11323	136	69	conducted	conduct	VERB
hls-11323	136	70	in	in	ADP
hls-11323	136	71	china	china	PROPN
hls-11323	136	72	found	find	VERB
hls-11323	136	73	that	that	SCONJ
hls-11323	136	74	crp	crp	PROPN
hls-11323	136	75	was	be	AUX
hls-11323	136	76	strongly	strongly	ADV
hls-11323	136	77	correlated	correlate	VERB
hls-11323	136	78	with	with	ADP
hls-11323	136	79	murray	murray	PROPN
hls-11323	136	80	score	score	NOUN
hls-11323	136	81	which	which	PRON
hls-11323	136	82	was	be	AUX
hls-11323	136	83	originally	originally	ADV
hls-11323	136	84	used	use	VERB
hls-11323	136	85	to	to	PART
hls-11323	136	86	determine	determine	VERB
hls-11323	136	87	the	the	DET
hls-11323	136	88	severity	severity	NOUN
hls-11323	136	89	of	of	ADP
hls-11323	136	90	lung	lung	NOUN
hls-11323	136	91	injury	injury	NOUN
hls-11323	136	92	in	in	ADP
hls-11323	136	93	patients	patient	NOUN
hls-11323	136	94	developing	develop	VERB
hls-11323	136	95	acute	acute	ADJ
hls-11323	136	96	respiratory	respiratory	ADJ
hls-11323	136	97	distress	distress	NOUN
hls-11323	136	98	syndrome.3	syndrome.3	PROPN
hls-11323	136	99	in	in	ADP
hls-11323	136	100	our	our	PRON
hls-11323	136	101	study	study	NOUN
hls-11323	136	102	,	,	PUNCT
hls-11323	136	103	crp	crp	PROPN
hls-11323	136	104	showed	show	VERB
hls-11323	136	105	high	high	ADJ
hls-11323	136	106	significant	significant	ADJ
hls-11323	136	107	increase	increase	NOUN
hls-11323	136	108	in	in	ADP
hls-11323	136	109	deceased	deceased	ADJ
hls-11323	136	110	patients	patient	NOUN
hls-11323	136	111	more	more	ADV
hls-11323	136	112	than	than	ADP
hls-11323	136	113	in	in	ADP
hls-11323	136	114	discharged	discharge	VERB
hls-11323	136	115	patients	patient	NOUN
hls-11323	136	116	,	,	PUNCT
hls-11323	136	117	and	and	CCONJ
hls-11323	136	118	crp	crp	PROPN
hls-11323	136	119	>	>	PROPN
hls-11323	136	120	15.4	15.4	NUM
hls-11323	136	121	mg	mg	NUM
hls-11323	136	122	/	/	SYM
hls-11323	136	123	l	l	NOUN
hls-11323	136	124	had	have	VERB
hls-11323	136	125	a	a	DET
hls-11323	136	126	significant	significant	ADJ
hls-11323	136	127	prognostic	prognostic	ADJ
hls-11323	136	128	performance	performance	NOUN
hls-11323	136	129	with	with	ADP
hls-11323	136	130	mortality	mortality	NOUN
hls-11323	136	131	,	,	PUNCT
hls-11323	136	132	with	with	ADP
hls-11323	136	133	sensitivity	sensitivity	NOUN
hls-11323	136	134	80	80	NUM
hls-11323	136	135	%	%	NOUN
hls-11323	136	136	and	and	CCONJ
hls-11323	136	137	specificity	specificity	NOUN
hls-11323	136	138	69	69	NUM
hls-11323	136	139	%	%	NOUN
hls-11323	136	140	after	after	ADP
hls-11323	136	141	adjustment	adjustment	NOUN
hls-11323	136	142	with	with	ADP
hls-11323	136	143	alt	alt	ADJ
hls-11323	136	144	,	,	PUNCT
hls-11323	136	145	ast	ast	PROPN
hls-11323	136	146	,	,	PUNCT
hls-11323	136	147	pt	pt	NOUN
hls-11323	136	148	,	,	PUNCT
hls-11323	136	149	aptt	aptt	ADJ
hls-11323	136	150	,	,	PUNCT
hls-11323	136	151	and	and	CCONJ
hls-11323	136	152	age	age	NOUN
hls-11323	136	153	.	.	PUNCT
hls-11323	137	1	ferritin	ferritin	ADJ
hls-11323	137	2	,	,	PUNCT
hls-11323	137	3	although	although	SCONJ
hls-11323	137	4	known	know	VERB
hls-11323	137	5	primarily	primarily	ADV
hls-11323	137	6	as	as	ADP
hls-11323	137	7	an	an	DET
hls-11323	137	8	iron	iron	NOUN
hls-11323	137	9	storage	storage	NOUN
hls-11323	137	10	protein	protein	NOUN
hls-11323	137	11	;	;	PUNCT
hls-11323	137	12	has	have	VERB
hls-11323	137	13	multiple	multiple	ADJ
hls-11323	137	14	functions	function	NOUN
hls-11323	137	15	,	,	PUNCT
hls-11323	137	16	including	include	VERB
hls-11323	137	17	serving	serve	VERB
hls-11323	137	18	as	as	ADP
hls-11323	137	19	a	a	DET
hls-11323	137	20	signaling	signal	VERB
hls-11323	137	21	molecule	molecule	NOUN
hls-11323	137	22	and	and	CCONJ
hls-11323	137	23	direct	direct	ADJ
hls-11323	137	24	mediator	mediator	NOUN
hls-11323	137	25	of	of	ADP
hls-11323	137	26	the	the	DET
hls-11323	137	27	immune	immune	ADJ
hls-11323	137	28	system	system	NOUN
hls-11323	137	29	.	.	PUNCT
hls-11323	138	1	its	its	PRON
hls-11323	138	2	expression	expression	NOUN
hls-11323	138	3	can	can	AUX
hls-11323	138	4	be	be	AUX
hls-11323	138	5	induced	induce	VERB
hls-11323	138	6	by	by	ADP
hls-11323	138	7	 	 	SPACE
hls-11323	138	8	cytokines	cytokine	NOUN
hls-11323	138	9	,	,	PUNCT
hls-11323	138	10	and	and	CCONJ
hls-11323	138	11	it	it	PRON
hls-11323	138	12	may	may	AUX
hls-11323	138	13	also	also	ADV
hls-11323	138	14	plays	play	VERB
hls-11323	138	15	role	role	NOUN
hls-11323	138	16	in	in	ADP
hls-11323	138	17	induction	induction	NOUN
hls-11323	138	18	of	of	ADP
hls-11323	138	19	proand	proand	NOUN
hls-11323	138	20	anti	anti	ADJ
hls-11323	138	21	-	-	ADJ
hls-11323	138	22	inflammatory	inflammatory	ADJ
hls-11323	138	23	cytokines.16	cytokines.16	PROPN
hls-11323	138	24	it	it	PRON
hls-11323	138	25	was	be	AUX
hls-11323	138	26	observed	observe	VERB
hls-11323	138	27	that	that	SCONJ
hls-11323	138	28	hyperferritinemia	hyperferritinemia	NOUN
hls-11323	138	29	in	in	ADP
hls-11323	138	30	patients	patient	NOUN
hls-11323	138	31	with	with	ADP
hls-11323	138	32	severe	severe	ADJ
hls-11323	138	33	covid-19	covid-19	PROPN
hls-11323	138	34	infection	infection	NOUN
hls-11323	138	35	was	be	AUX
hls-11323	138	36	between	between	ADP
hls-11323	138	37	1.5	1.5	NUM
hls-11323	138	38	and	and	CCONJ
hls-11323	138	39	5.3	5.3	NUM
hls-11323	138	40	times	time	NOUN
hls-11323	138	41	higher	high	ADJ
hls-11323	138	42	in	in	ADP
hls-11323	138	43	patients	patient	NOUN
hls-11323	138	44	with	with	ADP
hls-11323	138	45	severe	severe	ADJ
hls-11323	138	46	disease	disease	NOUN
hls-11323	138	47	usually	usually	ADV
hls-11323	138	48	reaching	reach	VERB
hls-11323	138	49	>	>	X
hls-11323	138	50	800	800	NUM
hls-11323	138	51	 	 	SPACE
hls-11323	138	52	μg	μg	NOUN
hls-11323	138	53	/	/	SYM
hls-11323	138	54	l	l	PROPN
hls-11323	138	55	and	and	CCONJ
hls-11323	138	56	less	less	ADJ
hls-11323	138	57	than	than	ADP
hls-11323	138	58	theses	thesis	NOUN
hls-11323	138	59	values	value	NOUN
hls-11323	138	60	in	in	ADP
hls-11323	138	61	patients	patient	NOUN
hls-11323	138	62	with	with	ADP
hls-11323	138	63	moderate	moderate	ADJ
hls-11323	138	64	disease.17	disease.17	NOUN
hls-11323	138	65	a	a	DET
hls-11323	138	66	study	study	NOUN
hls-11323	138	67	conducted	conduct	VERB
hls-11323	138	68	in	in	ADP
hls-11323	138	69	wuhan	wuhan	PROPN
hls-11323	138	70	,	,	PUNCT
hls-11323	138	71	china	china	PROPN
hls-11323	138	72	on	on	ADP
hls-11323	138	73	patients	patient	NOUN
hls-11323	138	74	survived	survive	VERB
hls-11323	138	75	the	the	DET
hls-11323	138	76	infection	infection	NOUN
hls-11323	138	77	and	and	CCONJ
hls-11323	138	78	patients	patient	NOUN
hls-11323	138	79	died	die	VERB
hls-11323	138	80	during	during	ADP
hls-11323	138	81	their	their	PRON
hls-11323	138	82	stay	stay	NOUN
hls-11323	138	83	in	in	ADP
hls-11323	138	84	the	the	DET
hls-11323	138	85	hospital	hospital	NOUN
hls-11323	138	86	found	find	VERB
hls-11323	138	87	that	that	SCONJ
hls-11323	138	88	ferritin	ferritin	ADJ
hls-11323	138	89	levels	level	NOUN
hls-11323	138	90	on	on	ADP
hls-11323	138	91	admission	admission	NOUN
hls-11323	138	92	was	be	AUX
hls-11323	138	93	around	around	ADV
hls-11323	138	94	1400	1400	NUM
hls-11323	138	95	 	 	SPACE
hls-11323	138	96	μg	μg	PROPN
hls-11323	138	97	/	/	SYM
hls-11323	138	98	l	l	PROPN
hls-11323	138	99	in	in	ADP
hls-11323	138	100	non	non	NOUN
hls-11323	138	101	-	-	NOUN
hls-11323	138	102	survivors	survivor	NOUN
hls-11323	138	103	,	,	PUNCT
hls-11323	138	104	which	which	PRON
hls-11323	138	105	is	be	AUX
hls-11323	138	106	between	between	ADP
hls-11323	138	107	3	3	NUM
hls-11323	138	108	and	and	CCONJ
hls-11323	138	109	4	4	NUM
hls-11323	138	110	times	time	NOUN
hls-11323	138	111	higher	high	ADJ
hls-11323	138	112	than	than	ADP
hls-11323	138	113	that	that	PRON
hls-11323	138	114	observed	observe	VERB
hls-11323	138	115	in	in	ADP
hls-11323	138	116	survivors.18	survivors.18	PROPN
hls-11323	138	117	in	in	ADP
hls-11323	138	118	our	our	PRON
hls-11323	138	119	study	study	NOUN
hls-11323	138	120	,	,	PUNCT
hls-11323	138	121	ferritin	ferritin	PROPN
hls-11323	138	122	showed	show	VERB
hls-11323	138	123	significant	significant	ADJ
hls-11323	138	124	increase	increase	NOUN
hls-11323	138	125	in	in	ADP
hls-11323	138	126	deceased	deceased	ADJ
hls-11323	138	127	patients	patient	NOUN
hls-11323	138	128	more	more	ADV
hls-11323	138	129	than	than	ADP
hls-11323	138	130	discharged	discharge	VERB
hls-11323	138	131	patients	patient	NOUN
hls-11323	138	132	.	.	PUNCT
hls-11323	139	1	ferritin	ferritin	ADJ
hls-11323	139	2	levels	level	NOUN
hls-11323	139	3	above	above	ADP
hls-11323	139	4	677	677	NUM
hls-11323	139	5	ng	ng	PROPN
hls-11323	139	6	/	/	SYM
hls-11323	139	7	ml	ml	PROPN
hls-11323	139	8	were	be	AUX
hls-11323	139	9	significantly	significantly	ADV
hls-11323	139	10	predictive	predictive	ADJ
hls-11323	139	11	of	of	ADP
hls-11323	139	12	mortality	mortality	NOUN
hls-11323	139	13	,	,	PUNCT
hls-11323	139	14	with	with	ADP
hls-11323	139	15	a	a	DET
hls-11323	139	16	sensitivity	sensitivity	NOUN
hls-11323	139	17	of	of	ADP
hls-11323	139	18	87.5	87.5	NUM
hls-11323	139	19	%	%	NOUN
hls-11323	139	20	and	and	CCONJ
hls-11323	139	21	specificity	specificity	NOUN
hls-11323	139	22	70	70	NUM
hls-11323	139	23	%	%	NOUN
hls-11323	139	24	after	after	ADP
hls-11323	139	25	adjusting	adjust	VERB
hls-11323	139	26	for	for	ADP
hls-11323	139	27	alt	alt	ADJ
hls-11323	139	28	,	,	PUNCT
hls-11323	139	29	ast	ast	PROPN
hls-11323	139	30	,	,	PUNCT
hls-11323	139	31	pt	pt	NOUN
hls-11323	139	32	,	,	PUNCT
hls-11323	139	33	aptt	aptt	ADJ
hls-11323	139	34	,	,	PUNCT
hls-11323	139	35	and	and	CCONJ
hls-11323	139	36	age	age	NOUN
hls-11323	139	37	.	.	PUNCT
hls-11323	140	1	ferritin	ferritin	PROPN
hls-11323	140	2	was	be	AUX
hls-11323	140	3	also	also	ADV
hls-11323	140	4	found	find	VERB
hls-11323	140	5	to	to	PART
hls-11323	140	6	be	be	AUX
hls-11323	140	7	independent	independent	ADJ
hls-11323	140	8	significant	significant	ADJ
hls-11323	140	9	predictor	predictor	NOUN
hls-11323	140	10	of	of	ADP
hls-11323	140	11	mortality	mortality	NOUN
hls-11323	140	12	.	.	PUNCT
hls-11323	141	1	ldh	ldh	PROPN
hls-11323	141	2	is	be	AUX
hls-11323	141	3	a	a	DET
hls-11323	141	4	glycolytic	glycolytic	ADJ
hls-11323	141	5	enzyme	enzyme	NOUN
hls-11323	141	6	that	that	PRON
hls-11323	141	7	catalyzes	catalyze	VERB
hls-11323	141	8	the	the	DET
hls-11323	141	9	conversion	conversion	NOUN
hls-11323	141	10	between	between	ADP
hls-11323	141	11	l	l	NOUN
hls-11323	141	12	-	-	NOUN
hls-11323	141	13	lactate	lactate	NOUN
hls-11323	141	14	and	and	CCONJ
hls-11323	141	15	pyruvate	pyruvate	NOUN
hls-11323	141	16	and	and	CCONJ
hls-11323	141	17	conversion	conversion	NOUN
hls-11323	141	18	between	between	ADP
hls-11323	141	19	nadh	nadh	NOUN
hls-11323	141	20	and	and	CCONJ
hls-11323	141	21	nad+	nad+	PROPN
hls-11323	141	22	.	.	PUNCT
hls-11323	142	1	it	it	PRON
hls-11323	142	2	is	be	AUX
hls-11323	142	3	present	present	ADJ
hls-11323	142	4	in	in	ADP
hls-11323	142	5	the	the	DET
hls-11323	142	6	cytoplasm	cytoplasm	NOUN
hls-11323	142	7	of	of	ADP
hls-11323	142	8	all	all	DET
hls-11323	142	9	tissues	tissue	NOUN
hls-11323	142	10	especially	especially	ADV
hls-11323	142	11	the	the	DET
hls-11323	142	12	heart	heart	NOUN
hls-11323	142	13	,	,	PUNCT
hls-11323	142	14	liver	liver	NOUN
hls-11323	142	15	and	and	CCONJ
hls-11323	142	16	skeletal	skeletal	ADJ
hls-11323	142	17	muscles	muscle	NOUN
hls-11323	142	18	.	.	PUNCT
hls-11323	143	1	in	in	ADP
hls-11323	143	2	covid-19	covid-19	PROPN
hls-11323	143	3	infection	infection	NOUN
hls-11323	143	4	,	,	PUNCT
hls-11323	143	5	there	there	PRON
hls-11323	143	6	is	be	VERB
hls-11323	143	7	tissue	tissue	NOUN
hls-11323	143	8	injury	injury	NOUN
hls-11323	143	9	and	and	CCONJ
hls-11323	143	10	low	low	ADJ
hls-11323	143	11	oxygenation	oxygenation	NOUN
hls-11323	143	12	of	of	ADP
hls-11323	143	13	the	the	DET
hls-11323	143	14	cells	cell	NOUN
hls-11323	143	15	leading	lead	VERB
hls-11323	143	16	to	to	ADP
hls-11323	143	17	up	up	ADJ
hls-11323	143	18	-	-	PUNCT
hls-11323	143	19	regulation	regulation	NOUN
hls-11323	143	20	of	of	ADP
hls-11323	143	21	glycolytic	glycolytic	ADJ
hls-11323	143	22	pathway	pathway	NOUN
hls-11323	143	23	and	and	CCONJ
hls-11323	143	24	increased	increase	VERB
hls-11323	143	25	ldh	ldh	PROPN
hls-11323	143	26	levels	level	NOUN
hls-11323	143	27	especially	especially	ADV
hls-11323	143	28	in	in	ADP
hls-11323	143	29	severe	severe	ADJ
hls-11323	143	30	lung	lung	NOUN
hls-11323	143	31	injury	injury	NOUN
hls-11323	143	32	which	which	PRON
hls-11323	143	33	leads	lead	VERB
hls-11323	143	34	to	to	ADP
hls-11323	143	35	release	release	NOUN
hls-11323	143	36	of	of	ADP
hls-11323	143	37	large	large	ADJ
hls-11323	143	38	amounts	amount	NOUN
hls-11323	143	39	of	of	ADP
hls-11323	143	40	ldh	ldh	NOUN
hls-11323	143	41	isoenzyme	isoenzyme	NOUN
hls-11323	143	42	3.19	3.19	NUM
hls-11323	143	43	a	a	DET
hls-11323	143	44	meta	meta	ADJ
hls-11323	143	45	-	-	PUNCT
hls-11323	143	46	analysis	analysis	NOUN
hls-11323	143	47	performed	perform	VERB
hls-11323	143	48	by	by	ADP
hls-11323	143	49	martha	martha	PROPN
hls-11323	143	50	j.	j.	PROPN
hls-11323	143	51	showed	show	VERB
hls-11323	143	52	that	that	SCONJ
hls-11323	143	53	increased	increase	VERB
hls-11323	143	54	levels	level	NOUN
hls-11323	143	55	of	of	ADP
hls-11323	143	56	ldh	ldh	PROPN
hls-11323	143	57	was	be	AUX
hls-11323	143	58	associated	associate	VERB
hls-11323	143	59	with	with	ADP
hls-11323	143	60	poor	poor	ADJ
hls-11323	143	61	prognosis	prognosis	NOUN
hls-11323	143	62	and	and	CCONJ
hls-11323	143	63	high	high	ADJ
hls-11323	143	64	mortality	mortality	NOUN
hls-11323	143	65	rate	rate	NOUN
hls-11323	143	66	,	,	PUNCT
hls-11323	143	67	with	with	ADP
hls-11323	143	68	a	a	DET
hls-11323	143	69	sensitivity	sensitivity	NOUN
hls-11323	143	70	of	of	ADP
hls-11323	143	71	74	74	NUM
hls-11323	143	72	%	%	NOUN
hls-11323	143	73	and	and	CCONJ
hls-11323	143	74	specificity	specificity	NOUN
hls-11323	143	75	of	of	ADP
hls-11323	143	76	69	69	NUM
hls-11323	143	77	%	%	NOUN
hls-11323	143	78	.	.	PUNCT
hls-11323	144	1	positive	positive	ADJ
hls-11323	144	2	likelihood	likelihood	NOUN
hls-11323	144	3	ratio	ratio	NOUN
hls-11323	144	4	was	be	AUX
hls-11323	144	5	2.4	2.4	NUM
hls-11323	144	6	,	,	PUNCT
hls-11323	144	7	negative	negative	ADJ
hls-11323	144	8	likelihood	likelihood	NOUN
hls-11323	144	9	ratio	ratio	NOUN
hls-11323	144	10	was	be	AUX
hls-11323	144	11	0.38	0.38	NUM
hls-11323	144	12	and	and	CCONJ
hls-11323	144	13	area	area	NOUN
hls-11323	144	14	under	under	ADP
hls-11323	144	15	curve	curve	NOUN
hls-11323	144	16	of	of	ADP
hls-11323	144	17	0.77	0.77	NUM
hls-11323	144	18	,	,	PUNCT
hls-11323	144	19	independently	independently	ADV
hls-11323	144	20	from	from	ADP
hls-11323	144	21	age	age	NOUN
hls-11323	144	22	,	,	PUNCT
hls-11323	144	23	male	male	ADJ
hls-11323	144	24	sex	sex	NOUN
hls-11323	144	25	,	,	PUNCT
hls-11323	144	26	hypertension	hypertension	NOUN
hls-11323	144	27	and	and	CCONJ
hls-11323	144	28	diabetes.20	diabetes.20	NOUN
hls-11323	144	29	another	another	DET
hls-11323	144	30	metaanalysis	metaanalysis	NOUN
hls-11323	144	31	conducted	conduct	VERB
hls-11323	144	32	including	include	VERB
hls-11323	144	33	twenty	twenty	NUM
hls-11323	144	34	eight	eight	NUM
hls-11323	144	35	study	study	NOUN
hls-11323	144	36	showed	show	VERB
hls-11323	144	37	that	that	SCONJ
hls-11323	144	38	high	high	ADJ
hls-11323	144	39	levels	level	NOUN
hls-11323	144	40	of	of	ADP
hls-11323	144	41	ldh	ldh	PROPN
hls-11323	144	42	were	be	AUX
hls-11323	144	43	observed	observe	VERB
hls-11323	144	44	in	in	ADP
hls-11323	144	45	icu	icu	PROPN
hls-11323	144	46	patients	patient	NOUN
hls-11323	144	47	versus	versus	ADP
hls-11323	144	48	non	non	ADJ
hls-11323	144	49	-	-	ADJ
hls-11323	144	50	icu	icu	ADJ
hls-11323	144	51	patients	patient	NOUN
hls-11323	144	52	and	and	CCONJ
hls-11323	144	53	in	in	ADP
hls-11323	144	54	non	non	ADJ
hls-11323	144	55	-	-	NOUN
hls-11323	144	56	survivors	survivor	NOUN
hls-11323	144	57	compared	compare	VERB
hls-11323	144	58	with	with	ADP
hls-11323	144	59	survivors	survivor	NOUN
hls-11323	144	60	and	and	CCONJ
hls-11323	144	61	concluded	conclude	VERB
hls-11323	144	62	that	that	SCONJ
hls-11323	144	63	ldh	ldh	PROPN
hls-11323	144	64	is	be	AUX
hls-11323	144	65	an	an	DET
hls-11323	144	66	important	important	ADJ
hls-11323	144	67	severity	severity	NOUN
hls-11323	144	68	marker	marker	NOUN
hls-11323	144	69	for	for	ADP
hls-11323	144	70	covid-19	covid-19	PROPN
hls-11323	144	71	infection	infection	NOUN
hls-11323	144	72	and	and	CCONJ
hls-11323	144	73	can	can	AUX
hls-11323	144	74	be	be	AUX
hls-11323	144	75	used	use	VERB
hls-11323	144	76	as	as	ADP
hls-11323	144	77	a	a	DET
hls-11323	144	78	predictor	predictor	NOUN
hls-11323	144	79	of	of	ADP
hls-11323	144	80	survival.21	survival.21	PROPN
hls-11323	144	81	in	in	ADP
hls-11323	144	82	our	our	PRON
hls-11323	144	83	study	study	NOUN
hls-11323	144	84	,	,	PUNCT
hls-11323	144	85	ldh	ldh	PROPN
hls-11323	144	86	showed	show	VERB
hls-11323	144	87	highly	highly	ADV
hls-11323	144	88	significant	significant	ADJ
hls-11323	144	89	increase	increase	NOUN
hls-11323	144	90	in	in	ADP
hls-11323	144	91	deceased	deceased	ADJ
hls-11323	144	92	patients	patient	NOUN
hls-11323	144	93	more	more	ADV
hls-11323	144	94	than	than	ADP
hls-11323	144	95	discharged	discharge	VERB
hls-11323	144	96	patients	patient	NOUN
hls-11323	144	97	,	,	PUNCT
hls-11323	144	98	as	as	ADP
hls-11323	144	99	ldh	ldh	PROPN
hls-11323	144	100	levels	level	NOUN
hls-11323	144	101	>	>	X
hls-11323	144	102	500	500	NUM
hls-11323	144	103	iu	iu	NOUN
hls-11323	144	104	/	/	SYM
hls-11323	144	105	l	l	NOUN
hls-11323	144	106	had	have	VERB
hls-11323	144	107	a	a	DET
hls-11323	144	108	significant	significant	ADJ
hls-11323	144	109	prognostic	prognostic	ADJ
hls-11323	144	110	performance	performance	NOUN
hls-11323	144	111	with	with	ADP
hls-11323	144	112	mortality	mortality	NOUN
hls-11323	144	113	,	,	PUNCT
hls-11323	144	114	with	with	ADP
hls-11323	144	115	a	a	DET
hls-11323	144	116	sensitivity	sensitivity	NOUN
hls-11323	144	117	97.5	97.5	NUM
hls-11323	144	118	%	%	NOUN
hls-11323	144	119	and	and	CCONJ
hls-11323	144	120	specificity	specificity	NOUN
hls-11323	144	121	of	of	ADP
hls-11323	144	122	78	78	NUM
hls-11323	144	123	%	%	NOUN
hls-11323	144	124	after	after	ADP
hls-11323	144	125	adjusting	adjust	VERB
hls-11323	144	126	for	for	ADP
hls-11323	144	127	alt	alt	ADJ
hls-11323	144	128	,	,	PUNCT
hls-11323	144	129	ast	ast	PROPN
hls-11323	144	130	,	,	PUNCT
hls-11323	144	131	pt	pt	NOUN
hls-11323	144	132	,	,	PUNCT
hls-11323	144	133	aptt	aptt	ADJ
hls-11323	144	134	,	,	PUNCT
hls-11323	144	135	and	and	CCONJ
hls-11323	144	136	age	age	NOUN
hls-11323	144	137	.	.	PUNCT
hls-11323	145	1	ldh	ldh	PROPN
hls-11323	145	2	was	be	AUX
hls-11323	145	3	also	also	ADV
hls-11323	145	4	found	find	VERB
hls-11323	145	5	to	to	PART
hls-11323	145	6	be	be	AUX
hls-11323	145	7	independent	independent	ADJ
hls-11323	145	8	significant	significant	ADJ
hls-11323	145	9	article	article	NOUN
hls-11323	145	10	figure	figure	VERB
hls-11323	145	11	3	3	NUM
hls-11323	145	12	.	.	PUNCT
hls-11323	146	1	graph	graph	NOUN
hls-11323	146	2	showing	show	VERB
hls-11323	146	3	odds	odd	NOUN
hls-11323	146	4	ratio	ratio	NOUN
hls-11323	146	5	of	of	ADP
hls-11323	146	6	different	different	ADJ
hls-11323	146	7	markers	marker	NOUN
hls-11323	146	8	with	with	ADP
hls-11323	146	9	95	95	NUM
hls-11323	146	10	%	%	NOUN
hls-11323	146	11	ci	ci	NOUN
hls-11323	146	12	after	after	ADP
hls-11323	146	13	a	a	DET
hls-11323	146	14	multivariate	multivariate	NOUN
hls-11323	146	15	logistic	logistic	ADJ
hls-11323	146	16	regression	regression	NOUN
hls-11323	146	17	for	for	ADP
hls-11323	146	18	covid-19	covid-19	PROPN
hls-11323	146	19	mortality	mortality	NOUN
hls-11323	146	20	.	.	PUNCT
hls-11323	147	1	[	[	X
hls-11323	147	2	healthcare	healthcare	NOUN
hls-11323	147	3	in	in	ADP
hls-11323	147	4	low	low	ADJ
hls-11323	147	5	-	-	PUNCT
hls-11323	147	6	resource	resource	NOUN
hls-11323	147	7	settings	setting	NOUN
hls-11323	147	8	2023	2023	NUM
hls-11323	147	9	;	;	PUNCT
hls-11323	147	10	11(s2):11323	11(s2):11323	NUM
hls-11323	147	11	]	]	PUNCT
hls-11323	148	1	[	[	X
hls-11323	148	2	page	page	NOUN
hls-11323	148	3	5	5	NUM
hls-11323	148	4	]	]	X
hls-11323	148	5	non	non	ADJ
hls-11323	148	6	-co	-co	PROPN
hls-11323	148	7	mmerc	mmerc	PROPN
hls-11323	148	8	ial	ial	PROPN
hls-11323	148	9	us	us	PROPN
hls-11323	148	10	e	e	NOUN
hls-11323	148	11	o	o	NOUN
hls-11323	148	12	nly	nly	ADV
hls-11323	148	13	predictor	predictor	NOUN
hls-11323	148	14	of	of	ADP
hls-11323	148	15	mortality	mortality	NOUN
hls-11323	148	16	.	.	PUNCT
hls-11323	149	1	d	d	X
hls-11323	149	2	-	-	PUNCT
hls-11323	149	3	dimers	dimer	NOUN
hls-11323	149	4	are	be	AUX
hls-11323	149	5	fragments	fragment	NOUN
hls-11323	149	6	resulted	result	VERB
hls-11323	149	7	from	from	ADP
hls-11323	149	8	cleavage	cleavage	NOUN
hls-11323	149	9	of	of	ADP
hls-11323	149	10	fibrin	fibrin	NOUN
hls-11323	149	11	to	to	PART
hls-11323	149	12	break	break	VERB
hls-11323	149	13	down	down	ADP
hls-11323	149	14	clots	clot	NOUN
hls-11323	149	15	.	.	PUNCT
hls-11323	150	1	therefore	therefore	ADV
hls-11323	150	2	,	,	PUNCT
hls-11323	150	3	any	any	DET
hls-11323	150	4	increase	increase	NOUN
hls-11323	150	5	in	in	ADP
hls-11323	150	6	production	production	NOUN
hls-11323	150	7	or	or	CCONJ
hls-11323	150	8	degradation	degradation	NOUN
hls-11323	150	9	of	of	ADP
hls-11323	150	10	fibrin	fibrin	NOUN
hls-11323	150	11	will	will	AUX
hls-11323	150	12	elevate	elevate	VERB
hls-11323	150	13	plasma	plasma	NOUN
hls-11323	150	14	d	d	ADJ
hls-11323	150	15	-	-	PUNCT
hls-11323	150	16	dimer	dimer	ADJ
hls-11323	150	17	levels	level	NOUN
hls-11323	150	18	.	.	PUNCT
hls-11323	151	1	in	in	ADP
hls-11323	151	2	severe	severe	ADJ
hls-11323	151	3	covid-19	covid-19	PROPN
hls-11323	151	4	infection	infection	NOUN
hls-11323	151	5	,	,	PUNCT
hls-11323	151	6	proinflammatory	proinflammatory	ADJ
hls-11323	151	7	and	and	CCONJ
hls-11323	151	8	prothrombotic	prothrombotic	ADJ
hls-11323	151	9	events	event	NOUN
hls-11323	151	10	are	be	AUX
hls-11323	151	11	prominent	prominent	ADJ
hls-11323	151	12	leading	lead	VERB
hls-11323	151	13	to	to	ADP
hls-11323	151	14	d	d	ADJ
hls-11323	151	15	-	-	PUNCT
hls-11323	151	16	dimer	dimer	ADJ
hls-11323	151	17	production.22	production.22	NOUN
hls-11323	151	18	studies	study	NOUN
hls-11323	151	19	also	also	ADV
hls-11323	151	20	suggest	suggest	VERB
hls-11323	151	21	that	that	SCONJ
hls-11323	151	22	in	in	ADP
hls-11323	151	23	sars	sar	NOUN
hls-11323	151	24	-	-	PUNCT
hls-11323	151	25	cov-2	cov-2	PART
hls-11323	151	26	infection	infection	NOUN
hls-11323	151	27	there	there	PRON
hls-11323	151	28	is	be	VERB
hls-11323	151	29	dysregulation	dysregulation	NOUN
hls-11323	151	30	of	of	ADP
hls-11323	151	31	the	the	DET
hls-11323	151	32	coagulation	coagulation	NOUN
hls-11323	151	33	cascade	cascade	NOUN
hls-11323	151	34	with	with	ADP
hls-11323	151	35	diffuse	diffuse	ADJ
hls-11323	151	36	alveolar	alveolar	ADJ
hls-11323	151	37	damage	damage	NOUN
hls-11323	151	38	and	and	CCONJ
hls-11323	151	39	infiltration	infiltration	NOUN
hls-11323	151	40	with	with	ADP
hls-11323	151	41	mononuclear	mononuclear	ADJ
hls-11323	151	42	inflammatory	inflammatory	ADJ
hls-11323	151	43	cells	cell	NOUN
hls-11323	151	44	in	in	ADP
hls-11323	151	45	the	the	DET
hls-11323	151	46	interstitium	interstitium	NOUN
hls-11323	151	47	,	,	PUNCT
hls-11323	151	48	this	this	PRON
hls-11323	151	49	promotes	promote	VERB
hls-11323	151	50	prothrombotic	prothrombotic	ADJ
hls-11323	151	51	activity	activity	NOUN
hls-11323	151	52	.	.	PUNCT
hls-11323	152	1	furthermore	furthermore	ADV
hls-11323	152	2	,	,	PUNCT
hls-11323	152	3	proinflammatory	proinflammatory	ADJ
hls-11323	152	4	cytokines	cytokine	NOUN
hls-11323	152	5	cause	cause	VERB
hls-11323	152	6	endothelial	endothelial	ADJ
hls-11323	152	7	injury	injury	NOUN
hls-11323	152	8	,	,	PUNCT
hls-11323	152	9	which	which	PRON
hls-11323	152	10	enhances	enhance	VERB
hls-11323	152	11	coagulation	coagulation	NOUN
hls-11323	152	12	and	and	CCONJ
hls-11323	152	13	inhibit	inhibit	VERB
hls-11323	152	14	fibrinolysis	fibrinolysis	NOUN
hls-11323	152	15	in	in	ADP
hls-11323	152	16	those	those	DET
hls-11323	152	17	patients	patient	NOUN
hls-11323	152	18	.	.	PUNCT
hls-11323	153	1	these	these	DET
hls-11323	153	2	high	high	ADJ
hls-11323	153	3	levels	level	NOUN
hls-11323	153	4	of	of	ADP
hls-11323	153	5	d	d	NOUN
hls-11323	153	6	-	-	PUNCT
hls-11323	153	7	dimer	dimer	NOUN
hls-11323	153	8	that	that	PRON
hls-11323	153	9	indicate	indicate	VERB
hls-11323	153	10	increased	increase	VERB
hls-11323	153	11	hypercoagulability	hypercoagulability	NOUN
hls-11323	153	12	increase	increase	NOUN
hls-11323	153	13	severity	severity	NOUN
hls-11323	153	14	and	and	CCONJ
hls-11323	153	15	contribute	contribute	VERB
hls-11323	153	16	to	to	ADP
hls-11323	153	17	mortality.23	mortality.23	PROPN
hls-11323	153	18	reports	report	NOUN
hls-11323	153	19	from	from	ADP
hls-11323	153	20	wuhan	wuhan	PROPN
hls-11323	153	21	hospital	hospital	PROPN
hls-11323	153	22	showed	show	VERB
hls-11323	153	23	that	that	SCONJ
hls-11323	153	24	from	from	ADP
hls-11323	153	25	the	the	DET
hls-11323	153	26	patients	patient	NOUN
hls-11323	153	27	requiring	require	VERB
hls-11323	153	28	icu	icu	PROPN
hls-11323	153	29	admission	admission	NOUN
hls-11323	153	30	,	,	PUNCT
hls-11323	153	31	26	26	NUM
hls-11323	153	32	%	%	NOUN
hls-11323	153	33	had	have	AUX
hls-11323	153	34	increased	increase	VERB
hls-11323	153	35	d	d	ADJ
hls-11323	153	36	-	-	PUNCT
hls-11323	153	37	dimer	dimer	ADJ
hls-11323	153	38	levels	level	NOUN
hls-11323	153	39	.	.	PUNCT
hls-11323	154	1	the	the	DET
hls-11323	154	2	main	main	ADJ
hls-11323	154	3	differences	difference	NOUN
hls-11323	154	4	between	between	ADP
hls-11323	154	5	non	non	NOUN
hls-11323	154	6	-	-	NOUN
hls-11323	154	7	survivors	survivor	NOUN
hls-11323	154	8	compared	compare	VERB
hls-11323	154	9	to	to	ADP
hls-11323	154	10	survivors	survivor	NOUN
hls-11323	154	11	is	be	AUX
hls-11323	154	12	markedly	markedly	ADV
hls-11323	154	13	elevated	elevate	VERB
hls-11323	154	14	d	d	NOUN
hls-11323	154	15	-	-	PUNCT
hls-11323	154	16	dimer	dimer	NOUN
hls-11323	154	17	which	which	PRON
hls-11323	154	18	progress	progress	NOUN
hls-11323	154	19	on	on	ADP
hls-11323	154	20	day	day	NOUN
hls-11323	154	21	5	5	NUM
hls-11323	154	22	of	of	ADP
hls-11323	154	23	infection	infection	NOUN
hls-11323	154	24	,	,	PUNCT
hls-11323	154	25	also	also	ADV
hls-11323	154	26	lymphopenia	lymphopenia	NOUN
hls-11323	154	27	,	,	PUNCT
hls-11323	154	28	and	and	CCONJ
hls-11323	154	29	renal	renal	ADJ
hls-11323	154	30	dysfunction.24	dysfunction.24	NOUN
hls-11323	154	31	in	in	ADP
hls-11323	154	32	a	a	DET
hls-11323	154	33	multivariable	multivariable	ADJ
hls-11323	154	34	logistic	logistic	ADJ
hls-11323	154	35	regression	regression	NOUN
hls-11323	154	36	model	model	NOUN
hls-11323	154	37	of	of	ADP
hls-11323	154	38	171	171	NUM
hls-11323	154	39	patients	patient	NOUN
hls-11323	154	40	in	in	ADP
hls-11323	154	41	another	another	DET
hls-11323	154	42	wuhan	wuhan	PROPN
hls-11323	154	43	hospital	hospital	PROPN
hls-11323	154	44	,	,	PUNCT
hls-11323	154	45	an	an	DET
hls-11323	154	46	initial	initial	ADJ
hls-11323	154	47	d	d	NOUN
hls-11323	154	48	-	-	PUNCT
hls-11323	154	49	dimer	dimer	ADJ
hls-11323	154	50	level	level	NOUN
hls-11323	154	51	>	>	X
hls-11323	154	52	1.0	1.0	NUM
hls-11323	154	53	μg	μg	NOUN
hls-11323	154	54	/	/	SYM
hls-11323	154	55	ml	ml	PROPN
hls-11323	154	56	was	be	AUX
hls-11323	154	57	associated	associate	VERB
hls-11323	154	58	with	with	ADP
hls-11323	154	59	poor	poor	ADJ
hls-11323	154	60	prognosis	prognosis	NOUN
hls-11323	154	61	and	and	CCONJ
hls-11323	154	62	high	high	ADJ
hls-11323	154	63	mortality	mortality	NOUN
hls-11323	154	64	with	with	ADP
hls-11323	154	65	an	an	DET
hls-11323	154	66	odds	odd	NOUN
hls-11323	154	67	ratio	ratio	NOUN
hls-11323	154	68	of	of	ADP
hls-11323	154	69	18.42	18.42	NUM
hls-11323	154	70	(	(	PUNCT
hls-11323	154	71	2.64128.55	2.64128.55	NOUN
hls-11323	154	72	;	;	PUNCT
hls-11323	154	73	 	 	SPACE
hls-11323	154	74	p=0.003).25	p=0.003).25	NOUN
hls-11323	154	75	in	in	ADP
hls-11323	154	76	our	our	PRON
hls-11323	154	77	study	study	NOUN
hls-11323	154	78	,	,	PUNCT
hls-11323	154	79	there	there	PRON
hls-11323	154	80	was	be	VERB
hls-11323	154	81	highly	highly	ADV
hls-11323	154	82	significant	significant	ADJ
hls-11323	154	83	difference	difference	NOUN
hls-11323	154	84	in	in	ADP
hls-11323	154	85	ddimer	ddimer	NOUN
hls-11323	154	86	level	level	NOUN
hls-11323	154	87	between	between	ADP
hls-11323	154	88	deceased	deceased	ADJ
hls-11323	154	89	and	and	CCONJ
hls-11323	154	90	discharged	discharge	VERB
hls-11323	154	91	patients	patient	NOUN
hls-11323	154	92	,	,	PUNCT
hls-11323	154	93	as	as	ADP
hls-11323	154	94	d	d	NOUN
hls-11323	154	95	-	-	PUNCT
hls-11323	154	96	dimer	dimer	ADJ
hls-11323	154	97	levels	level	NOUN
hls-11323	154	98	>	>	X
hls-11323	154	99	2188	2188	NUM
hls-11323	154	100	ng	ng	NOUN
hls-11323	154	101	/	/	SYM
hls-11323	154	102	ml	ml	PROPN
hls-11323	154	103	had	have	AUX
hls-11323	154	104	a	a	DET
hls-11323	154	105	significant	significant	ADJ
hls-11323	154	106	prognostic	prognostic	ADJ
hls-11323	154	107	performance	performance	NOUN
hls-11323	154	108	with	with	ADP
hls-11323	154	109	mortality	mortality	NOUN
hls-11323	154	110	,	,	PUNCT
hls-11323	154	111	with	with	ADP
hls-11323	154	112	sensitivity	sensitivity	NOUN
hls-11323	154	113	92.5	92.5	NUM
hls-11323	154	114	%	%	NOUN
hls-11323	154	115	and	and	CCONJ
hls-11323	154	116	specificity	specificity	NOUN
hls-11323	154	117	63	63	NUM
hls-11323	154	118	%	%	NOUN
hls-11323	154	119	after	after	ADP
hls-11323	154	120	adjustment	adjustment	NOUN
hls-11323	154	121	with	with	ADP
hls-11323	154	122	alt	alt	ADJ
hls-11323	154	123	,	,	PUNCT
hls-11323	154	124	ast	ast	PROPN
hls-11323	154	125	,	,	PUNCT
hls-11323	154	126	pt	pt	NOUN
hls-11323	154	127	,	,	PUNCT
hls-11323	154	128	aptt	aptt	ADJ
hls-11323	154	129	,	,	PUNCT
hls-11323	154	130	and	and	CCONJ
hls-11323	154	131	age	age	NOUN
hls-11323	154	132	.	.	PUNCT
hls-11323	155	1	cytokine	cytokine	ADJ
hls-11323	155	2	storm	storm	NOUN
hls-11323	155	3	and	and	CCONJ
hls-11323	155	4	hypoxia	hypoxia	NOUN
hls-11323	155	5	associated	associate	VERB
hls-11323	155	6	with	with	ADP
hls-11323	155	7	covid-19	covid-19	PROPN
hls-11323	155	8	infection	infection	NOUN
hls-11323	155	9	,	,	PUNCT
hls-11323	155	10	may	may	AUX
hls-11323	155	11	also	also	ADV
hls-11323	155	12	contribute	contribute	VERB
hls-11323	155	13	to	to	ADP
hls-11323	155	14	liver	liver	NOUN
hls-11323	155	15	injury	injury	NOUN
hls-11323	155	16	in	in	ADP
hls-11323	155	17	seriously	seriously	ADV
hls-11323	155	18	ill	ill	ADJ
hls-11323	155	19	patients	patient	NOUN
hls-11323	155	20	,	,	PUNCT
hls-11323	155	21	as	as	SCONJ
hls-11323	155	22	shock	shock	NOUN
hls-11323	155	23	and	and	CCONJ
hls-11323	155	24	hypoxia	hypoxia	NOUN
hls-11323	155	25	leading	lead	VERB
hls-11323	155	26	to	to	ADP
hls-11323	155	27	hypoperfusion	hypoperfusion	NOUN
hls-11323	155	28	of	of	ADP
hls-11323	155	29	the	the	DET
hls-11323	155	30	liver	liver	NOUN
hls-11323	155	31	,	,	PUNCT
hls-11323	155	32	this	this	DET
hls-11323	155	33	inturn	inturn	NOUN
hls-11323	155	34	leads	lead	VERB
hls-11323	155	35	to	to	ADP
hls-11323	155	36	hepatic	hepatic	ADJ
hls-11323	155	37	dysfunction	dysfunction	NOUN
hls-11323	155	38	.	.	PUNCT
hls-11323	156	1	moreover	moreover	ADV
hls-11323	156	2	,	,	PUNCT
hls-11323	156	3	liver	liver	NOUN
hls-11323	156	4	damage	damage	NOUN
hls-11323	156	5	may	may	AUX
hls-11323	156	6	occur	occur	VERB
hls-11323	156	7	due	due	ADJ
hls-11323	156	8	the	the	DET
hls-11323	156	9	use	use	NOUN
hls-11323	156	10	of	of	ADP
hls-11323	156	11	medications	medication	NOUN
hls-11323	156	12	especially	especially	ADV
hls-11323	156	13	lopinavir	lopinavir	NOUN
hls-11323	156	14	and	and	CCONJ
hls-11323	156	15	ritonavir.26	ritonavir.26	ADJ
hls-11323	156	16	chen	chen	PROPN
hls-11323	156	17	et	et	PROPN
hls-11323	156	18	al.27	al.27	PROPN
hls-11323	156	19	evaluated	evaluate	VERB
hls-11323	156	20	99	99	NUM
hls-11323	156	21	confirmed	confirm	VERB
hls-11323	156	22	cases	case	NOUN
hls-11323	156	23	of	of	ADP
hls-11323	156	24	covid-19	covid-19	PROPN
hls-11323	156	25	patients	patient	NOUN
hls-11323	156	26	.	.	PUNCT
hls-11323	157	1	he	he	PRON
hls-11323	157	2	found	find	VERB
hls-11323	157	3	that	that	SCONJ
hls-11323	157	4	43	43	NUM
hls-11323	157	5	patients	patient	NOUN
hls-11323	157	6	presented	present	VERB
hls-11323	157	7	with	with	ADP
hls-11323	157	8	liver	liver	NOUN
hls-11323	157	9	dysfunction	dysfunction	NOUN
hls-11323	157	10	,	,	PUNCT
hls-11323	157	11	as	as	SCONJ
hls-11323	157	12	alt	alt	VERB
hls-11323	157	13	and/or	and/or	CCONJ
hls-11323	157	14	ast	ast	PROPN
hls-11323	157	15	were	be	AUX
hls-11323	157	16	elevated	elevate	VERB
hls-11323	157	17	especially	especially	ADV
hls-11323	157	18	in	in	ADP
hls-11323	157	19	severe	severe	ADJ
hls-11323	157	20	cases	case	NOUN
hls-11323	157	21	.	.	PUNCT
hls-11323	158	1	in	in	ADP
hls-11323	158	2	a	a	DET
hls-11323	158	3	multicenter	multicenter	ADJ
hls-11323	158	4	retrospective	retrospective	ADJ
hls-11323	158	5	cohort	cohort	NOUN
hls-11323	158	6	study	study	NOUN
hls-11323	158	7	conducted	conduct	VERB
hls-11323	158	8	in	in	ADP
hls-11323	158	9	hubei	hubei	PROPN
hls-11323	158	10	province	province	PROPN
hls-11323	158	11	,	,	PUNCT
hls-11323	158	12	liver	liver	NOUN
hls-11323	158	13	injury	injury	NOUN
hls-11323	158	14	indicators	indicator	NOUN
hls-11323	158	15	were	be	AUX
hls-11323	158	16	evaluated	evaluate	VERB
hls-11323	158	17	and	and	CCONJ
hls-11323	158	18	their	their	PRON
hls-11323	158	19	relation	relation	NOUN
hls-11323	158	20	to	to	ADP
hls-11323	158	21	death	death	NOUN
hls-11323	158	22	risk	risk	NOUN
hls-11323	158	23	was	be	AUX
hls-11323	158	24	recorded	record	VERB
hls-11323	158	25	.	.	PUNCT
hls-11323	159	1	the	the	DET
hls-11323	159	2	study	study	NOUN
hls-11323	159	3	found	find	VERB
hls-11323	159	4	that	that	SCONJ
hls-11323	159	5	ast	ast	NOUN
hls-11323	159	6	was	be	AUX
hls-11323	159	7	elevated	elevate	VERB
hls-11323	159	8	before	before	ADP
hls-11323	159	9	alt	alt	ADV
hls-11323	159	10	and	and	CCONJ
hls-11323	159	11	both	both	PRON
hls-11323	159	12	were	be	AUX
hls-11323	159	13	highly	highly	ADV
hls-11323	159	14	increased	increase	VERB
hls-11323	159	15	in	in	ADP
hls-11323	159	16	severe	severe	ADJ
hls-11323	159	17	group	group	NOUN
hls-11323	159	18	of	of	ADP
hls-11323	159	19	patients	patient	NOUN
hls-11323	159	20	,	,	PUNCT
hls-11323	159	21	and	and	CCONJ
hls-11323	159	22	that	that	SCONJ
hls-11323	159	23	ast	ast	NOUN
hls-11323	159	24	is	be	AUX
hls-11323	159	25	in	in	ADP
hls-11323	159	26	particular	particular	ADJ
hls-11323	159	27	was	be	AUX
hls-11323	159	28	associated	associate	VERB
hls-11323	159	29	with	with	ADP
hls-11323	159	30	mortality	mortality	NOUN
hls-11323	159	31	risk.28	risk.28	NOUN
hls-11323	159	32	in	in	ADP
hls-11323	159	33	our	our	PRON
hls-11323	159	34	study	study	NOUN
hls-11323	159	35	,	,	PUNCT
hls-11323	159	36	alt	alt	VERB
hls-11323	159	37	and	and	CCONJ
hls-11323	159	38	ast	ast	NOUN
hls-11323	159	39	were	be	AUX
hls-11323	159	40	significantly	significantly	ADV
hls-11323	159	41	elevated	elevate	VERB
hls-11323	159	42	in	in	ADP
hls-11323	159	43	deceased	deceased	ADJ
hls-11323	159	44	patients	patient	NOUN
hls-11323	159	45	more	more	ADV
hls-11323	159	46	than	than	ADP
hls-11323	159	47	discharged	discharge	VERB
hls-11323	159	48	patients	patient	NOUN
hls-11323	159	49	.	.	PUNCT
hls-11323	160	1	however	however	ADV
hls-11323	160	2	,	,	PUNCT
hls-11323	160	3	we	we	PRON
hls-11323	160	4	did	do	AUX
hls-11323	160	5	not	not	PART
hls-11323	160	6	find	find	VERB
hls-11323	160	7	any	any	DET
hls-11323	160	8	significant	significant	ADJ
hls-11323	160	9	prognostic	prognostic	ADJ
hls-11323	160	10	performance	performance	NOUN
hls-11323	160	11	with	with	ADP
hls-11323	160	12	mortality	mortality	NOUN
hls-11323	160	13	.	.	PUNCT
hls-11323	161	1	viral	viral	ADJ
hls-11323	161	2	,	,	PUNCT
hls-11323	161	3	bacterial	bacterial	ADJ
hls-11323	161	4	,	,	PUNCT
hls-11323	161	5	or	or	CCONJ
hls-11323	161	6	fungal	fungal	ADJ
hls-11323	161	7	infection	infection	NOUN
hls-11323	161	8	leads	lead	VERB
hls-11323	161	9	to	to	ADP
hls-11323	161	10	activation	activation	NOUN
hls-11323	161	11	of	of	ADP
hls-11323	161	12	host	host	NOUN
hls-11323	161	13	defense	defense	NOUN
hls-11323	161	14	mechanisms	mechanism	NOUN
hls-11323	161	15	results	result	VERB
hls-11323	161	16	in	in	ADP
hls-11323	161	17	activation	activation	NOUN
hls-11323	161	18	of	of	ADP
hls-11323	161	19	coagulation	coagulation	NOUN
hls-11323	161	20	pathways	pathway	NOUN
hls-11323	161	21	as	as	ADP
hls-11323	161	22	a	a	DET
hls-11323	161	23	part	part	NOUN
hls-11323	161	24	of	of	ADP
hls-11323	161	25	communication	communication	NOUN
hls-11323	161	26	between	between	ADP
hls-11323	161	27	humoral	humoral	ADJ
hls-11323	161	28	and	and	CCONJ
hls-11323	161	29	cellular	cellular	ADJ
hls-11323	161	30	components	component	NOUN
hls-11323	161	31	of	of	ADP
hls-11323	161	32	the	the	DET
hls-11323	161	33	immune	immune	ADJ
hls-11323	161	34	response	response	NOUN
hls-11323	161	35	in	in	ADP
hls-11323	161	36	what	what	PRON
hls-11323	161	37	is	be	AUX
hls-11323	161	38	called	call	VERB
hls-11323	161	39	thromboinflammation	thromboinflammation	NOUN
hls-11323	161	40	or	or	CCONJ
hls-11323	161	41	immunothrombosis.29	immunothrombosis.29	ADJ
hls-11323	161	42	evidence	evidence	NOUN
hls-11323	161	43	of	of	ADP
hls-11323	161	44	coagulopathy	coagulopathy	ADJ
hls-11323	161	45	has	have	AUX
hls-11323	161	46	been	be	AUX
hls-11323	161	47	reported	report	VERB
hls-11323	161	48	with	with	ADP
hls-11323	161	49	appearance	appearance	NOUN
hls-11323	161	50	of	of	ADP
hls-11323	161	51	covid-19	covid-19	PROPN
hls-11323	161	52	infection	infection	NOUN
hls-11323	161	53	in	in	ADP
hls-11323	161	54	china	china	PROPN
hls-11323	161	55	.	.	PUNCT
hls-11323	162	1	reports	report	NOUN
hls-11323	162	2	of	of	ADP
hls-11323	162	3	the	the	DET
hls-11323	162	4	first	first	ADJ
hls-11323	162	5	99	99	NUM
hls-11323	162	6	patients	patient	NOUN
hls-11323	162	7	hospitalized	hospitalize	VERB
hls-11323	162	8	in	in	ADP
hls-11323	162	9	wuhan	wuhan	PROPN
hls-11323	162	10	demonstrated	demonstrate	VERB
hls-11323	162	11	elevated	elevated	ADJ
hls-11323	162	12	aptt	aptt	ADV
hls-11323	162	13	in	in	ADP
hls-11323	162	14	6	6	NUM
hls-11323	162	15	%	%	NOUN
hls-11323	162	16	and	and	CCONJ
hls-11323	162	17	elevated	elevated	ADJ
hls-11323	162	18	pt	pt	NOUN
hls-11323	162	19	in	in	ADP
hls-11323	162	20	5%.27	5%.27	NUM
hls-11323	162	21	another	another	DET
hls-11323	162	22	report	report	NOUN
hls-11323	162	23	from	from	ADP
hls-11323	162	24	another	another	DET
hls-11323	162	25	wuhan	wuhan	PROPN
hls-11323	162	26	hospital	hospital	NOUN
hls-11323	162	27	showed	show	VERB
hls-11323	162	28	mild	mild	ADJ
hls-11323	162	29	elevation	elevation	NOUN
hls-11323	162	30	in	in	ADP
hls-11323	162	31	pt	pt	PROPN
hls-11323	162	32	but	but	CCONJ
hls-11323	162	33	normal	normal	ADJ
hls-11323	162	34	aptt	aptt	ADV
hls-11323	162	35	in	in	ADP
hls-11323	162	36	the	the	DET
hls-11323	162	37	first	first	ADJ
hls-11323	162	38	138	138	NUM
hls-11323	162	39	patients	patient	NOUN
hls-11323	162	40	admitted	admit	VERB
hls-11323	162	41	to	to	ADP
hls-11323	162	42	the	the	DET
hls-11323	162	43	hospital.24	hospital.24	NOUN
hls-11323	162	44	in	in	ADP
hls-11323	162	45	our	our	PRON
hls-11323	162	46	study	study	NOUN
hls-11323	162	47	,	,	PUNCT
hls-11323	162	48	pt	pt	PROPN
hls-11323	162	49	and	and	CCONJ
hls-11323	162	50	aptt	aptt	PROPN
hls-11323	162	51	were	be	AUX
hls-11323	162	52	significantly	significantly	ADV
hls-11323	162	53	elevated	elevate	VERB
hls-11323	162	54	in	in	ADP
hls-11323	162	55	deceased	deceased	ADJ
hls-11323	162	56	patients	patient	NOUN
hls-11323	162	57	more	more	ADV
hls-11323	162	58	than	than	ADP
hls-11323	162	59	discharged	discharge	VERB
hls-11323	162	60	patients	patient	NOUN
hls-11323	162	61	.	.	PUNCT
hls-11323	163	1	however	however	ADV
hls-11323	163	2	,	,	PUNCT
hls-11323	163	3	we	we	PRON
hls-11323	163	4	did	do	AUX
hls-11323	163	5	not	not	PART
hls-11323	163	6	find	find	VERB
hls-11323	163	7	any	any	DET
hls-11323	163	8	significant	significant	ADJ
hls-11323	163	9	prognostic	prognostic	ADJ
hls-11323	163	10	performance	performance	NOUN
hls-11323	163	11	with	with	ADP
hls-11323	163	12	mortality	mortality	NOUN
hls-11323	163	13	.	.	PUNCT
hls-11323	164	1	pct	pct	NOUN
hls-11323	164	2	is	be	AUX
hls-11323	164	3	a	a	DET
hls-11323	164	4	product	product	NOUN
hls-11323	164	5	of	of	ADP
hls-11323	164	6	calcitonin	calcitonin	NOUN
hls-11323	164	7	-	-	PUNCT
hls-11323	164	8	related	relate	VERB
hls-11323	164	9	gene	gene	NOUN
hls-11323	164	10	,	,	PUNCT
hls-11323	164	11	produced	produce	VERB
hls-11323	164	12	by	by	ADP
hls-11323	164	13	epithelial	epithelial	ADJ
hls-11323	164	14	cells	cell	NOUN
hls-11323	164	15	during	during	ADP
hls-11323	164	16	bacterial	bacterial	ADJ
hls-11323	164	17	infection	infection	NOUN
hls-11323	164	18	;	;	PUNCT
hls-11323	164	19	it	it	PRON
hls-11323	164	20	is	be	AUX
hls-11323	164	21	considered	consider	VERB
hls-11323	164	22	as	as	ADP
hls-11323	164	23	biomarker	biomarker	NOUN
hls-11323	164	24	of	of	ADP
hls-11323	164	25	blood	blood	NOUN
hls-11323	164	26	infection	infection	NOUN
hls-11323	164	27	,	,	PUNCT
hls-11323	164	28	and	and	CCONJ
hls-11323	164	29	usually	usually	ADV
hls-11323	164	30	used	use	VERB
hls-11323	164	31	to	to	PART
hls-11323	164	32	monitor	monitor	VERB
hls-11323	164	33	antibiotic	antibiotic	ADJ
hls-11323	164	34	therapy.30	therapy.30	NOUN
hls-11323	164	35	in	in	ADP
hls-11323	164	36	a	a	DET
hls-11323	164	37	recent	recent	ADJ
hls-11323	164	38	study	study	NOUN
hls-11323	164	39	,	,	PUNCT
hls-11323	164	40	elevated	elevate	VERB
hls-11323	164	41	serum	serum	NOUN
hls-11323	164	42	level	level	NOUN
hls-11323	164	43	of	of	ADP
hls-11323	164	44	pct	pct	NOUN
hls-11323	164	45	in	in	ADP
hls-11323	164	46	covid-19	covid-19	PROPN
hls-11323	164	47	infected	infected	ADJ
hls-11323	164	48	patients	patient	NOUN
hls-11323	164	49	was	be	AUX
hls-11323	164	50	associated	associate	VERB
hls-11323	164	51	with	with	ADP
hls-11323	164	52	high	high	ADJ
hls-11323	164	53	mortality	mortality	NOUN
hls-11323	164	54	with	with	ADP
hls-11323	164	55	high	high	ADJ
hls-11323	164	56	sensitivity	sensitivity	NOUN
hls-11323	164	57	,	,	PUNCT
hls-11323	164	58	and	and	CCONJ
hls-11323	164	59	reported	report	VERB
hls-11323	164	60	that	that	SCONJ
hls-11323	164	61	serum	serum	NOUN
hls-11323	164	62	level	level	NOUN
hls-11323	164	63	of	of	ADP
hls-11323	164	64	pct	pct	NOUN
hls-11323	164	65	(	(	PUNCT
hls-11323	164	66	≥	≥	NUM
hls-11323	164	67	0.10	0.10	NUM
hls-11323	164	68	 	 	SPACE
hls-11323	164	69	ng	ng	PROPN
hls-11323	164	70	/	/	SYM
hls-11323	164	71	ml	ml	PROPN
hls-11323	164	72	)	)	PUNCT
hls-11323	164	73	was	be	AUX
hls-11323	164	74	independent	independent	ADJ
hls-11323	164	75	risk	risk	NOUN
hls-11323	164	76	factor	factor	NOUN
hls-11323	164	77	for	for	ADP
hls-11323	164	78	mortality	mortality	NOUN
hls-11323	164	79	specially	specially	ADV
hls-11323	164	80	in	in	ADP
hls-11323	164	81	old	old	ADJ
hls-11323	164	82	patients	patient	NOUN
hls-11323	164	83	(	(	PUNCT
hls-11323	164	84	age	age	NOUN
hls-11323	164	85	≥	≥	NUM
hls-11323	164	86	60	60	NUM
hls-11323	164	87	y	y	NOUN
hls-11323	164	88	)	)	PUNCT
hls-11323	164	89	and	and	CCONJ
hls-11323	164	90	severe	severe	ADJ
hls-11323	164	91	covid-19	covid-19	PROPN
hls-11323	164	92	infection.15	infection.15	NOUN
hls-11323	164	93	in	in	ADP
hls-11323	164	94	our	our	PRON
hls-11323	164	95	study	study	NOUN
hls-11323	164	96	,	,	PUNCT
hls-11323	164	97	pct	pct	NOUN
hls-11323	164	98	showed	show	VERB
hls-11323	164	99	significant	significant	ADJ
hls-11323	164	100	increase	increase	NOUN
hls-11323	164	101	in	in	ADP
hls-11323	164	102	deceased	deceased	ADJ
hls-11323	164	103	patients	patient	NOUN
hls-11323	164	104	more	more	ADV
hls-11323	164	105	than	than	ADP
hls-11323	164	106	discharged	discharge	VERB
hls-11323	164	107	patients	patient	NOUN
hls-11323	164	108	,	,	PUNCT
hls-11323	164	109	as	as	ADP
hls-11323	164	110	pct	pct	NOUN
hls-11323	164	111	levels	level	NOUN
hls-11323	164	112	>	>	X
hls-11323	164	113	2.09	2.09	NUM
hls-11323	164	114	ng	ng	NOUN
hls-11323	164	115	/	/	SYM
hls-11323	164	116	ml	ml	AUX
hls-11323	164	117	had	have	VERB
hls-11323	164	118	a	a	DET
hls-11323	164	119	significant	significant	ADJ
hls-11323	164	120	prognostic	prognostic	ADJ
hls-11323	164	121	performance	performance	NOUN
hls-11323	164	122	with	with	ADP
hls-11323	164	123	mortality	mortality	NOUN
hls-11323	164	124	with	with	ADP
hls-11323	164	125	,	,	PUNCT
hls-11323	164	126	sensitivity	sensitivity	NOUN
hls-11323	164	127	90	90	NUM
hls-11323	164	128	%	%	NOUN
hls-11323	164	129	and	and	CCONJ
hls-11323	164	130	specificity	specificity	NOUN
hls-11323	164	131	79	79	NUM
hls-11323	164	132	%	%	NOUN
hls-11323	164	133	after	after	ADP
hls-11323	164	134	adjustment	adjustment	NOUN
hls-11323	164	135	with	with	ADP
hls-11323	164	136	alt	alt	ADJ
hls-11323	164	137	,	,	PUNCT
hls-11323	164	138	ast	ast	PROPN
hls-11323	164	139	,	,	PUNCT
hls-11323	164	140	pt	pt	NOUN
hls-11323	164	141	,	,	PUNCT
hls-11323	164	142	aptt	aptt	ADJ
hls-11323	164	143	,	,	PUNCT
hls-11323	164	144	and	and	CCONJ
hls-11323	164	145	age	age	NOUN
hls-11323	164	146	,	,	PUNCT
hls-11323	164	147	it	it	PRON
hls-11323	164	148	was	be	AUX
hls-11323	164	149	independently	independently	ADV
hls-11323	164	150	significant	significant	ADJ
hls-11323	164	151	for	for	ADP
hls-11323	164	152	predicting	predict	VERB
hls-11323	164	153	mortality	mortality	NOUN
hls-11323	164	154	.	.	PUNCT
hls-11323	165	1	cardiac	cardiac	ADJ
hls-11323	165	2	complications	complication	NOUN
hls-11323	165	3	during	during	ADP
hls-11323	165	4	the	the	DET
hls-11323	165	5	covid-19	covid-19	PROPN
hls-11323	165	6	infection	infection	NOUN
hls-11323	165	7	are	be	AUX
hls-11323	165	8	predisposed	predispose	VERB
hls-11323	165	9	by	by	ADP
hls-11323	165	10	old	old	ADJ
hls-11323	165	11	age	age	NOUN
hls-11323	165	12	,	,	PUNCT
hls-11323	165	13	prior	prior	ADJ
hls-11323	165	14	cardiovascular	cardiovascular	ADJ
hls-11323	165	15	disease	disease	NOUN
hls-11323	165	16	and	and	CCONJ
hls-11323	165	17	severe	severe	ADJ
hls-11323	165	18	disease	disease	NOUN
hls-11323	165	19	presentation	presentation	NOUN
hls-11323	165	20	.	.	PUNCT
hls-11323	166	1	the	the	DET
hls-11323	166	2	pathogenic	pathogenic	ADJ
hls-11323	166	3	mechanisms	mechanism	NOUN
hls-11323	166	4	include	include	VERB
hls-11323	166	5	pro	pro	ADJ
hls-11323	166	6	-	-	ADJ
hls-11323	166	7	inflammatory	inflammatory	ADJ
hls-11323	166	8	cytokines	cytokine	NOUN
hls-11323	166	9	(	(	PUNCT
hls-11323	166	10	il-6	il-6	NOUN
hls-11323	166	11	,	,	PUNCT
hls-11323	166	12	il-7	il-7	X
hls-11323	166	13	,	,	PUNCT
hls-11323	166	14	il-22	il-22	NOUN
hls-11323	166	15	,	,	PUNCT
hls-11323	166	16	cxcl10	cxcl10	NOUN
hls-11323	166	17	)	)	PUNCT
hls-11323	166	18	which	which	PRON
hls-11323	166	19	contribute	contribute	VERB
hls-11323	166	20	to	to	ADP
hls-11323	166	21	plaque	plaque	NOUN
hls-11323	166	22	rupture	rupture	NOUN
hls-11323	166	23	,	,	PUNCT
hls-11323	166	24	activation	activation	NOUN
hls-11323	166	25	of	of	ADP
hls-11323	166	26	pro	pro	ADJ
hls-11323	166	27	-	-	ADJ
hls-11323	166	28	coagulation	coagulation	ADJ
hls-11323	166	29	factors	factor	NOUN
hls-11323	166	30	;	;	PUNCT
hls-11323	166	31	and	and	CCONJ
hls-11323	166	32	hemodynamic	hemodynamic	ADJ
hls-11323	166	33	changes	change	NOUN
hls-11323	166	34	leading	lead	VERB
hls-11323	166	35	to	to	ADP
hls-11323	166	36	ischemia	ischemia	NOUN
hls-11323	166	37	and	and	CCONJ
hls-11323	166	38	thrombosis	thrombosis	NOUN
hls-11323	166	39	.	.	PUNCT
hls-11323	167	1	these	these	DET
hls-11323	167	2	cardiac	cardiac	ADJ
hls-11323	167	3	events	event	NOUN
hls-11323	167	4	lead	lead	VERB
hls-11323	167	5	to	to	ADP
hls-11323	167	6	production	production	NOUN
hls-11323	167	7	of	of	ADP
hls-11323	167	8	the	the	DET
hls-11323	167	9	n	n	CCONJ
hls-11323	167	10	-	-	PUNCT
hls-11323	167	11	terminal	terminal	ADJ
hls-11323	167	12	pro	pro	X
hls-11323	167	13	b	b	NOUN
hls-11323	167	14	type	type	NOUN
hls-11323	167	15	natriuretic	natriuretic	ADJ
hls-11323	167	16	peptide	peptide	NOUN
hls-11323	167	17	(	(	PUNCT
hls-11323	167	18	nt	nt	NOUN
hls-11323	167	19	-	-	PUNCT
hls-11323	167	20	probnp	probnp	NOUN
hls-11323	167	21	)	)	PUNCT
hls-11323	167	22	in	in	ADP
hls-11323	167	23	those	those	DET
hls-11323	167	24	patients.29	patients.29	NOUN
hls-11323	167	25	a	a	DET
hls-11323	167	26	meta	meta	ADJ
hls-11323	167	27	-	-	PUNCT
hls-11323	167	28	analysis	analysis	NOUN
hls-11323	167	29	involving	involve	VERB
hls-11323	167	30	4,189	4,189	NUM
hls-11323	167	31	patients	patient	NOUN
hls-11323	167	32	enrolled	enrol	VERB
hls-11323	167	33	in	in	ADP
hls-11323	167	34	28	28	NUM
hls-11323	167	35	studies	study	NOUN
hls-11323	167	36	reported	report	VERB
hls-11323	167	37	that	that	SCONJ
hls-11323	167	38	patients	patient	NOUN
hls-11323	167	39	with	with	ADP
hls-11323	167	40	severe	severe	ADJ
hls-11323	167	41	covid-19	covid-19	PROPN
hls-11323	167	42	infection	infection	NOUN
hls-11323	167	43	had	have	VERB
hls-11323	167	44	significant	significant	ADJ
hls-11323	167	45	high	high	ADJ
hls-11323	167	46	level	level	NOUN
hls-11323	167	47	nt	nt	NOUN
hls-11323	167	48	-	-	PUNCT
hls-11323	167	49	probnp	probnp	NOUN
hls-11323	167	50	,	,	PUNCT
hls-11323	167	51	and	and	CCONJ
hls-11323	167	52	its	its	PRON
hls-11323	167	53	level	level	NOUN
hls-11323	167	54	rises	rise	VERB
hls-11323	167	55	progressively	progressively	ADV
hls-11323	167	56	in	in	ADP
hls-11323	167	57	non	non	ADJ
hls-11323	167	58	-	-	ADJ
hls-11323	167	59	survivors.5	survivors.5	ADJ
hls-11323	167	60	in	in	ADP
hls-11323	167	61	another	another	DET
hls-11323	167	62	study	study	NOUN
hls-11323	167	63	involving	involve	VERB
hls-11323	167	64	138	138	NUM
hls-11323	167	65	patients	patient	NOUN
hls-11323	167	66	,	,	PUNCT
hls-11323	167	67	the	the	DET
hls-11323	167	68	average	average	ADJ
hls-11323	167	69	levels	level	NOUN
hls-11323	167	70	of	of	ADP
hls-11323	167	71	nt	nt	NOUN
hls-11323	167	72	-	-	PUNCT
hls-11323	167	73	probnp	probnp	NOUN
hls-11323	167	74	(	(	PUNCT
hls-11323	167	75	301.2	301.2	NUM
hls-11323	167	76	ng	ng	PROPN
hls-11323	167	77	/	/	SYM
hls-11323	167	78	l	l	PROPN
hls-11323	167	79	vs	vs	ADP
hls-11323	167	80	2887.5	2887.5	NUM
hls-11323	167	81	ng	ng	PROPN
hls-11323	167	82	/	/	SYM
hls-11323	167	83	l	l	PROPN
hls-11323	167	84	;	;	PUNCT
hls-11323	167	85	p<0.01	p<0.01	PROPN
hls-11323	167	86	)	)	PUNCT
hls-11323	167	87	were	be	AUX
hls-11323	167	88	maximum	maximum	ADJ
hls-11323	167	89	in	in	ADP
hls-11323	167	90	icu	icu	PROPN
hls-11323	167	91	patients	patient	NOUN
hls-11323	167	92	who	who	PRON
hls-11323	167	93	stayed	stay	VERB
hls-11323	167	94	on	on	ADP
hls-11323	167	95	mechanical	mechanical	ADJ
hls-11323	167	96	ventilation	ventilation	NOUN
hls-11323	167	97	,	,	PUNCT
hls-11323	167	98	or	or	CCONJ
hls-11323	167	99	extracorporeal	extracorporeal	NOUN
hls-11323	167	100	membrane	membrane	NOUN
hls-11323	167	101	oxygenation	oxygenation	NOUN
hls-11323	167	102	or	or	CCONJ
hls-11323	167	103	deceased	deceased	ADJ
hls-11323	167	104	patients.24	patients.24	NOUN
hls-11323	167	105	in	in	ADP
hls-11323	167	106	our	our	PRON
hls-11323	167	107	study	study	NOUN
hls-11323	167	108	,	,	PUNCT
hls-11323	167	109	probnp	probnp	PROPN
hls-11323	167	110	showed	show	VERB
hls-11323	167	111	significant	significant	ADJ
hls-11323	167	112	increase	increase	NOUN
hls-11323	167	113	in	in	ADP
hls-11323	167	114	deceased	deceased	ADJ
hls-11323	167	115	patients	patient	NOUN
hls-11323	167	116	more	more	ADV
hls-11323	167	117	than	than	ADP
hls-11323	167	118	discharged	discharge	VERB
hls-11323	167	119	patients	patient	NOUN
hls-11323	167	120	,	,	PUNCT
hls-11323	167	121	as	as	ADP
hls-11323	167	122	probnp	probnp	NOUN
hls-11323	167	123	levels	level	NOUN
hls-11323	167	124	>	>	X
hls-11323	167	125	1755	1755	NUM
hls-11323	167	126	pg	pg	NOUN
hls-11323	167	127	/	/	SYM
hls-11323	167	128	ml	ml	AUX
hls-11323	167	129	had	have	VERB
hls-11323	167	130	a	a	DET
hls-11323	167	131	significant	significant	ADJ
hls-11323	167	132	prognostic	prognostic	ADJ
hls-11323	167	133	performance	performance	NOUN
hls-11323	167	134	with	with	ADP
hls-11323	167	135	mortality	mortality	NOUN
hls-11323	167	136	,	,	PUNCT
hls-11323	167	137	with	with	ADP
hls-11323	167	138	sensitivity	sensitivity	NOUN
hls-11323	167	139	85	85	NUM
hls-11323	167	140	%	%	NOUN
hls-11323	167	141	and	and	CCONJ
hls-11323	167	142	specificity	specificity	NOUN
hls-11323	167	143	84	84	NUM
hls-11323	167	144	%	%	NOUN
hls-11323	167	145	after	after	ADP
hls-11323	167	146	adjustment	adjustment	NOUN
hls-11323	167	147	with	with	ADP
hls-11323	167	148	alt	alt	ADJ
hls-11323	167	149	,	,	PUNCT
hls-11323	167	150	ast	ast	PROPN
hls-11323	167	151	,	,	PUNCT
hls-11323	167	152	pt	pt	NOUN
hls-11323	167	153	,	,	PUNCT
hls-11323	167	154	aptt	aptt	ADJ
hls-11323	167	155	,	,	PUNCT
hls-11323	167	156	and	and	CCONJ
hls-11323	167	157	age	age	NOUN
hls-11323	167	158	,	,	PUNCT
hls-11323	167	159	and	and	CCONJ
hls-11323	167	160	it	it	PRON
hls-11323	167	161	was	be	AUX
hls-11323	167	162	independently	independently	ADV
hls-11323	167	163	significant	significant	ADJ
hls-11323	167	164	for	for	ADP
hls-11323	167	165	predicting	predict	VERB
hls-11323	167	166	mortality	mortality	NOUN
hls-11323	167	167	.	.	PUNCT
hls-11323	168	1	after	after	ADP
hls-11323	168	2	assessment	assessment	NOUN
hls-11323	168	3	of	of	ADP
hls-11323	168	4	many	many	ADJ
hls-11323	168	5	biochemical	biochemical	ADJ
hls-11323	168	6	markers	marker	NOUN
hls-11323	168	7	during	during	ADP
hls-11323	168	8	covid-19	covid-19	PROPN
hls-11323	168	9	infection	infection	NOUN
hls-11323	168	10	,	,	PUNCT
hls-11323	168	11	we	we	PRON
hls-11323	168	12	found	find	VERB
hls-11323	168	13	that	that	SCONJ
hls-11323	168	14	there	there	PRON
hls-11323	168	15	was	be	VERB
hls-11323	168	16	significant	significant	ADJ
hls-11323	168	17	prognostic	prognostic	ADJ
hls-11323	168	18	performance	performance	NOUN
hls-11323	168	19	of	of	ADP
hls-11323	168	20	crp	crp	PROPN
hls-11323	168	21	,	,	PUNCT
hls-11323	168	22	ferritin	ferritin	PROPN
hls-11323	168	23	,	,	PUNCT
hls-11323	168	24	ldh	ldh	PROPN
hls-11323	168	25	,	,	PUNCT
hls-11323	168	26	d	d	NOUN
hls-11323	168	27	-	-	PUNCT
hls-11323	168	28	dimer	dimer	ADJ
hls-11323	168	29	,	,	PUNCT
hls-11323	168	30	pct	pct	NOUN
hls-11323	168	31	and	and	CCONJ
hls-11323	168	32	pro	pro	ADJ
hls-11323	168	33	-	-	ADJ
hls-11323	168	34	bnp	bnp	ADJ
hls-11323	168	35	with	with	ADP
hls-11323	168	36	mortality	mortality	NOUN
hls-11323	168	37	,	,	PUNCT
hls-11323	168	38	and	and	CCONJ
hls-11323	168	39	the	the	DET
hls-11323	168	40	highest	high	ADJ
hls-11323	168	41	performance	performance	NOUN
hls-11323	168	42	of	of	ADP
hls-11323	168	43	variables	variable	NOUN
hls-11323	168	44	were	be	AUX
hls-11323	168	45	ldh	ldh	ADJ
hls-11323	168	46	>	>	X
hls-11323	168	47	pct	pct	NOUN
hls-11323	168	48	>	>	X
hls-11323	168	49	pro	pro	ADJ
hls-11323	168	50	-	-	ADJ
hls-11323	168	51	bnp	bnp	ADJ
hls-11323	168	52	>	>	SYM
hls-11323	168	53	crp	crp	PROPN
hls-11323	168	54	,	,	PUNCT
hls-11323	168	55	and	and	CCONJ
hls-11323	168	56	the	the	DET
hls-11323	168	57	least	least	ADJ
hls-11323	168	58	was	be	AUX
hls-11323	168	59	d	d	NOUN
hls-11323	168	60	-	-	PUNCT
hls-11323	168	61	dimer	dimer	NOUN
hls-11323	168	62	and	and	CCONJ
hls-11323	168	63	ferritin	ferritin	NOUN
hls-11323	168	64	.	.	PUNCT
hls-11323	169	1	the	the	DET
hls-11323	169	2	cut	cut	VERB
hls-11323	169	3	off	off	ADP
hls-11323	169	4	value	value	NOUN
hls-11323	169	5	for	for	ADP
hls-11323	169	6	ldh	ldh	PROPN
hls-11323	169	7	was	be	AUX
hls-11323	169	8	>	>	X
hls-11323	169	9	500	500	NUM
hls-11323	169	10	iu	iu	PROPN
hls-11323	169	11	/	/	SYM
hls-11323	169	12	l	l	NOUN
hls-11323	169	13	,	,	PUNCT
hls-11323	169	14	for	for	ADP
hls-11323	169	15	pct	pct	NOUN
hls-11323	169	16	was	be	AUX
hls-11323	169	17	>	>	X
hls-11323	169	18	2.09	2.09	NUM
hls-11323	169	19	ng	ng	NOUN
hls-11323	169	20	/	/	SYM
hls-11323	169	21	ml	ml	PROPN
hls-11323	169	22	,	,	PUNCT
hls-11323	169	23	for	for	ADP
hls-11323	169	24	pro	pro	ADJ
hls-11323	169	25	-	-	ADJ
hls-11323	169	26	bnp	bnp	ADJ
hls-11323	169	27	was	be	AUX
hls-11323	169	28	>	>	X
hls-11323	169	29	1755	1755	NUM
hls-11323	169	30	pg	pg	NOUN
hls-11323	169	31	/	/	SYM
hls-11323	169	32	ml	ml	ADP
hls-11323	169	33	,	,	PUNCT
hls-11323	169	34	and	and	CCONJ
hls-11323	169	35	for	for	ADP
hls-11323	169	36	crp	crp	PROPN
hls-11323	169	37	>	>	X
hls-11323	169	38	15.4	15.4	NUM
hls-11323	169	39	mg	mg	PROPN
hls-11323	169	40	/	/	SYM
hls-11323	169	41	l.	l.	PROPN
hls-11323	169	42	univariat	univariat	PROPN
hls-11323	169	43	analysis	analysis	NOUN
hls-11323	169	44	showed	show	VERB
hls-11323	169	45	that	that	SCONJ
hls-11323	169	46	each	each	DET
hls-11323	169	47	one	one	NUM
hls-11323	169	48	of	of	ADP
hls-11323	169	49	the	the	DET
hls-11323	169	50	variables	variable	NOUN
hls-11323	169	51	was	be	AUX
hls-11323	169	52	associated	associate	VERB
hls-11323	169	53	with	with	ADP
hls-11323	169	54	mortality	mortality	NOUN
hls-11323	169	55	after	after	ADP
hls-11323	169	56	adjustment	adjustment	NOUN
hls-11323	169	57	with	with	ADP
hls-11323	169	58	alt	alt	ADJ
hls-11323	169	59	,	,	PUNCT
hls-11323	169	60	ast	ast	PROPN
hls-11323	169	61	,	,	PUNCT
hls-11323	169	62	pt	pt	NOUN
hls-11323	169	63	,	,	PUNCT
hls-11323	169	64	aptt	aptt	ADJ
hls-11323	169	65	,	,	PUNCT
hls-11323	169	66	and	and	CCONJ
hls-11323	169	67	age	age	NOUN
hls-11323	169	68	,	,	PUNCT
hls-11323	169	69	multivariate	multivariate	VERB
hls-11323	169	70	analysis	analysis	NOUN
hls-11323	169	71	showed	show	VERB
hls-11323	169	72	that	that	SCONJ
hls-11323	169	73	ferritin	ferritin	VERB
hls-11323	169	74	>	>	X
hls-11323	169	75	677	677	NUM
hls-11323	169	76	ng	ng	PROPN
hls-11323	169	77	/	/	SYM
hls-11323	169	78	ml	ml	PROPN
hls-11323	169	79	,	,	PUNCT
hls-11323	169	80	ldh	ldh	X
hls-11323	169	81	>	>	X
hls-11323	169	82	500	500	NUM
hls-11323	169	83	iu	iu	PROPN
hls-11323	169	84	/	/	SYM
hls-11323	169	85	l	l	NOUN
hls-11323	169	86	,	,	PUNCT
hls-11323	169	87	pct	pct	NOUN
hls-11323	169	88	>	>	X
hls-11323	169	89	2.09	2.09	NUM
hls-11323	169	90	ng	ng	PROPN
hls-11323	169	91	/	/	SYM
hls-11323	169	92	ml	ml	PROPN
hls-11323	169	93	,	,	PUNCT
hls-11323	169	94	and	and	CCONJ
hls-11323	169	95	pro	pro	ADJ
hls-11323	169	96	-	-	ADJ
hls-11323	169	97	bnp	bnp	ADJ
hls-11323	169	98	>	>	X
hls-11323	169	99	1755	1755	NUM
hls-11323	169	100	pg	pg	NOUN
hls-11323	169	101	/	/	SYM
hls-11323	169	102	ml	ml	NOUN
hls-11323	169	103	were	be	AUX
hls-11323	169	104	still	still	ADV
hls-11323	169	105	independently	independently	ADV
hls-11323	169	106	significant	significant	ADJ
hls-11323	169	107	for	for	ADP
hls-11323	169	108	predicting	predict	VERB
hls-11323	169	109	mortality	mortality	NOUN
hls-11323	169	110	.	.	PUNCT
hls-11323	170	1	conclusions	conclusion	NOUN
hls-11323	170	2	early	early	ADJ
hls-11323	170	3	assessment	assessment	NOUN
hls-11323	170	4	of	of	ADP
hls-11323	170	5	biochemical	biochemical	ADJ
hls-11323	170	6	markers	marker	NOUN
hls-11323	170	7	in	in	ADP
hls-11323	170	8	patients	patient	NOUN
hls-11323	170	9	with	with	ADP
hls-11323	170	10	covid-19	covid-19	PROPN
hls-11323	170	11	infection	infection	NOUN
hls-11323	170	12	can	can	AUX
hls-11323	170	13	assist	assist	VERB
hls-11323	170	14	clinicians	clinician	NOUN
hls-11323	170	15	in	in	ADP
hls-11323	170	16	tailoring	tailor	VERB
hls-11323	170	17	treatment	treatment	NOUN
hls-11323	170	18	and	and	CCONJ
hls-11323	170	19	providing	provide	VERB
hls-11323	170	20	more	more	ADV
hls-11323	170	21	intensive	intensive	ADJ
hls-11323	170	22	care	care	NOUN
hls-11323	170	23	to	to	ADP
hls-11323	170	24	those	those	PRON
hls-11323	170	25	at	at	ADP
hls-11323	170	26	a	a	DET
hls-11323	170	27	greater	great	ADJ
hls-11323	170	28	risk	risk	NOUN
hls-11323	170	29	of	of	ADP
hls-11323	170	30	mortality	mortality	NOUN
hls-11323	170	31	.	.	PUNCT
hls-11323	171	1	ferritin	ferritin	ADJ
hls-11323	171	2	,	,	PUNCT
hls-11323	171	3	ldh	ldh	ADJ
hls-11323	171	4	,	,	PUNCT
hls-11323	171	5	pct	pct	NOUN
hls-11323	171	6	and	and	CCONJ
hls-11323	171	7	probnp	probnp	NOUN
hls-11323	171	8	are	be	AUX
hls-11323	171	9	important	important	ADJ
hls-11323	171	10	markers	marker	NOUN
hls-11323	171	11	to	to	PART
hls-11323	171	12	assess	assess	VERB
hls-11323	171	13	as	as	SCONJ
hls-11323	171	14	they	they	PRON
hls-11323	171	15	have	have	AUX
hls-11323	171	16	demonstrated	demonstrate	VERB
hls-11323	171	17	high	high	ADJ
hls-11323	171	18	sensitivity	sensitivity	NOUN
hls-11323	171	19	and	and	CCONJ
hls-11323	171	20	specificity	specificity	NOUN
hls-11323	171	21	,	,	PUNCT
hls-11323	171	22	prognostic	prognostic	ADJ
hls-11323	171	23	performance	performance	NOUN
hls-11323	171	24	,	,	PUNCT
hls-11323	171	25	and	and	CCONJ
hls-11323	171	26	independent	independent	ADJ
hls-11323	171	27	significance	significance	NOUN
hls-11323	171	28	in	in	ADP
hls-11323	171	29	predicting	predict	VERB
hls-11323	171	30	mortality	mortality	NOUN
hls-11323	171	31	.	.	PUNCT
hls-11323	172	1	by	by	ADP
hls-11323	172	2	monitoring	monitor	VERB
hls-11323	172	3	these	these	DET
hls-11323	172	4	markers	marker	NOUN
hls-11323	172	5	,	,	PUNCT
hls-11323	172	6	clinicians	clinician	NOUN
hls-11323	172	7	can	can	AUX
hls-11323	172	8	better	well	ADV
hls-11323	172	9	identify	identify	VERB
hls-11323	172	10	patients	patient	NOUN
hls-11323	172	11	who	who	PRON
hls-11323	172	12	may	may	AUX
hls-11323	172	13	require	require	VERB
hls-11323	172	14	more	more	ADV
hls-11323	172	15	aggressive	aggressive	ADJ
hls-11323	172	16	interventions	intervention	NOUN
hls-11323	172	17	or	or	CCONJ
hls-11323	172	18	closer	close	ADJ
hls-11323	172	19	monitoring	monitoring	NOUN
hls-11323	172	20	to	to	PART
hls-11323	172	21	improve	improve	VERB
hls-11323	172	22	outcomes	outcome	NOUN
hls-11323	172	23	references	reference	NOUN
hls-11323	172	24	1	1	X
hls-11323	172	25	.	.	PUNCT
hls-11323	172	26	lu	lu	NOUN
hls-11323	172	27	r	r	PROPN
hls-11323	172	28	,	,	PUNCT
hls-11323	172	29	zhao	zhao	PROPN
hls-11323	172	30	x	x	PROPN
hls-11323	172	31	,	,	PUNCT
hls-11323	172	32	li	li	PROPN
hls-11323	172	33	j.	j.	PROPN
hls-11323	172	34	genomic	genomic	PROPN
hls-11323	172	35	characterization	characterization	NOUN
hls-11323	172	36	and	and	CCONJ
hls-11323	172	37	epidemiology	epidemiology	NOUN
hls-11323	172	38	of	of	ADP
hls-11323	172	39	2019	2019	NUM
hls-11323	172	40	novel	novel	ADJ
hls-11323	172	41	coronavirus	coronavirus	NOUN
hls-11323	172	42	:	:	PUNCT
hls-11323	172	43	implication	implication	NOUN
hls-11323	172	44	for	for	ADP
hls-11323	172	45	virus	virus	NOUN
hls-11323	172	46	origins	origin	NOUN
hls-11323	172	47	and	and	CCONJ
hls-11323	172	48	receptor	receptor	NOUN
hls-11323	172	49	binding	bind	VERB
hls-11323	172	50	.	.	PUNCT
hls-11323	173	1	lancet	lancet	PROPN
hls-11323	173	2	2020;395:565	2020;395:565	NUM
hls-11323	173	3	-	-	SYM
hls-11323	173	4	74	74	NUM
hls-11323	173	5	.	.	PUNCT
hls-11323	174	1	2	2	X
hls-11323	174	2	.	.	X
hls-11323	174	3	chen	chen	PROPN
hls-11323	174	4	t	t	PROPN
hls-11323	174	5	,	,	PUNCT
hls-11323	174	6	wu	wu	PROPN
hls-11323	174	7	d	d	PROPN
hls-11323	174	8	,	,	PUNCT
hls-11323	174	9	chen	chen	PROPN
hls-11323	174	10	h	h	PROPN
hls-11323	174	11	,	,	PUNCT
hls-11323	174	12	yan	yan	PROPN
hls-11323	174	13	w	w	PROPN
hls-11323	174	14	,	,	PUNCT
hls-11323	174	15	yang	yang	PROPN
hls-11323	174	16	d.	d.	PROPN
hls-11323	174	17	clinical	clinical	PROPN
hls-11323	174	18	characteristics	characteristic	NOUN
hls-11323	174	19	of	of	ADP
hls-11323	174	20	113	113	NUM
hls-11323	174	21	deceased	deceased	ADJ
hls-11323	174	22	patients	patient	NOUN
hls-11323	174	23	with	with	ADP
hls-11323	174	24	coronavirus	coronavirus	NOUN
hls-11323	174	25	disease	disease	NOUN
hls-11323	174	26	2019	2019	NUM
hls-11323	174	27	:	:	PUNCT
hls-11323	174	28	retrospective	retrospective	ADJ
hls-11323	174	29	study	study	NOUN
hls-11323	174	30	.	.	PUNCT
hls-11323	175	1	bmj.2020	bmj.2020	NOUN
hls-11323	175	2	;	;	PUNCT
hls-11323	175	3	368	368	NUM
hls-11323	175	4	:	:	PUNCT
hls-11323	175	5	m1091	m1091	NOUN
hls-11323	175	6	.	.	NOUN
hls-11323	176	1	3	3	X
hls-11323	176	2	.	.	X
hls-11323	176	3	hariyanto	hariyanto	PROPN
hls-11323	176	4	i	i	PRON
hls-11323	176	5	and	and	CCONJ
hls-11323	176	6	kurniawan	kurniawan	PROPN
hls-11323	176	7	a.	a.	PROPN
hls-11323	176	8	thyroid	thyroid	PROPN
hls-11323	176	9	disease	disease	NOUN
hls-11323	176	10	is	be	AUX
hls-11323	176	11	associated	associate	VERB
hls-11323	176	12	with	with	ADP
hls-11323	176	13	severe	severe	ADJ
hls-11323	176	14	corona	corona	NOUN
hls-11323	176	15	disease	disease	NOUN
hls-11323	176	16	2019	2019	NUM
hls-11323	176	17	(	(	PUNCT
hls-11323	176	18	covid-19	covid-19	PROPN
hls-11323	176	19	)	)	PUNCT
hls-11323	176	20	infection	infection	NOUN
hls-11323	176	21	.	.	PUNCT
hls-11323	177	1	article	article	NOUN
hls-11323	178	1	[	[	X
hls-11323	178	2	page	page	NOUN
hls-11323	178	3	6	6	NUM
hls-11323	178	4	]	]	PUNCT
hls-11323	179	1	[	[	X
hls-11323	179	2	healthcare	healthcare	NOUN
hls-11323	179	3	in	in	ADP
hls-11323	179	4	low	low	ADJ
hls-11323	179	5	-	-	PUNCT
hls-11323	179	6	resource	resource	NOUN
hls-11323	179	7	settings	setting	NOUN
hls-11323	179	8	2023	2023	NUM
hls-11323	179	9	;	;	PUNCT
hls-11323	179	10	11(s2):11323	11(s2):11323	NUM
hls-11323	179	11	]	]	X
hls-11323	179	12	non	non	ADJ
hls-11323	179	13	-co	-co	PROPN
hls-11323	179	14	mmerc	mmerc	PROPN
hls-11323	179	15	ial	ial	PROPN
hls-11323	179	16	us	us	PROPN
hls-11323	179	17	e	e	NOUN
hls-11323	179	18	o	o	NOUN
hls-11323	179	19	nly	nly	ADV
hls-11323	179	20	diabetes	diabete	VERB
hls-11323	179	21	metab	metab	NOUN
hls-11323	179	22	syndr	syndr	NOUN
hls-11323	179	23	2020;14:1429	2020;14:1429	PROPN
hls-11323	179	24	-	-	PUNCT
hls-11323	179	25	30	30	NUM
hls-11323	179	26	.	.	PUNCT
hls-11323	180	1	4	4	NUM
hls-11323	180	2	.	.	PUNCT
hls-11323	181	1	liu	liu	PROPN
hls-11323	181	2	y	y	PROPN
hls-11323	181	3	,	,	PUNCT
hls-11323	181	4	yang	yang	PROPN
hls-11323	181	5	y	y	PROPN
hls-11323	181	6	,	,	PUNCT
hls-11323	181	7	zhang	zhang	PROPN
hls-11323	181	8	c	c	X
hls-11323	181	9	,	,	PUNCT
hls-11323	181	10	et	et	PROPN
hls-11323	181	11	al	al	PROPN
hls-11323	181	12	.	.	PROPN
hls-11323	182	1	clinical	clinical	ADJ
hls-11323	182	2	and	and	CCONJ
hls-11323	182	3	biochemical	biochemical	ADJ
hls-11323	182	4	indexes	index	NOUN
hls-11323	182	5	from	from	ADP
hls-11323	182	6	2019	2019	NUM
hls-11323	182	7	-	-	PUNCT
hls-11323	182	8	ncov	ncov	ADV
hls-11323	182	9	infected	infected	ADJ
hls-11323	182	10	patients	patient	NOUN
hls-11323	182	11	linked	link	VERB
hls-11323	182	12	to	to	ADP
hls-11323	182	13	viral	viral	ADJ
hls-11323	182	14	loads	load	NOUN
hls-11323	182	15	and	and	CCONJ
hls-11323	182	16	lung	lung	NOUN
hls-11323	182	17	injury	injury	NOUN
hls-11323	182	18	.	.	PUNCT
hls-11323	183	1	science	science	PROPN
hls-11323	183	2	china	china	PROPN
hls-11323	183	3	.	.	PUNCT
hls-11323	184	1	life	life	NOUN
hls-11323	184	2	sciences	science	NOUN
hls-11323	184	3	2020;63:364–74	2020;63:364–74	PRON
hls-11323	184	4	.	.	PUNCT
hls-11323	185	1	5	5	NUM
hls-11323	185	2	.	.	X
hls-11323	185	3	hariyanto	hariyanto	PROPN
hls-11323	185	4	t	t	PROPN
hls-11323	185	5	,	,	PUNCT
hls-11323	185	6	japar	japar	ADV
hls-11323	185	7	k	k	PROPN
hls-11323	185	8	,	,	PUNCT
hls-11323	185	9	kwenandar	kwenandar	PROPN
hls-11323	185	10	f	f	PROPN
hls-11323	185	11	,	,	PUNCT
hls-11323	185	12	et	et	PROPN
hls-11323	185	13	al	al	PROPN
hls-11323	185	14	.	.	PROPN
hls-11323	186	1	inflammatory	inflammatory	ADJ
hls-11323	186	2	and	and	CCONJ
hls-11323	186	3	hematologic	hematologic	NOUN
hls-11323	186	4	markers	marker	NOUN
hls-11323	186	5	as	as	ADP
hls-11323	186	6	predictors	predictor	NOUN
hls-11323	186	7	of	of	ADP
hls-11323	186	8	severe	severe	ADJ
hls-11323	186	9	outcomes	outcome	NOUN
hls-11323	186	10	in	in	ADP
hls-11323	186	11	covid-19	covid-19	PROPN
hls-11323	186	12	infection	infection	NOUN
hls-11323	186	13	:	:	PUNCT
hls-11323	186	14	a	a	DET
hls-11323	186	15	systematic	systematic	ADJ
hls-11323	186	16	review	review	NOUN
hls-11323	186	17	and	and	CCONJ
hls-11323	186	18	meta	meta	ADJ
hls-11323	186	19	-	-	PUNCT
hls-11323	186	20	analysis	analysis	NOUN
hls-11323	186	21	.	.	PUNCT
hls-11323	187	1	am	be	AUX
hls-11323	187	2	j	j	PROPN
hls-11323	187	3	emerg	emerg	PROPN
hls-11323	187	4	med	med	ADJ
hls-11323	187	5	2021;41:110–9	2021;41:110–9	NUM
hls-11323	187	6	.	.	PUNCT
hls-11323	188	1	6	6	NUM
hls-11323	188	2	.	.	X
hls-11323	188	3	kubina	kubina	NOUN
hls-11323	188	4	r	r	NOUN
hls-11323	188	5	,	,	PUNCT
hls-11323	188	6	dziedzic	dziedzic	ADJ
hls-11323	188	7	a.	a.	NOUN
hls-11323	188	8	molecular	molecular	ADJ
hls-11323	188	9	and	and	CCONJ
hls-11323	188	10	serological	serological	ADJ
hls-11323	188	11	tests	test	NOUN
hls-11323	188	12	for	for	ADP
hls-11323	188	13	covid-19	covid-19	PROPN
hls-11323	188	14	a	a	DET
hls-11323	188	15	comparative	comparative	ADJ
hls-11323	188	16	review	review	NOUN
hls-11323	188	17	of	of	ADP
hls-11323	188	18	sars	sar	NOUN
hls-11323	188	19	-	-	PUNCT
hls-11323	188	20	cov-2	cov-2	NOUN
hls-11323	188	21	coronavirus	coronavirus	NOUN
hls-11323	188	22	laboratory	laboratory	NOUN
hls-11323	188	23	and	and	CCONJ
hls-11323	188	24	point	point	NOUN
hls-11323	188	25	-	-	PUNCT
hls-11323	188	26	of	of	ADP
hls-11323	188	27	-	-	PUNCT
hls-11323	188	28	care	care	NOUN
hls-11323	188	29	diagnostics	diagnostic	NOUN
hls-11323	188	30	.	.	PUNCT
hls-11323	189	1	diagnostics	diagnostic	NOUN
hls-11323	189	2	2020;10:434	2020;10:434	NUM
hls-11323	189	3	.	.	PROPN
hls-11323	190	1	7	7	NUM
hls-11323	190	2	.	.	X
hls-11323	190	3	letelier	letelier	PROPN
hls-11323	190	4	p	p	NOUN
hls-11323	190	5	,	,	PUNCT
hls-11323	190	6	encina	encina	NOUN
hls-11323	190	7	n	n	CCONJ
hls-11323	190	8	,	,	PUNCT
hls-11323	190	9	morales	morale	VERB
hls-11323	190	10	p	p	PRON
hls-11323	190	11	,	,	PUNCT
hls-11323	190	12	et	et	PROPN
hls-11323	190	13	al	al	PROPN
hls-11323	190	14	.	.	PUNCT
hls-11323	191	1	role	role	NOUN
hls-11323	191	2	of	of	ADP
hls-11323	191	3	biochemical	biochemical	ADJ
hls-11323	191	4	markers	marker	NOUN
hls-11323	191	5	in	in	ADP
hls-11323	191	6	the	the	DET
hls-11323	191	7	monitoring	monitoring	NOUN
hls-11323	191	8	of	of	ADP
hls-11323	191	9	covid-19	covid-19	PROPN
hls-11323	191	10	patients	patient	NOUN
hls-11323	191	11	.	.	PUNCT
hls-11323	192	1	j	j	PROPN
hls-11323	192	2	med	med	PROPN
hls-11323	192	3	biochem	biochem	PROPN
hls-11323	192	4	2012;40:115–28	2012;40:115–28	PROPN
hls-11323	192	5	.	.	PROPN
hls-11323	192	6	8	8	NUM
hls-11323	192	7	.	.	PUNCT
hls-11323	192	8	centers	center	NOUN
hls-11323	192	9	of	of	ADP
hls-11323	192	10	disease	disease	NOUN
hls-11323	192	11	control	control	NOUN
hls-11323	192	12	and	and	CCONJ
hls-11323	192	13	prevention	prevention	NOUN
hls-11323	192	14	(	(	PUNCT
hls-11323	192	15	2020	2020	NUM
hls-11323	192	16	)	)	PUNCT
hls-11323	192	17	covid-19	covid-19	PROPN
hls-11323	192	18	(	(	PUNCT
hls-11323	192	19	coronavirus	coronavirus	NOUN
hls-11323	192	20	disease	disease	NOUN
hls-11323	192	21	):	):	PUNCT
hls-11323	192	22	people	people	NOUN
hls-11323	192	23	with	with	ADP
hls-11323	192	24	certain	certain	ADJ
hls-11323	192	25	medical	medical	ADJ
hls-11323	192	26	conditions	condition	NOUN
hls-11323	192	27	.	.	PUNCT
hls-11323	193	1	2020	2020	NUM
hls-11323	193	2	.	.	PUNCT
hls-11323	194	1	accessed	access	VERB
hls-11323	194	2	august	august	PROPN
hls-11323	194	3	31	31	NUM
hls-11323	194	4	,	,	PUNCT
hls-11323	194	5	2021	2021	NUM
hls-11323	194	6	.	.	PUNCT
hls-11323	195	1	available	available	ADJ
hls-11323	195	2	from	from	ADP
hls-11323	195	3	:	:	PUNCT
hls-11323	195	4	https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautiona/people-with-medical-conditions.html	https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautiona/people-with-medical-conditions.html	PROPN
hls-11323	195	5	9	9	NUM
hls-11323	195	6	.	.	PUNCT
hls-11323	196	1	chen	chen	PROPN
hls-11323	196	2	t	t	PROPN
hls-11323	196	3	,	,	PUNCT
hls-11323	196	4	dai	dai	PROPN
hls-11323	196	5	z	z	PROPN
hls-11323	196	6	,	,	PUNCT
hls-11323	196	7	mo	mo	PROPN
hls-11323	196	8	p	p	PROPN
hls-11323	196	9	,	,	PUNCT
hls-11323	196	10	et	et	PROPN
hls-11323	196	11	al	al	PROPN
hls-11323	196	12	.	.	PROPN
hls-11323	196	13	clinical	clinical	ADJ
hls-11323	196	14	characteristics	characteristic	NOUN
hls-11323	196	15	and	and	CCONJ
hls-11323	196	16	outcomes	outcome	NOUN
hls-11323	196	17	of	of	ADP
hls-11323	196	18	older	old	ADJ
hls-11323	196	19	patients	patient	NOUN
hls-11323	196	20	with	with	ADP
hls-11323	196	21	coronavirus	coronavirus	NOUN
hls-11323	196	22	disease	disease	NOUN
hls-11323	196	23	2019	2019	NUM
hls-11323	196	24	(	(	PUNCT
hls-11323	196	25	covid-19	covid-19	PROPN
hls-11323	196	26	)	)	PUNCT
hls-11323	196	27	in	in	ADP
hls-11323	196	28	wuhan	wuhan	PROPN
hls-11323	196	29	,	,	PUNCT
hls-11323	196	30	china	china	PROPN
hls-11323	196	31	:	:	PUNCT
hls-11323	196	32	a	a	DET
hls-11323	196	33	single	single	ADJ
hls-11323	196	34	-	-	PUNCT
hls-11323	196	35	centered	center	VERB
hls-11323	196	36	,	,	PUNCT
hls-11323	196	37	retrospective	retrospective	ADJ
hls-11323	196	38	study	study	NOUN
hls-11323	196	39	.	.	PUNCT
hls-11323	197	1	j	j	PROPN
hls-11323	197	2	gerontol	gerontol	VERB
hls-11323	197	3	2020;75:1788–95	2020;75:1788–95	NUM
hls-11323	197	4	.	.	PUNCT
hls-11323	198	1	10	10	NUM
hls-11323	198	2	.	.	PUNCT
hls-11323	199	1	koyyada	koyyada	PROPN
hls-11323	199	2	r	r	PROPN
hls-11323	199	3	,	,	PUNCT
hls-11323	199	4	nagalla	nagalla	NOUN
hls-11323	199	5	b	b	NOUN
hls-11323	199	6	,	,	PUNCT
hls-11323	199	7	tummala	tummala	NOUN
hls-11323	199	8	a	a	NOUN
hls-11323	199	9	,	,	PUNCT
hls-11323	199	10	et	et	PROPN
hls-11323	199	11	al	al	PROPN
hls-11323	199	12	.	.	PUNCT
hls-11323	199	13	prevalence	prevalence	NOUN
hls-11323	199	14	and	and	CCONJ
hls-11323	199	15	impact	impact	NOUN
hls-11323	199	16	of	of	ADP
hls-11323	199	17	preexisting	preexist	VERB
hls-11323	199	18	comorbidities	comorbiditie	NOUN
hls-11323	199	19	on	on	ADP
hls-11323	199	20	overall	overall	ADJ
hls-11323	199	21	clinical	clinical	ADJ
hls-11323	199	22	outcomes	outcome	NOUN
hls-11323	199	23	of	of	ADP
hls-11323	199	24	hospitalized	hospitalize	VERB
hls-11323	199	25	covid-19	covid-19	PROPN
hls-11323	199	26	patients	patient	NOUN
hls-11323	199	27	.	.	PUNCT
hls-11323	200	1	biomed	biome	VERB
hls-11323	200	2	res	re	NOUN
hls-11323	200	3	int	int	NOUN
hls-11323	200	4	2022:2349890	2022:2349890	NUM
hls-11323	200	5	.	.	PROPN
hls-11323	200	6	11	11	NUM
hls-11323	200	7	.	.	PUNCT
hls-11323	201	1	sharif	sharif	PROPN
hls-11323	201	2	n	n	CCONJ
hls-11323	201	3	,	,	PUNCT
hls-11323	201	4	opu	opu	PROPN
hls-11323	201	5	r	r	PROPN
hls-11323	201	6	,	,	PUNCT
hls-11323	201	7	ahmed	ahmed	PROPN
hls-11323	201	8	s	s	PROPN
hls-11323	201	9	,	,	PUNCT
hls-11323	201	10	et	et	PROPN
hls-11323	201	11	al	al	PROPN
hls-11323	201	12	.	.	PUNCT
hls-11323	201	13	prevalence	prevalence	NOUN
hls-11323	201	14	and	and	CCONJ
hls-11323	201	15	impact	impact	NOUN
hls-11323	201	16	of	of	ADP
hls-11323	201	17	comorbidities	comorbiditie	NOUN
hls-11323	201	18	on	on	ADP
hls-11323	201	19	disease	disease	NOUN
hls-11323	201	20	prognosis	prognosis	NOUN
hls-11323	201	21	among	among	ADP
hls-11323	201	22	patients	patient	NOUN
hls-11323	201	23	with	with	ADP
hls-11323	201	24	covid-19	covid-19	PROPN
hls-11323	201	25	in	in	ADP
hls-11323	201	26	bangladesh	bangladesh	PROPN
hls-11323	201	27	:	:	PUNCT
hls-11323	201	28	a	a	DET
hls-11323	201	29	nationwide	nationwide	ADJ
hls-11323	201	30	study	study	NOUN
hls-11323	201	31	amid	amid	ADP
hls-11323	201	32	the	the	DET
hls-11323	201	33	second	second	ADJ
hls-11323	201	34	wave	wave	NOUN
hls-11323	201	35	.	.	PUNCT
hls-11323	202	1	diabetes	diabetes	NOUN
hls-11323	202	2	metab	metab	ADJ
hls-11323	202	3	syndr	syndr	NOUN
hls-11323	202	4	2021;15:102148	2021;15:102148	NUM
hls-11323	202	5	.	.	PUNCT
hls-11323	203	1	12	12	NUM
hls-11323	203	2	.	.	PUNCT
hls-11323	203	3	foresta	foresta	PROPN
hls-11323	204	1	c	c	X
hls-11323	204	2	,	,	PUNCT
hls-11323	204	3	rocca	rocca	PROPN
hls-11323	204	4	s	s	PROPN
hls-11323	204	5	,	,	PUNCT
hls-11323	204	6	di	di	NOUN
hls-11323	204	7	nisio	nisio	PROPN
hls-11323	204	8	a.	a.	PROPN
hls-11323	204	9	gender	gender	PROPN
hls-11323	204	10	susceptibility	susceptibility	NOUN
hls-11323	204	11	to	to	ADP
hls-11323	204	12	covid-19	covid-19	PROPN
hls-11323	204	13	:	:	PUNCT
hls-11323	204	14	a	a	DET
hls-11323	204	15	review	review	NOUN
hls-11323	204	16	of	of	ADP
hls-11323	204	17	the	the	DET
hls-11323	204	18	putative	putative	ADJ
hls-11323	204	19	role	role	NOUN
hls-11323	204	20	of	of	ADP
hls-11323	204	21	sex	sex	NOUN
hls-11323	204	22	hormones	hormone	NOUN
hls-11323	204	23	and	and	CCONJ
hls-11323	204	24	x	x	NOUN
hls-11323	204	25	chromosome	chromosome	NOUN
hls-11323	204	26	.	.	PUNCT
hls-11323	205	1	j	j	PROPN
hls-11323	205	2	endocrinol	endocrinol	NOUN
hls-11323	205	3	invest	invest	VERB
hls-11323	205	4	2021;44:951–6	2021;44:951–6	NUM
hls-11323	205	5	.	.	PROPN
hls-11323	205	6	13	13	NUM
hls-11323	205	7	.	.	PUNCT
hls-11323	206	1	davies	davy	NOUN
hls-11323	206	2	g	g	PROPN
hls-11323	206	3	,	,	PUNCT
hls-11323	206	4	klepac	klepac	PROPN
hls-11323	206	5	p	p	PROPN
hls-11323	206	6	,	,	PUNCT
hls-11323	206	7	liu	liu	PROPN
hls-11323	206	8	y	y	PROPN
hls-11323	206	9	,	,	PUNCT
hls-11323	206	10	et	et	PROPN
hls-11323	206	11	al	al	PROPN
hls-11323	206	12	.	.	PUNCT
hls-11323	206	13	age	age	NOUN
hls-11323	206	14	-	-	PUNCT
hls-11323	206	15	dependent	dependent	ADJ
hls-11323	206	16	effects	effect	NOUN
hls-11323	206	17	in	in	ADP
hls-11323	206	18	the	the	DET
hls-11323	206	19	transmission	transmission	NOUN
hls-11323	206	20	and	and	CCONJ
hls-11323	206	21	control	control	NOUN
hls-11323	206	22	of	of	ADP
hls-11323	206	23	covid-19	covid-19	PROPN
hls-11323	206	24	epidemics	epidemic	NOUN
hls-11323	206	25	.	.	PUNCT
hls-11323	207	1	nature	nature	NOUN
hls-11323	207	2	med	me	VERB
hls-11323	207	3	2020;26:1205	2020;26:1205	PROPN
hls-11323	207	4	-	-	SYM
hls-11323	207	5	11	11	NUM
hls-11323	207	6	.	.	PUNCT
hls-11323	208	1	14	14	NUM
hls-11323	208	2	.	.	PUNCT
hls-11323	208	3	kalra	kalra	PROPN
hls-11323	208	4	l	l	PROPN
hls-11323	208	5	,	,	PUNCT
hls-11323	208	6	smith	smith	PROPN
hls-11323	208	7	c	c	PROPN
hls-11323	208	8	,	,	PUNCT
hls-11323	208	9	hodsoll	hodsoll	PROPN
hls-11323	208	10	j	j	PROPN
hls-11323	208	11	,	,	PUNCT
hls-11323	208	12	et	et	PROPN
hls-11323	208	13	al	al	PROPN
hls-11323	208	14	.	.	PROPN
hls-11323	208	15	elevated	elevate	VERB
hls-11323	208	16	c	c	ADJ
hls-11323	208	17	-	-	PUNCT
hls-11323	208	18	reactive	reactive	ADJ
hls-11323	208	19	protein	protein	NOUN
hls-11323	208	20	increases	increase	VERB
hls-11323	208	21	diagnostic	diagnostic	ADJ
hls-11323	208	22	accuracy	accuracy	NOUN
hls-11323	208	23	of	of	ADP
hls-11323	208	24	algorithm	algorithm	NOUN
hls-11323	208	25	-	-	PUNCT
hls-11323	208	26	defined	define	VERB
hls-11323	208	27	strokeassociated	strokeassociate	VERB
hls-11323	208	28	pneumonia	pneumonia	NOUN
hls-11323	208	29	in	in	ADP
hls-11323	208	30	afebrile	afebrile	ADJ
hls-11323	208	31	patients	patient	NOUN
hls-11323	208	32	.	.	PUNCT
hls-11323	209	1	int	int	NOUN
hls-11323	209	2	j	j	PROPN
hls-11323	209	3	stroke	stroke	NOUN
hls-11323	209	4	2019;14:167	2019;14:167	PROPN
hls-11323	209	5	-	-	SYM
hls-11323	209	6	73	73	NUM
hls-11323	209	7	.	.	PUNCT
hls-11323	209	8	15	15	NUM
hls-11323	209	9	.	.	PUNCT
hls-11323	210	1	xu	xu	PROPN
hls-11323	211	1	j	j	PROPN
hls-11323	211	2	,	,	PUNCT
hls-11323	211	3	xu	xu	PROPN
hls-11323	212	1	c	c	X
hls-11323	212	2	,	,	PUNCT
hls-11323	212	3	zhang	zhang	PROPN
hls-11323	212	4	r	r	PROPN
hls-11323	212	5	,	,	PUNCT
hls-11323	212	6	et	et	PROPN
hls-11323	212	7	al	al	PROPN
hls-11323	212	8	.	.	PROPN
hls-11323	212	9	associations	association	NOUN
hls-11323	212	10	of	of	ADP
hls-11323	212	11	procalcitonin	procalcitonin	NOUN
hls-11323	212	12	,	,	PUNCT
hls-11323	212	13	creaction	creaction	NOUN
hls-11323	212	14	protein	protein	NOUN
hls-11323	212	15	and	and	CCONJ
hls-11323	212	16	neutrophil	neutrophil	ADJ
hls-11323	212	17	-	-	PUNCT
hls-11323	212	18	to	to	ADP
hls-11323	212	19	-	-	PUNCT
hls-11323	212	20	lymphocyte	lymphocyte	ADJ
hls-11323	212	21	ratio	ratio	NOUN
hls-11323	212	22	with	with	ADP
hls-11323	212	23	mortality	mortality	NOUN
hls-11323	212	24	in	in	ADP
hls-11323	212	25	hospitalized	hospitalize	VERB
hls-11323	212	26	covid-19	covid-19	PROPN
hls-11323	212	27	patients	patient	NOUN
hls-11323	212	28	in	in	ADP
hls-11323	212	29	china	china	PROPN
hls-11323	212	30	.	.	PUNCT
hls-11323	213	1	sci	sci	PROPN
hls-11323	213	2	rep	rep	PROPN
hls-11323	213	3	2020;10:1	2020;10:1	PROPN
hls-11323	213	4	-	-	SYM
hls-11323	213	5	10	10	NUM
hls-11323	213	6	.	.	PUNCT
hls-11323	213	7	16	16	NUM
hls-11323	213	8	.	.	PUNCT
hls-11323	214	1	rosário	rosário	PROPN
hls-11323	214	2	c	c	PROPN
hls-11323	214	3	,	,	PUNCT
hls-11323	214	4	zandman	zandman	NOUN
hls-11323	214	5	-	-	PUNCT
hls-11323	214	6	goddard	goddard	NOUN
hls-11323	214	7	g	g	NOUN
hls-11323	214	8	,	,	PUNCT
hls-11323	214	9	meyron	meyron	NOUN
hls-11323	214	10	-	-	PUNCT
hls-11323	214	11	holtz	holtz	NOUN
hls-11323	214	12	g	g	NOUN
hls-11323	214	13	,	,	PUNCT
hls-11323	214	14	et	et	PROPN
hls-11323	214	15	al	al	PROPN
hls-11323	214	16	.	.	PUNCT
hls-11323	215	1	the	the	DET
hls-11323	215	2	hyperferritinemic	hyperferritinemic	ADJ
hls-11323	215	3	syndrome	syndrome	NOUN
hls-11323	215	4	:	:	PUNCT
hls-11323	215	5	macrophage	macrophage	ADJ
hls-11323	215	6	activation	activation	NOUN
hls-11323	215	7	syndrome	syndrome	NOUN
hls-11323	215	8	,	,	PUNCT
hls-11323	215	9	still	still	ADV
hls-11323	215	10	’s	’	VERB
hls-11323	215	11	disease	disease	NOUN
hls-11323	215	12	,	,	PUNCT
hls-11323	215	13	septic	septic	ADJ
hls-11323	215	14	shock	shock	NOUN
hls-11323	215	15	and	and	CCONJ
hls-11323	215	16	catastrophic	catastrophic	ADJ
hls-11323	215	17	antiphospholipid	antiphospholipid	NOUN
hls-11323	215	18	syndrome	syndrome	NOUN
hls-11323	215	19	.	.	PUNCT
hls-11323	216	1	bmc	bmc	PROPN
hls-11323	216	2	med	med	ADJ
hls-11323	216	3	2013;11:1	2013;11:1	NUM
hls-11323	216	4	-	-	SYM
hls-11323	216	5	11	11	NUM
hls-11323	216	6	.	.	PUNCT
hls-11323	217	1	17	17	NUM
hls-11323	217	2	.	.	PUNCT
hls-11323	218	1	ji	ji	PROPN
hls-11323	218	2	d	d	PROPN
hls-11323	218	3	,	,	PUNCT
hls-11323	218	4	zhang	zhang	PROPN
hls-11323	218	5	s	s	PROPN
hls-11323	218	6	,	,	PUNCT
hls-11323	218	7	chen	chen	PROPN
hls-11323	218	8	z	z	PROPN
hls-11323	218	9	,	,	PUNCT
hls-11323	218	10	et	et	PROPN
hls-11323	218	11	al	al	PROPN
hls-11323	218	12	.	.	PROPN
hls-11323	219	1	clinical	clinical	ADJ
hls-11323	219	2	characteristics	characteristic	NOUN
hls-11323	219	3	predicting	predict	VERB
hls-11323	219	4	progression	progression	NOUN
hls-11323	219	5	of	of	ADP
hls-11323	219	6	covid-19	covid-19	PROPN
hls-11323	219	7	(	(	PUNCT
hls-11323	219	8	2/17/2020	2/17/2020	NUM
hls-11323	219	9	)	)	PUNCT
hls-11323	219	10	.	.	PUNCT
hls-11323	220	1	available	available	ADJ
hls-11323	220	2	at	at	ADP
hls-11323	220	3	ssrn	ssrn	NOUN
hls-11323	220	4	3539674	3539674	NUM
hls-11323	220	5	.	.	PUNCT
hls-11323	221	1	18	18	NUM
hls-11323	221	2	.	.	PUNCT
hls-11323	222	1	hou	hou	PROPN
hls-11323	222	2	f	f	PROPN
hls-11323	222	3	,	,	PUNCT
hls-11323	222	4	yu	yu	PROPN
hls-11323	222	5	t	t	PROPN
hls-11323	222	6	,	,	PUNCT
hls-11323	222	7	du	du	PROPN
hls-11323	222	8	r	r	PROPN
hls-11323	222	9	,	,	PUNCT
hls-11323	222	10	et	et	PROPN
hls-11323	222	11	al	al	PROPN
hls-11323	222	12	.	.	PUNCT
hls-11323	223	1	clinical	clinical	ADJ
hls-11323	223	2	course	course	NOUN
hls-11323	223	3	and	and	CCONJ
hls-11323	223	4	risk	risk	NOUN
hls-11323	223	5	factors	factor	NOUN
hls-11323	223	6	for	for	ADP
hls-11323	223	7	mortality	mortality	NOUN
hls-11323	223	8	of	of	ADP
hls-11323	223	9	adult	adult	NOUN
hls-11323	223	10	inpatients	inpatient	NOUN
hls-11323	223	11	with	with	ADP
hls-11323	223	12	covid-19	covid-19	PROPN
hls-11323	223	13	in	in	ADP
hls-11323	223	14	wuhan	wuhan	PROPN
hls-11323	223	15	,	,	PUNCT
hls-11323	223	16	china	china	PROPN
hls-11323	223	17	:	:	PUNCT
hls-11323	223	18	a	a	DET
hls-11323	223	19	retrospective	retrospective	ADJ
hls-11323	223	20	cohort	cohort	NOUN
hls-11323	223	21	study	study	NOUN
hls-11323	223	22	.	.	PUNCT
hls-11323	224	1	lancet	lancet	PROPN
hls-11323	224	2	2020;395:1054–62	2020;395:1054–62	PROPN
hls-11323	224	3	.	.	PROPN
hls-11323	224	4	19	19	NUM
hls-11323	224	5	.	.	PUNCT
hls-11323	225	1	henry	henry	PROPN
hls-11323	225	2	m	m	PROPN
hls-11323	225	3	,	,	PUNCT
hls-11323	225	4	aggarwal	aggarwal	PROPN
hls-11323	225	5	g	g	PROPN
hls-11323	225	6	,	,	PUNCT
hls-11323	225	7	wong	wong	PROPN
hls-11323	225	8	j	j	PROPN
hls-11323	225	9	,	,	PUNCT
hls-11323	225	10	et	et	PROPN
hls-11323	225	11	al	al	PROPN
hls-11323	225	12	.	.	PUNCT
hls-11323	225	13	lactate	lactate	PROPN
hls-11323	225	14	dehydrogenase	dehydrogenase	NOUN
hls-11323	225	15	levels	level	NOUN
hls-11323	225	16	predict	predict	VERB
hls-11323	225	17	coronavirus	coronavirus	NOUN
hls-11323	225	18	disease	disease	NOUN
hls-11323	225	19	2019	2019	NUM
hls-11323	225	20	(	(	PUNCT
hls-11323	225	21	covid-19	covid-19	PROPN
hls-11323	225	22	)	)	PUNCT
hls-11323	225	23	severity	severity	NOUN
hls-11323	225	24	and	and	CCONJ
hls-11323	225	25	mortality	mortality	NOUN
hls-11323	225	26	:	:	PUNCT
hls-11323	225	27	a	a	DET
hls-11323	225	28	pooled	pooled	ADJ
hls-11323	225	29	analysis	analysis	NOUN
hls-11323	225	30	.	.	PUNCT
hls-11323	226	1	am	be	AUX
hls-11323	226	2	j	j	PROPN
hls-11323	226	3	emerg	emerg	PROPN
hls-11323	226	4	med	med	PROPN
hls-11323	226	5	2020;38:1722–26	2020;38:1722–26	NUM
hls-11323	226	6	.	.	PUNCT
hls-11323	227	1	20	20	NUM
hls-11323	227	2	.	.	PUNCT
hls-11323	228	1	martha	martha	PROPN
hls-11323	228	2	w	w	PROPN
hls-11323	228	3	,	,	PUNCT
hls-11323	228	4	wibowo	wibowo	PROPN
hls-11323	228	5	a	a	PRON
hls-11323	228	6	,	,	PUNCT
hls-11323	228	7	pranata	pranata	PROPN
hls-11323	228	8	r.	r.	PROPN
hls-11323	228	9	prognostic	prognostic	PROPN
hls-11323	228	10	value	value	NOUN
hls-11323	228	11	of	of	ADP
hls-11323	228	12	elevated	elevated	ADJ
hls-11323	228	13	lactate	lactate	NOUN
hls-11323	228	14	dehydrogenase	dehydrogenase	NOUN
hls-11323	228	15	in	in	ADP
hls-11323	228	16	patients	patient	NOUN
hls-11323	228	17	with	with	ADP
hls-11323	228	18	covid-19	covid-19	PROPN
hls-11323	228	19	:	:	PUNCT
hls-11323	228	20	a	a	DET
hls-11323	228	21	systematic	systematic	ADJ
hls-11323	228	22	review	review	NOUN
hls-11323	228	23	and	and	CCONJ
hls-11323	228	24	meta	meta	ADJ
hls-11323	228	25	-	-	PUNCT
hls-11323	228	26	analysis	analysis	NOUN
hls-11323	228	27	.	.	PUNCT
hls-11323	229	1	postgrad	postgrad	PROPN
hls-11323	229	2	med	med	PROPN
hls-11323	229	3	j	j	PROPN
hls-11323	229	4	2022;98:422–7	2022;98:422–7	NUM
hls-11323	229	5	.	.	PUNCT
hls-11323	230	1	21	21	NUM
hls-11323	230	2	.	.	PUNCT
hls-11323	230	3	szarpak	szarpak	PROPN
hls-11323	230	4	l	l	NOUN
hls-11323	230	5	,	,	PUNCT
hls-11323	230	6	ruetzler	ruetzler	NOUN
hls-11323	230	7	k	k	PROPN
hls-11323	230	8	,	,	PUNCT
hls-11323	230	9	safiejko	safiejko	PROPN
hls-11323	230	10	k	k	PROPN
hls-11323	230	11	,	,	PUNCT
hls-11323	230	12	et	et	PROPN
hls-11323	230	13	al	al	PROPN
hls-11323	230	14	.	.	PUNCT
hls-11323	230	15	lactate	lactate	PROPN
hls-11323	230	16	dehydrogenase	dehydrogenase	NOUN
hls-11323	230	17	level	level	NOUN
hls-11323	230	18	as	as	ADP
hls-11323	230	19	a	a	DET
hls-11323	230	20	covid-19	covid-19	PROPN
hls-11323	230	21	severity	severity	NOUN
hls-11323	230	22	marker	marker	NOUN
hls-11323	230	23	.	.	PUNCT
hls-11323	231	1	am	be	AUX
hls-11323	231	2	j	j	PROPN
hls-11323	231	3	emerg	emerg	PROPN
hls-11323	231	4	med	med	PROPN
hls-11323	231	5	2021;45:638–9	2021;45:638–9	NUM
hls-11323	231	6	.	.	PUNCT
hls-11323	232	1	22	22	NUM
hls-11323	232	2	.	.	PUNCT
hls-11323	233	1	mikacenic	mikacenic	PROPN
hls-11323	233	2	c	c	PROPN
hls-11323	233	3	,	,	PUNCT
hls-11323	233	4	hahn	hahn	PROPN
hls-11323	233	5	o	o	NOUN
hls-11323	233	6	,	,	PUNCT
hls-11323	233	7	price	price	NOUN
hls-11323	233	8	l	l	NOUN
hls-11323	233	9	,	,	PUNCT
hls-11323	233	10	et	et	PROPN
hls-11323	233	11	al	al	PROPN
hls-11323	233	12	.	.	PUNCT
hls-11323	233	13	biomarkers	biomarker	NOUN
hls-11323	233	14	of	of	ADP
hls-11323	233	15	endothelial	endothelial	ADJ
hls-11323	233	16	activation	activation	NOUN
hls-11323	233	17	are	be	AUX
hls-11323	233	18	associated	associate	VERB
hls-11323	233	19	with	with	ADP
hls-11323	233	20	poor	poor	ADJ
hls-11323	233	21	outcome	outcome	NOUN
hls-11323	233	22	in	in	ADP
hls-11323	233	23	critical	critical	ADJ
hls-11323	233	24	illness	illness	NOUN
hls-11323	233	25	.	.	PUNCT
hls-11323	234	1	plos	plos	PROPN
hls-11323	234	2	one	one	NUM
hls-11323	234	3	2015;10	2015;10	NUM
hls-11323	234	4	:	:	PUNCT
hls-11323	234	5	e0141251	e0141251	NOUN
hls-11323	234	6	.	.	PUNCT
hls-11323	235	1	23	23	NUM
hls-11323	235	2	.	.	PUNCT
hls-11323	236	1	lippi	lippi	PROPN
hls-11323	236	2	g	g	PROPN
hls-11323	236	3	,	,	PUNCT
hls-11323	236	4	favaloro	favaloro	PROPN
hls-11323	236	5	e.	e.	PROPN
hls-11323	236	6	d	d	PROPN
hls-11323	236	7	-	-	PUNCT
hls-11323	236	8	dimer	dimer	NOUN
hls-11323	236	9	is	be	AUX
hls-11323	236	10	associated	associate	VERB
hls-11323	236	11	with	with	ADP
hls-11323	236	12	severity	severity	NOUN
hls-11323	236	13	of	of	ADP
hls-11323	236	14	coronavirus	coronavirus	NOUN
hls-11323	236	15	disease	disease	NOUN
hls-11323	236	16	2019	2019	NUM
hls-11323	236	17	:	:	PUNCT
hls-11323	236	18	a	a	DET
hls-11323	236	19	pooled	pooled	ADJ
hls-11323	236	20	analysis	analysis	NOUN
hls-11323	236	21	.	.	PUNCT
hls-11323	237	1	thrombosis	thrombosis	NOUN
hls-11323	237	2	haemostasis	haemostasis	NOUN
hls-11323	237	3	2020;120:876–8	2020;120:876–8	X
hls-11323	237	4	.	.	PUNCT
hls-11323	238	1	24	24	NUM
hls-11323	238	2	.	.	PUNCT
hls-11323	239	1	wang	wang	PROPN
hls-11323	239	2	d	d	PROPN
hls-11323	239	3	,	,	PUNCT
hls-11323	239	4	hu	hu	PROPN
hls-11323	239	5	b	b	PROPN
hls-11323	239	6	,	,	PUNCT
hls-11323	239	7	hu	hu	PROPN
hls-11323	240	1	c	c	X
hls-11323	240	2	,	,	PUNCT
hls-11323	240	3	et	et	PROPN
hls-11323	240	4	al	al	PROPN
hls-11323	240	5	.	.	PROPN
hls-11323	241	1	clinical	clinical	ADJ
hls-11323	241	2	characteristics	characteristic	NOUN
hls-11323	241	3	of	of	ADP
hls-11323	241	4	138	138	NUM
hls-11323	241	5	hospitalized	hospitalize	VERB
hls-11323	241	6	patients	patient	NOUN
hls-11323	241	7	with	with	ADP
hls-11323	241	8	2019	2019	NUM
hls-11323	241	9	novel	novel	ADJ
hls-11323	241	10	coronavirus	coronavirus	NOUN
hls-11323	241	11	–	–	PUNCT
hls-11323	241	12	infected	infected	ADJ
hls-11323	241	13	pneumonia	pneumonia	NOUN
hls-11323	241	14	in	in	ADP
hls-11323	241	15	wuhan	wuhan	PROPN
hls-11323	241	16	,	,	PUNCT
hls-11323	241	17	china	china	PROPN
hls-11323	241	18	.	.	PROPN
hls-11323	242	1	jama	jama	PROPN
hls-11323	242	2	2020;323:1061	2020;323:1061	NUM
hls-11323	242	3	-	-	SYM
hls-11323	242	4	9	9	NUM
hls-11323	242	5	.	.	NUM
hls-11323	242	6	25	25	NUM
hls-11323	242	7	.	.	PUNCT
hls-11323	243	1	zhou	zhou	PROPN
hls-11323	243	2	f	f	PROPN
hls-11323	243	3	,	,	PUNCT
hls-11323	243	4	yu	yu	PROPN
hls-11323	243	5	t	t	PROPN
hls-11323	243	6	,	,	PUNCT
hls-11323	243	7	du	du	PROPN
hls-11323	243	8	r	r	PROPN
hls-11323	243	9	,	,	PUNCT
hls-11323	243	10	et	et	PROPN
hls-11323	243	11	al	al	PROPN
hls-11323	243	12	.	.	PUNCT
hls-11323	244	1	clinical	clinical	ADJ
hls-11323	244	2	course	course	NOUN
hls-11323	244	3	and	and	CCONJ
hls-11323	244	4	risk	risk	NOUN
hls-11323	244	5	factors	factor	NOUN
hls-11323	244	6	for	for	ADP
hls-11323	244	7	mortality	mortality	NOUN
hls-11323	244	8	of	of	ADP
hls-11323	244	9	adult	adult	NOUN
hls-11323	244	10	inpatients	inpatient	NOUN
hls-11323	244	11	with	with	ADP
hls-11323	244	12	covid-19	covid-19	PROPN
hls-11323	244	13	in	in	ADP
hls-11323	244	14	wuhan	wuhan	PROPN
hls-11323	244	15	,	,	PUNCT
hls-11323	244	16	china	china	PROPN
hls-11323	244	17	:	:	PUNCT
hls-11323	244	18	a	a	DET
hls-11323	244	19	retrospective	retrospective	ADJ
hls-11323	244	20	cohort	cohort	NOUN
hls-11323	244	21	study	study	NOUN
hls-11323	244	22	.	.	PUNCT
hls-11323	245	1	lancet	lancet	PROPN
hls-11323	245	2	2020;395:1054–62	2020;395:1054–62	PROPN
hls-11323	245	3	.	.	PROPN
hls-11323	245	4	26	26	NUM
hls-11323	245	5	.	.	PUNCT
hls-11323	246	1	hui	hui	PROPN
hls-11323	246	2	s	s	PROPN
hls-11323	246	3	,	,	PUNCT
hls-11323	246	4	memish	memish	VERB
hls-11323	246	5	a	a	PRON
hls-11323	246	6	,	,	PUNCT
hls-11323	246	7	zumla	zumla	NOUN
hls-11323	246	8	a.	a.	NOUN
hls-11323	246	9	severe	severe	ADJ
hls-11323	246	10	acute	acute	ADJ
hls-11323	246	11	respiratory	respiratory	ADJ
hls-11323	246	12	syndrome	syndrome	NOUN
hls-11323	246	13	vs.	vs.	ADP
hls-11323	246	14	the	the	DET
hls-11323	246	15	middle	middle	PROPN
hls-11323	246	16	east	east	PROPN
hls-11323	246	17	respiratory	respiratory	ADJ
hls-11323	246	18	syndrome	syndrome	NOUN
hls-11323	246	19	.	.	PUNCT
hls-11323	247	1	curr	curr	PROPN
hls-11323	247	2	opin	opin	NOUN
hls-11323	247	3	pulm	pulm	NOUN
hls-11323	247	4	med	me	VERB
hls-11323	247	5	2014;20:233	2014;20:233	NUM
hls-11323	247	6	-	-	PUNCT
hls-11323	247	7	41	41	NUM
hls-11323	247	8	.	.	PUNCT
hls-11323	248	1	27	27	NUM
hls-11323	248	2	.	.	PUNCT
hls-11323	249	1	chen	chen	PROPN
hls-11323	249	2	n	n	CCONJ
hls-11323	249	3	,	,	PUNCT
hls-11323	249	4	zhou	zhou	PROPN
hls-11323	249	5	m	m	PROPN
hls-11323	249	6	,	,	PUNCT
hls-11323	249	7	dong	dong	PROPN
hls-11323	249	8	x	x	PROPN
hls-11323	249	9	,	,	PUNCT
hls-11323	249	10	et	et	PROPN
hls-11323	249	11	al	al	PROPN
hls-11323	249	12	.	.	PROPN
hls-11323	249	13	epidemiological	epidemiological	ADJ
hls-11323	249	14	and	and	CCONJ
hls-11323	249	15	clinical	clinical	ADJ
hls-11323	249	16	characteristics	characteristic	NOUN
hls-11323	249	17	of	of	ADP
hls-11323	249	18	99	99	NUM
hls-11323	249	19	cases	case	NOUN
hls-11323	249	20	of	of	ADP
hls-11323	249	21	2019	2019	NUM
hls-11323	249	22	novel	novel	ADJ
hls-11323	249	23	coronavirus	coronavirus	NOUN
hls-11323	249	24	pneumonia	pneumonia	NOUN
hls-11323	249	25	in	in	ADP
hls-11323	249	26	wuhan	wuhan	PROPN
hls-11323	249	27	,	,	PUNCT
hls-11323	249	28	china	china	PROPN
hls-11323	249	29	:	:	PUNCT
hls-11323	249	30	a	a	DET
hls-11323	249	31	descriptive	descriptive	ADJ
hls-11323	249	32	study	study	NOUN
hls-11323	249	33	.	.	PUNCT
hls-11323	250	1	lancet	lancet	PROPN
hls-11323	250	2	2020;395:507–13	2020;395:507–13	PROPN
hls-11323	250	3	.	.	PUNCT
hls-11323	250	4	28	28	NUM
hls-11323	250	5	.	.	PUNCT
hls-11323	251	1	lei	lei	PROPN
hls-11323	251	2	f	f	PROPN
hls-11323	251	3	,	,	PUNCT
hls-11323	251	4	liu	liu	PROPN
hls-11323	251	5	m	m	PROPN
hls-11323	251	6	,	,	PUNCT
hls-11323	251	7	zhou	zhou	PROPN
hls-11323	251	8	f	f	PROPN
hls-11323	251	9	,	,	PUNCT
hls-11323	251	10	et	et	PROPN
hls-11323	251	11	al	al	PROPN
hls-11323	251	12	.	.	PROPN
hls-11323	251	13	longitudinal	longitudinal	PROPN
hls-11323	251	14	association	association	PROPN
hls-11323	251	15	between	between	ADP
hls-11323	251	16	markers	marker	NOUN
hls-11323	251	17	of	of	ADP
hls-11323	251	18	liver	liver	NOUN
hls-11323	251	19	injury	injury	NOUN
hls-11323	251	20	and	and	CCONJ
hls-11323	251	21	mortality	mortality	NOUN
hls-11323	251	22	in	in	ADP
hls-11323	251	23	covid-19	covid-19	PROPN
hls-11323	251	24	in	in	ADP
hls-11323	251	25	china	china	PROPN
hls-11323	251	26	.	.	PUNCT
hls-11323	252	1	hepatology	hepatology	PROPN
hls-11323	253	1	2020;72:389–98	2020;72:389–98	PRON
hls-11323	253	2	.	.	PROPN
hls-11323	254	1	29	29	NUM
hls-11323	254	2	.	.	PUNCT
hls-11323	255	1	jackson	jackson	PROPN
hls-11323	255	2	p	p	PROPN
hls-11323	255	3	,	,	PUNCT
hls-11323	255	4	darbousset	darbousset	NOUN
hls-11323	255	5	r	r	NOUN
hls-11323	255	6	,	,	PUNCT
hls-11323	255	7	schoenwaelder	schoenwaelder	PROPN
hls-11323	255	8	m.	m.	PROPN
hls-11323	255	9	thromboinflammation	thromboinflammation	PROPN
hls-11323	255	10	:	:	PUNCT
hls-11323	255	11	challenges	challenge	NOUN
hls-11323	255	12	of	of	ADP
hls-11323	255	13	therapeutically	therapeutically	ADV
hls-11323	255	14	targeting	target	VERB
hls-11323	255	15	coagulation	coagulation	NOUN
hls-11323	255	16	and	and	CCONJ
hls-11323	255	17	other	other	ADJ
hls-11323	255	18	host	host	NOUN
hls-11323	255	19	defense	defense	NOUN
hls-11323	255	20	mechanisms	mechanism	NOUN
hls-11323	255	21	.	.	PUNCT
hls-11323	256	1	blood	blood	NOUN
hls-11323	256	2	2019;133:906–18	2019;133:906–18	NUM
hls-11323	256	3	.	.	NOUN
hls-11323	256	4	30	30	NUM
hls-11323	256	5	.	.	PUNCT
hls-11323	257	1	mierzchała	mierzchała	NOUN
hls-11323	257	2	-	-	PUNCT
hls-11323	257	3	pasierb	pasierb	PROPN
hls-11323	257	4	m	m	PROPN
hls-11323	257	5	,	,	PUNCT
hls-11323	257	6	lipińska	lipińska	NOUN
hls-11323	257	7	-	-	PUNCT
hls-11323	257	8	gediga	gediga	NOUN
hls-11323	257	9	m.	m.	NOUN
hls-11323	257	10	sepsis	sepsis	NOUN
hls-11323	257	11	diagnosis	diagnosis	NOUN
hls-11323	257	12	and	and	CCONJ
hls-11323	257	13	monitoring	monitoring	NOUN
hls-11323	257	14	procalcitonin	procalcitonin	VERB
hls-11323	257	15	as	as	ADP
hls-11323	257	16	standard	standard	NOUN
hls-11323	257	17	,	,	PUNCT
hls-11323	257	18	but	but	CCONJ
hls-11323	257	19	what	what	PRON
hls-11323	257	20	next	next	ADJ
hls-11323	257	21	?	?	PUNCT
hls-11323	258	1	anaesthesiol	anaesthesiol	PROPN
hls-11323	258	2	intensive	intensive	ADJ
hls-11323	258	3	ther	ther	ADV
hls-11323	258	4	2019;51:299	2019;51:299	NOUN
hls-11323	258	5	-	-	SYM
hls-11323	258	6	305	305	NUM
hls-11323	258	7	.	.	PUNCT
hls-11323	259	1	article	article	NOUN
hls-11323	260	1	[	[	X
hls-11323	260	2	healthcare	healthcare	NOUN
hls-11323	260	3	in	in	ADP
hls-11323	260	4	low	low	ADJ
hls-11323	260	5	-	-	PUNCT
hls-11323	260	6	resource	resource	NOUN
hls-11323	260	7	settings	setting	NOUN
hls-11323	260	8	2023	2023	NUM
hls-11323	260	9	;	;	PUNCT
hls-11323	260	10	11(s2):11323	11(s2):11323	NUM
hls-11323	260	11	]	]	PUNCT
hls-11323	261	1	[	[	X
hls-11323	261	2	page	page	NOUN
hls-11323	261	3	7	7	NUM
hls-11323	261	4	]	]	X
hls-11323	261	5	non	non	ADJ
hls-11323	261	6	-co	-co	PROPN
hls-11323	261	7	mmerc	mmerc	PROPN
hls-11323	261	8	ial	ial	PROPN
hls-11323	261	9	us	us	PROPN
hls-11323	261	10	e	e	NOUN
hls-11323	261	11	o	o	NOUN
hls-11323	261	12	nly	nly	ADV